10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

FORM 10-K

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)

 OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended January 2, 2021

OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ........... to ...........

Commission file number 1-10245

RCM TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in its Charter)

Nevada		95--1480559
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)
2500 McClellan Avenue, Suite 350, Pennsauken, New Jersey		08109-4613
(Address of Principal Executive Offices)		(Zip Code)
Registrant's telephone number, including area code:		(856) 356-4500
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class	Trading Symbol	Name of Each Exchange on Which Registered
Common Stock, par value $0.05 per share	RCMT	The NASDAQ Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act:		None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  YES [   ]   NO [X]

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  YES [   ]   NO [X]

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  YES [X]   NO [   ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  YES [X]   NO [   ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company.  (See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act).  (Check one):

Large Accelerated Filer [   ]	Accelerated Filer [   ]	Non-Accelerated Filer [X]	Smaller Reporting Company [X]
			Emerging Growth Company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [   ]

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  [   ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

YES [   ]   NO [X]

The aggregate market value of the voting stock held by non-affiliates of the registrant was approximately $9.6 million based upon the closing price of $1.33 per share of the registrant’s common stock on June 27, 2020 on The NASDAQ Global Market.  For purposes of making this calculation only, the registrant included all directors, executive officers and beneficial owners of more than 5% of the Common Stock of the Company as affiliates.

The number of shares of registrant’s common stock (par value $0.05 per share) outstanding as of April 1, 2021:  11,485,310. 

Documents Incorporated by Reference

Portions of the definitive proxy statement for the registrant’s 2021 Annual Meeting of Stockholders (the “2021 Proxy Statement”) are incorporated by reference into Items 10, 11, 12, 13 and 14 in Part III of this Annual Report on Form 10-K.  If the 2021 Proxy Statement is not filed by May 3, 2021 (the first business day following the day that is 120 days after the last day of the registrant’s 2020 fiscal year), an amendment to this annual report on Form 10-K setting forth this information will be duly filed with the Securities and Exchange Commission.

RCM TECHNOLOGIES, INC.

FORM 10-K

TABLE OF CONTENTS

PART I			1
	Item 1.	Business	2
	Item 1A.	Risk Factors	14
	Item 1B.	Unresolved Staff Comments	20
	Item 2.	Properties	20
	Item 3.	Legal Proceedings	21
	Item 4.	Mine Safety Disclosures	21
PART II			22
	Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	22
	Item 6.	Selected Financial Data	22
	Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
	Item 7A.	Quantitative and Qualitative Disclosures about Market Risk	43
	Item 8.	Financial Statements and Supplementary Data	43
	Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	43
	Item 9A.	Controls and Procedures	44
	Item 9B.	Other Information	45
PART III			46
	Item 10.	Directors, Executive Officers and Corporate Governance	46
	Item 11.	Executive Compensation	46
	Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	46
	Item 13.	Certain Relationships and Related Transactions, and Director Independence	46
	Item 14.	Principal Accountant Fees and Services	46
PART IV			47
	Item 15.	Exhibits and Financial Statement Schedules	47
	Item 16.	Form 10-K Summary	49
	Signatures		50

PART I

Private Securities Litigation Reform Act Safe Harbor Statement

Certain statements included herein and in other reports and public filings made by RCM Technologies, Inc. (“RCM” or the “Company”) are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include, without limitation, statements regarding the adoption by businesses of new technology solutions; the use by businesses of outsourced solutions, such as those offered by the Company, in connection with such adoption; the Company’s strategic and business initiatives and growth strategies; and the outcome of litigation (at both the trial and appellate levels) and arbitrations, or other business disputes, involving the Company.  Readers are cautioned that such forward-looking statements, as well as others made by the Company, which may be identified by words such as “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” “believe,” and similar expressions, are only predictions and are subject to risks and uncertainties that could cause the Company’s actual results and financial position to differ materially from such statements.  Such risks and uncertainties include, without limitation:  (i) unemployment and general economic conditions affecting the provision of information technology and engineering services and solutions and the placement of temporary staffing personnel; (ii) the effects of the COVID-19 pandemic; (iii) the Company’s ability to continue to attract, train and retain personnel qualified to meet the requirements of its clients; (iv) the Company’s ability to identify appropriate acquisition candidates, complete such acquisitions and successfully integrate acquired businesses; (v) the Company’s relationships with and reliance upon significant customers, and ability to collect accounts receivable from such customers; (vi) risks associated with foreign currency fluctuations and changes in exchange rates, particularly with respect to the Canadian dollar; (vii) uncertainties regarding amounts of deferred consideration and earnout payments to become payable to former shareholders of acquired businesses; (viii) the adverse effect a potential decrease in the trading price of the Company’s common stock would have upon the Company’s ability to acquire businesses through the issuance of its securities; (ix) the Company’s ability to obtain financing on satisfactory terms; (x) the reliance of the Company upon the continued service of its executive officers; (xi) the Company’s ability to remain competitive in the markets that it serves; (xii) the Company’s ability to maintain its unemployment insurance premiums and workers compensation premiums; (xiii) the risk of claims being made against the Company associated with providing temporary staffing services; (xiv) the Company’s ability to manage significant amounts of information and periodically expand and upgrade its information processing capabilities; (xv) the risk of cyber attacks on our information technology systems or those of our third party vendors; (xvi) the Company’s ability to remain in compliance with federal and state wage and hour laws and regulations; (xvii) uncertainties in predictions as to the future need for the Company’s services; (xviii) uncertainties relating to the allocation of costs and expenses to each of the Company’s operating segments; (ixx) the costs of conducting and the outcome of litigation, arbitrations and other business disputes involving the Company, and the applicability of insurance coverage with respect to any such litigation; (xx) the results of, and costs relating to, any interactions with shareholders of the Company who may pursue specific initiatives with respect to the Company’s governance and strategic direction, including without limitation a contested proxy solicitation initiated by such shareholders, or any similar such interactions; and (xxi) other economic, competitive, health and governmental factors affecting the Company’s operations, markets, products and services.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.  Except as required by law, the Company undertakes no obligation to publicly release the results of any revision of these forward-looking statements to reflect these trends or circumstances after the date they are made or to reflect the occurrence of unanticipated events.

1

ITEM 1.  BUSINESS

General

RCM Technologies, Inc. is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. The Company provides these services through the deployment of advanced engineering, specialty health care and information technology services.  For over 40 years, the Company has developed and assembled an attractive, diverse and extensive portfolio of capabilities, service offerings and delivery options.  This combination, paired with RCM’s efficient pricing structure, offers clients a compelling value proposition.

RCM consists of three operating segments: Engineering, Specialty Health Care and Information Technology Services.

• The Engineering segment provides a comprehensive portfolio of engineering and design services across three verticals: (1) Energy Services, (2) Process & Industrial and (3) Aerospace. The segment also offers a complementary suite of services to augment its engineering portfolio, including design and supply of high-quality engineered process solutions and equipment, technical writing and digital documentation across marine, locomotive, transportation and aerospace markets, and engineering, procurement and construction management (“EPC”), as well as demand side management/energy conservation services.

• The Specialty Health Care segment provides staffing solutions of health care professionals, primarily health information management professionals, nurses, paraprofessionals, physicians and various therapists.  The segment also provides Teletherapy services targeting the education sector with an emphasis on behavioral health.

• The Information Technology, or IT, segment provides enterprise business solutions, application services, infrastructure solutions, life sciences solutions and other vertical-specific offerings.

The Company services some of the largest national and international companies in North America as well as a lengthy roster of Fortune 1000 and mid-sized businesses in such industries as Aerospace/Defense, Educational Institutions, Energy, Financial Services, Health Care, Life Sciences, Manufacturing & Distribution, the Public Sector and Technology.  RCM sells and delivers its services through a network of approximately 26 offices in selected regions throughout North America and Serbia.

During the fiscal year ended January 2, 2021, approximately 38.4% of RCM’s total revenues were derived from Engineering services, 40.2% from Specialty Health Care services, and the remaining 21.4% from IT services.

Impact of COVID-19

As discussed in more detail below under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II, Item 7 of this Form 10-K, the COVID-19 pandemic has had a substantial impact on our business, particularly in our Specialty Health Care segment, where it impacted the schools where many of the Company’s personnel work.

Industry Overview

Businesses today face intense competition, the challenge of constant technological change and the ongoing need for business process optimization.  To address these issues and to compete more effectively, companies are continually evaluating the need for implementing innovative solutions to upgrade their systems, applications and processes.  As a result, the ability of an organization to integrate and align advanced technologies with new business objectives is critical.

2

ITEM 1.  BUSINESS (CONTINUED)

Industry Overview (Continued)

The Company’s Engineering group remains focused on areas of growth, primarily within the electric power, aerospace, marine and transportation, commercial and industrial, oil and gas, as well as biofuel industries. Given the current composition of its customer base, the Engineering group’s performance is well balanced between its three segments.   In recent years, many electric utilities have prioritized transitioning their power generation assets to cleaner sources of energy. Much of this transformation is being driven by investments in renewable energy. The Energy Information Administration (“EIA”) estimates that 38% of the United States’ electric generation capacity will be comprised of wind and solar assets by 2050. This expansion will require extensive investment in the nation’s transmission infrastructure to interconnect these renewable resources to the energy grid. According to a 2020 study conducted by Princeton University’s Andlinger Center for Energy and the Environment, existing high voltage transmission capacity will need to triple by 2050 and require an additional $2.4 trillion in investment to connect wind and solar generation assets to the broader energy grid. Projects of this scale will require engineering and design expertise, as well as the utilization of EPC services.  The process & industrial group has also seen growth as global industries retool and pivot their platforms to assist in the fight against COVID-19.  As an example, the demand for sanitizers has increased substantially.  This growth and anticipated future growth has led manufacturers to lean on engineering services firms and equipment suppliers to assist them in scaling their production efforts to meet global demand.

In the health care services industry, a shortage of nurses and other medical personnel in the United States has led to increases in business activity for health care service companies, including the Company’s Specialty Health Care group.  Due in part to an aging population and improved medical technology, the demand for selected health care professionals is expected to continue over the next several years, with an emphasis on leveraging technology to expand access to care. The increased adoption of telemedicine, an area in which the Specialty Health Care group has developed new service offerings, is a primary example.  In addition, public educational institutions are outsourcing their requirements for school nurses, therapists and paraprofessionals to lower their costs and it is expected that this will continue and grow. Each of these dynamics have been exacerbated by COVID-19. The pandemic has also altered patterns in health care delivery, with newer delivery models gaining traction, namely telemedicine. Given federal and state regulatory changes as well as private insurer reimbursement methods, utilization of telemedicine services increased significantly. Data from the Center for Disease Control and Prevention (“CDC”) showed a 50% increase in telehealth visits in the first quarter of 2020, and represents 30% of weekly health center visits. As the COVID-19 pandemic continues, CDC researchers stated that maintaining the expansion of telehealth remains critical to providing access to care. Annual telehealth revenues totaled $3 billion in 2019 within the United States. It is expected the total addressable market opportunity will continue to expand and grow. Expanding access to behavioral health and mental well-being is also a priority for public health officials. Compared with 2019, the CDC stated the proportion of children’s mental health-related emergency department visits increased by 24% and 31% for children aged 5-11 and 12-17, respectively. Increasing and maintaining access to proper care remains a top priority and the market opportunity for these services is expected to continue to grow.

Companies must integrate and manage computing environments consisting of multiple computing platforms, operating systems, databases and networking protocols and off-the-shelf software applications to support business objectives.  Companies also need to keep pace with new technology developments, which often rapidly render existing equipment and internal skills obsolete.  At the same time, varied factors have caused many organizations to focus on core competencies and trim workforces in the IT management area.  Accordingly, these organizations often lack the quantity, quality and variety of IT skills necessary to design and support IT solutions.  IT managers are charged with supporting increasingly complex systems and applications of significant strategic value, while working under budgetary, personnel and expertise constraints within their own organizations.

The Company believes its target market for IT services is among middle-market companies, which typically lack the time and technical resources to satisfy all of their IT needs internally.  These companies commonly require sophisticated, experienced IT assistance to achieve their business objectives and often rely on IT service providers to help implement and manage their systems.  RCM is structured to provide middle-market companies a single source for their IT needs.

3

ITEM 1.  BUSINESS (CONTINUED)

Business Strategy

RCM is dedicated to providing solutions to meet its clients’ business needs by delivering engineering, specialty health care and information technology services.  The Company’s objective is to remain a recognized leader of specialized professional staffing, consulting services and solutions in major markets throughout North America.  The Company adapts operating strategies to achieve this objective.  The following is a discussion of the key elements of its growth and operating strategies:

Growth Strategy

Promote Full Life Cycle Solution Capability

The Company promotes a full life cycle solution capability to its customers.  The goal of the full life cycle solution strategy is to fully address a client’s project implementation cycle at each stage of its development and deployment.  This entails the Company working with its clients from the initial conceptualization of a project through its design and project execution, and extending into ongoing management and support of the delivered product.  RCM’s strategy is to build projects and solutions offerings selectively, utilizing its extensive resource base.

The Company believes that the effective execution of this strategy will generate improved margins on its existing resources.  The completion of this service-offering continuum is intended to afford the Company the opportunity to strengthen long-term client relationships that will further contribute to a more predictable revenue stream.

In addition to a full life cycle solution offering, the Company continues to focus on transitioning into higher value oriented services in an effort to increase its margins on its various service lines and generate revenue that is more sustainable.  The Company believes this transition is accomplished by pursuing additional vertical market specific solutions in conjunction or combination with longer-term based solutions, through expansion of its client relationships and by pursuing strategic alliances and partnerships.

Achieve Internal Growth

The Company continues to promote its internal growth strategies which it designed to better serve the Company’s customers, generate higher revenue and achieve greater operating efficiencies.  Every division of the Company continuously focuses on services and client diversification.  Business units are collaborating on penetrating and servicing accounts as sales teams are increasing their activity levels.  This enables clients to be supported by specialists in their areas of need while RCM productivity increases.

RCM provides an orientation program in which sales managers and professionals receive relevant information about Company operations.

RCM has adopted an industry-centric approach to sales and marketing.  This initiative contemplates that clients within the same industry sectors tend to have common business challenges.  It therefore allows the Company to present and deliver enhanced value to those clients in the vertical markets in which RCM has assembled the greatest work experience. RCM’s consultants continue to acquire project experience that offers differentiated awareness of the business challenges that clients in that industry are facing.  This alignment also facilitates and creates additional cross-selling opportunities.  The Company believes this strategy will lead to greater account penetration and enhanced client relationships.

Operational strategies contributing to RCM’s internal productivity include the delineation of certain new solutions practice areas in markets where its clients had historically known the Company as a contract service provider.  The formation of these practice areas facilitates the flow of project opportunities and the delivery of project-based solutions.

4

ITEM 1.  BUSINESS (CONTINUED)

Growth Strategy (Continued)

Pursue Selective Strategic Acquisitions

The industries in which the Company operates continues to be highly fragmented, and the Company plans to continue to selectively assess opportunities to make strategic acquisitions as such opportunities are presented to the Company. The Company's acquisition strategy is designed to broaden the scope of services and technical competencies and grow its full life cycle solution capabilities.  In considering acquisition opportunities, the Company focuses principally on companies with (i) technologies or market segments RCM has targeted for strategic value enhancement, (ii) margins that are accretive to existing margins, (iii) experienced management personnel, (iv) substantial growth prospects and (v) sellers who desire to join the Company’s management team.  To retain and provide incentives for management of its acquired companies, the Company has generally structured a significant portion of the acquisition price in the form of multi-tiered consideration based on growth of operating profitability of the acquired company over a two to four year period.

Operating Strategy

Develop and Maintain Strong Customer Relationships

The Company seeks to develop and maintain strong interactive customer relationships by anticipating and focusing on its customers’ needs.  The Company emphasizes a relationship-oriented approach to business, rather than the transaction or assignment-oriented approach that the Company believes is used by many of its competitors.  This industry-centric strategy is designed to allow RCM to expand further its relationships with clients in RCM’s targeted sectors.

To develop close customer relationships, the Company’s practice managers and/or sales people regularly meet with both existing and prospective clients to identify areas of need and help design solutions and identify the resources needed to execute their strategies.  The Company’s managers also maintain close communications with their customers during each project and on an ongoing basis after its completion.  The Company believes that this relationship-oriented approach can result in greater customer satisfaction.  Additionally, the Company believes that by collaborating with its customers in designing business solutions, it can generate new opportunities to cross-sell additional services that the Company has to offer.  The Company focuses on providing customers with qualified individuals or teams of experts compatible with the business needs of its customers and makes a concerted effort to follow the progress of such relationships to ensure their continued success.

Attract and Retain Highly Qualified Consultants and Technical Resources

The Company believes it has been successful in attracting and retaining highly qualified consultants and contractors by (i) providing stimulating and challenging work assignments, (ii) offering competitive wages, (iii) effectively communicating with its candidates, (iv) providing selective training to maintain and upgrade skills and (v) aligning the needs of its customers with appropriately skilled personnel.  The Company believes it has been successful in retaining these personnel due in part to its use of practice managers who are dedicated to maintaining contact with, and monitoring the satisfaction levels of, the Company’s consultants and contractors while they are on assignment.

5

ITEM 1.  BUSINESS (CONTINUED)

Engineering

RCM provides a full range of Engineering services including Project Management Engineering & Design, Engineering Analysis, Engineer-Procure-Construct, Configuration Management, Hardware/Software Validation & Verification, Quality Assurance, Technical Writing & Publications, Manufacturing Process Planning & Improvement and 3D/BIM Integrated Design.  Engineering services are provided at the site of the client or at the Company’s own facilities.

The Company’s Engineering segment consists of three business units – Energy Services, Aerospace Services and Process and Industrial Services.

• Energy Services: Provides solutions to the utility industry, including power generation and transmission and distribution. The group also specializes in projects in the nuclear industry, with experience that encompasses multi-disciplined engineering and design services as well as providing technical support during design, construction and plant operational phases. The Company believes that the deregulation of the utilities industry and the aging of nuclear power plants offer the Company an opportunity to capture a greater share of professional services and project management requirements of the utilities industry. Electric utilities have prioritized transitioning their power generation assets to cleaner sources of energy. This expansion requires large-scale investment in the nation’s transmission infrastructure to interconnect these renewable resources to the energy grid.

• Aerospace Services: Provides engineering and technical services to the aerospace & defense industry. According to the Congressional Budget Office (“CBO”), the Department of Defense plans to spend over $1 trillion in procurement-related aviation expenditures over the next three decades. Given RCM’s customer account relationships with several of the largest defense prime contractors, the Company believes there is ample opportunity for engineering services and technical publication work, including production and procurement engineering services as well as the need for sustainment and development program publication services.

• Process and Industrial Services: Provides engineering services to the industrial, chemical, commercial and oil and gas industries in the United States, Europe and Canada. As the world’s industrial output rebounds from 2020’s pandemic-related weakness, the Company believes it is positioned well to take advantage. With many companies in the chemical industry reprioritizing spending towards decarbonization technologies, many US chemical companies are expected to place an emphasis on renewable feedstocks and new carbon recycling technologies. The Company believes its process engineering services can play a vital role across this multibillion-dollar opportunity.

The Company provides its engineering services through a number of delivery methods.  These include managed tasks and resources, complete project services, outsourcing, both on and off-site, and a full complement of resourcing alternatives.

As of January 2, 2021, the Company assigned approximately 370 engineering and technical personnel to its customers.

6

ITEM 1.  BUSINESS (CONTINUED)

Specialty Health Care

The Company’s Specialty Health Care Group specializes in long-term and short-term staffing as well as executive search and placement solutions for many of the largest healthcare institutions and school districts across the United States. The segment’s portfolio of services includes, but is not limited to, the following fields:

• Allied and Therapy Staffing: Specializes in recruiting outstanding professionals across the health care industry. Our allied health care professionals and therapists work in schools, health systems, hospitals, nursing homes, and rehabilitation facilities.

• Correctional Healthcare Staffing: Staffing services for local, state and federal correctional facilities and provide screening, onboarding, and employee assessments as well as employee and inmate vaccination and treatment services.

• Health Information Management: Provide healthcare organizations with experienced medical coding professionals that manage staffing shortages, backlogs, vacation coverage and long-term coding support.

• Nursing Services: Provides nurse placement and staffing services in healthcare facilities, schools, hospitals and correctional facilities.

• Physicians and Advanced Practice: Our national locum tenens (temporary practitioner) practice specializes in placing physicians, physician assistants and nurse practitioners.

• School Services: Provides full-time and part-time nurse employment services for school districts across the country. The Company also offers other health care professionals to perform school evaluations and treat students, including occupational and physical therapists, speech and language pathologists, as well as special education support services and registered behavioral technicians to support students’ individualized education plan and behavioral health needs.

• Telepractice: RCM’s teletherapy solution is an evidence-based service delivery option for students to receive Special Education services such as Speech-Language Therapy, Occupational Therapy, Physical Therapy, Behavioral and Mental Health services and other healthcare services through an online platform.

As the COVID-19 pandemic has demonstrated, maintaining the utilization of telemedicine remains critical to providing necessary access to care. Expanding access to behavioral health and mental wellness services is also a priority for many public health officials. Compared with 2019, the CDC stated that children’s mental health-related emergency department visits increased by 24% and 31% for children aged 5-11 and 12-17, respectively. The Company’s School Services and Telepractice offerings are well positioned to provide solutions in these areas of priority as the market opportunity for these services is expected to continue to grow.

As of January 2, 2021, the Company assigned approximately 1,460 specialty health care services personnel to its customers.

7

ITEM 1.  BUSINESS (CONTINUED)

Information Technology

The Company’s IT segment is an integrated group of business units providing staff supplementation services and project solutions with physical locations in the United States, Canada and Puerto Rico primarily supporting Financial, Technical, Manufacturing, Life Sciences and Distribution applications.  Specialization in project solutions include, but are not limited to, the following areas:

• Life Sciences: Specializes in providing innovative options to pharmaceutical, medical device and biotechnology companies in need of guidance, support or remediation of quality, compliance or business challenges. The group assists in staffing, solution planning and remediation needs in the areas of automation, compliance, data analytics, technical quality assurance and management, and validation and verification.

• IT Services & Solutions: Global provider of business and technology solutions designed to improve the operational performance of our clients. Specialties include software development, infrastructure services, and managed IT solutions.  The Company has a 40-year history of providing qualified IT candidates to customers in a timely and cost-effective manner to address their specific business needs. The Company offers scalable solutions that can provide emerging growth companies with a single qualified resource or an entire project team along with RCM’s project management oversight to Fortune 100 clients.

RCM’s sector knowledge coupled with technical and business process experience enable the Company to provide strategic planning, project execution and management and support services throughout the entire project life cycle.  RCM has successfully completed multimillion-dollar projects in a variety of industry verticals using time-tested methodologies that manage strict budgets, timelines and quality metrics.

The Company believes that its ability to deliver information technology solutions across a wide range of technical platforms provides an important competitive advantage.  RCM ensures that its consultants have the expertise and skills needed to keep pace with rapidly evolving information technologies.  The Company’s strategy is to maintain expertise and acquire knowledge in multiple technologies so it can offer its clients non-biased technology solutions best suited to their business needs.

The Company provides its IT services through a number of flexible delivery methods.  These include management consulting engagements, project management of client efforts, project implementation of client initiatives, outsourcing, both on and off site, and a full complement of resourcing alternatives.

As of January 2, 2021, the Company assigned approximately 230 information technology personnel to its customers.

8

ITEM 1.  BUSINESS (CONTINUED)

Branch Offices

The Company’s organization consists of 26 branch offices located in the United States, Canada, Puerto Rico and Serbia.  The locations and services of each of the branch offices are set forth in the table below.

LOCATION		NUMBER OF OFFICES	SERVICES PROVIDED(1)
UNITED STATES
	California	2	HC
	Connecticut	1	E
	Florida	1	HC
	Hawaii	1	HC
	Illinois	1	HC
	Maryland	1	IT
	Massachusetts	1	IT
	New Jersey	3	E, IT
	New York	4	E, HC, IT
	Pennsylvania	1	E
	Rhode Island	1	E
	Tennessee	1	HC
		18
CANADA		4	E, IT
PUERTO RICO		1	E, IT
SERBIA		3	E, IT

(1) Services provided are abbreviated as follows:

E     - Engineering

HC  - Specialty Health Care

IT    - Information Technology

The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Serbia.

From its headquarters locations in New Jersey, the Company provides its branch offices with centralized administrative, marketing, finance, MIS, human resources and legal support.  Centralized administrative functions minimize the administrative burdens on branch office managers and allow them to spend more time focusing on sales and marketing and practice development activities.

Branch offices are primarily located in markets that the Company believes have strong growth prospects for the Company’s services.  The Company’s branches are operated in a decentralized, entrepreneurial manner with most offices operating as independent profit centers.

9

ITEM 1.  BUSINESS (CONTINUED)

Sales and Marketing

Sales and marketing efforts are conducted at the local and national level through the Company’s network of branch offices.  Sales activities and productivity are tracked and rankings established and published.  Sales between business units are recognized and financially encouraged.  The Company emphasizes long-term personal relationships with customers that are developed through regular assessment of customer requirements and proactive monitoring of service performance.  The Company’s sales personnel make regular visits to existing and prospective customers.  New customers are obtained through active sales programs and referrals.  The Company encourages its employees to participate in national and regional trade associations, local chambers of commerce and other civic associations.  The Company seeks to develop strategic partnering relationships with its customers by providing comprehensive solutions for all aspects of a customer’s engineering, information technology and other professional services needs.  The Company concentrates on providing carefully screened professionals with the appropriate skills in a timely manner and at competitive prices.  The Company regularly monitors the quality of the services provided by its personnel and obtains feedback from its customers as to their satisfaction with the services provided.

The Company serves Fortune 1000 companies and many middle market clients.  The Company’s relationships with these customers are typically formed at the customers’ local or regional level and from time to time, when appropriate, at the corporate level for national accounts.

The Company’s larger recognizable customers include:

Engineering Services	Health Care Services	Life Sciences & IT Services
Al-Corn Clean Fuel American Electric Power Bruce Power Con Edison Covanta Eversource Energy Exelon First Energy Hamilton Sundstrand HICO America Lockheed Martin Ontario Power Generation Pratt and Whitney Praxair Sikorsky Aircraft United Technologies Corporation Verizon WE Energies	AMN Healthcare Aya Healthcare Chicago Public Schools Cross Country Hawaii Department of Education New York City Board of Education Right Sourcing San Bernardino County Thera Dynamic Physical Therapy	ADP Amgen Bayada Bimbo Bakeries Bruckner Supply Company FlightSafety International Ginkgo Bioworks Johnson and Johnson Kronos Lily del Caribe Patheon Pfizer Regeneron Pharmaceuticals Triverus Consulting United Health Group Western Alliance Bank

Key Customers

The Company has established long-term relationships with many of its customers across each of its business segments. RCM’s emphasis on client retention has resulted in repeat business from many of its largest strategic accounts. During the fiscal year ended January 2, 2021, New York City Board of Education represented 10.6% of the Company’s revenues.  No other client accounted for 10% or more of total revenues during the year.   The Company’s five, ten and twenty largest customers accounted for approximately 33.4%, 46.6% and 60.7%, respectively, of the Company’s revenues for the fiscal year ended January 2, 2021.

10

ITEM 1.  BUSINESS (CONTINUED)

Other Information

Safeguards - Business, Disaster and Contingency Planning

RCM has implemented a number of safeguards to protect the Company from various system-related risks including Redundant Telecommunications and server systems architecture, multi-tiered server and desktop backup infrastructure, and data center physical and environmental controls.  In addition, RCM has developed disaster recovery / business continuity procedures for all offices.

Given the significant amount of data generated in the Company’s key processes including recruiting, sales, payroll and customer invoicing, RCM has established redundant procedures, functioning on a daily basis, within the Company’s primary data center, which is a third-party Internet Data Center (“IDC”).  This redundancy should mitigate the risks related to hardware, application and data loss by utilizing the concept of live differential backups of servers and desktops to Storage Area Network (SAN) devices on its backup LAN, culminating in offsite tape storage at an independent facility. Controls within the data center environment ensure that all systems are proactively monitored and data is properly archived.

Additionally, RCM has contracted and brokered strategic relationships with third-party vendors to meet its recovery objectives in the event of a system disruption.  For example, comprehensive service level agreements for RCM’s data circuits and network devices guarantee minimal outages as well as network redundancy and scalability.

The Company’s ability to protect its data assets against damage from fire, power loss, telecommunications failures, and facility violations is critical.  To address potential cyber security threats, the Company uses a third-party mail management service to filter all emails destined for the RCMT domain before being delivered to the corporate mail servers. The service has also been deployed to safeguard the enterprise from malicious internet content. The deployment of virus, spam, and patch management controls extends from the perimeter network to all desktops and is centrally monitored and managed.  In addition to the virus and malware controls, an Intrusion Protection System (IPS) monitors and alerts on changes in network traffic patterns as well as known hostile signatures.

The Company maintains a disaster recovery plan that outlines the recovery time / point objectives (RTO / RPO), organization structure, roles and procedures, including site addendum disaster plans for all of its key operating offices.  Corporate IT personnel regulate the maintenance and integrity of backed-up data throughout the Company.

The IDC provides RCM with a robust data center environment with redundant HVAC, commercial power feeds, ten 2000kW diesel generator sets with five 10,000-gallon, above-ground fuel oil storage tanks to provide standby power and dry pipe fire suppression.  In addition, the IDC provides 24x7 security staffing, closed-circuit monitors, secure-card key access, biometrics scanners, man traps, and alarmed doors.  

11

ITEM 1.  BUSINESS (CONTINUED)

Competition

The market for engineering and IT services is highly competitive and is subject to rapid change.  As the market demand has shifted, many software companies have adopted tactics to pursue services and consulting offerings making them direct competitors when in the past they may have been alliance partners.  Primary competitors include participants from a variety of market segments, including publicly and privately held firms, systems consulting and implementation firms, application software firms, service groups of computer equipment companies, facilities management companies, general management consulting firms and staffing companies.  In addition, the Company competes with its clients’ internal resources, particularly where these resources represent a fixed cost to the client.  Such competition may impose additional pricing pressures on the Company.

The Company believes its principal competitive advantages in the engineering and IT services market include: strong relationships with existing clients, a long-term track record with over 1,000 clients, a broad range of services, technical expertise, knowledge and experience in multiple industry sectors, quality and flexibility of service, responsiveness to client needs and speed in delivering IT solutions.

Additionally, the Company competes for suitable acquisition candidates based on its differentiated acquisition model, its entrepreneurial and decentralized operating philosophy, and its strong corporate-level support and resources.

Seasonality

The Company’s operating results can be affected by the seasonal fluctuations in client expenditures.  Expenditures in the Engineering and Information Technology segments can be negatively impacted during the first quarter of the year when clients are finalizing their budgets.  Quarterly results generally fluctuate depending on, among other things, the number of billing days in a quarter and the seasonality of clients’ businesses. The business is also affected by the timing of holidays and seasonal vacation patterns, generally resulting in lower revenues and gross profit in the fourth quarter of each year, not considering any non-seasonal impact. Extreme weather conditions may also affect demand in the first and fourth quarters of the year as certain clients’ facilities are located in geographic areas subject to closure or reduced hours due to inclement weather.  The Company generally experiences an increase in its cost of sales and a corresponding decrease in gross profit and gross margin percentage in the first and second fiscal quarters of each year as a result of resetting certain state and federal employment tax rates and related salary limitations.  Also, the Company’s Specialty Health Care segment typically experiences a significant decline in revenues due to the substantial closure of one of its largest customers, the New York City Department of Education, and other educational institution clients during the third quarter due to their summer recess.

Government Regulations

The Company is a consulting firm and employment service provider and  is generally subject to one or more of the following types of government regulation: (1) regulation of the employer/employee relationship between a firm and its employees, including tax withholding or reporting, social security or retirement, benefits, workplace compliance, wage and hour, anti-discrimination, immigration and workers’ compensation, (2) registration, licensing, record keeping and reporting requirements, and (3) federal contractor compliance.  The Company believes it is in material compliance with all employee related statutes.

12

ITEM 1.  BUSINESS (CONTINUED)

Intellectual Property

Management believes the RCM Technologies, Inc. name is extremely valuable and important to its business. The Company endeavors to protect its intellectual property rights and maintain certain trademarks, trade names, service marks and other intellectual property rights, including The Source of Smart Solutions®.  The Company is not currently aware of any infringing uses or other conditions that would be reasonably likely to materially and adversely affect the Company’s use of its proprietary rights.

Workforce

As of January 2, 2021, the Company employed an administrative, sales, recruiting and management staff of approximately 215 people, including licensed engineers and certified IT specialists who, from time to time, participate in engineering design and IT projects undertaken by the Company.  As of January 2, 2021, there were approximately 370 engineering and technical personnel, 1,460 specialty health care services personnel and 230 information technology personnel assigned by the Company to work on client projects or assignments for various periods.  None of the Company’s employees are party to a collective bargaining agreement.

Access to Company Information

The Company is a Nevada corporation organized in 1971.  The address of its principal executive office is 2500 McClellan Avenue, Suite 350, Pennsauken, NJ  08109-4613.

RCM electronically files its annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and all amendments to those reports with the Securities and Exchange Commission (“SEC”).  The SEC maintains an Internet site (http://www.sec.gov) that contains reports, proxies, information statements, and other information regarding issuers that file electronically.

RCM makes available on its website or by responding free of charge to requests addressed to the Company’s Corporate Secretary, its annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and all amendments to those reports filed by the Company with the SEC pursuant to Sections 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended.  These reports are available as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC.  The Company’s website is http://www.rcmt.com.  The information contained on the Company’s website, or on other websites linked to the Company’s website, is not part of this document.  Reference herein to the Company’s website is an inactive text reference only.

RCM has adopted a Code of Conduct applicable to all of its directors, officers and employees. In addition, the Company has adopted a Code of Ethics, within the meaning of applicable SEC rules, applicable to its Chief Executive Officer, Chief Financial Officer and Controller. Both the Code of Conduct and Code of Ethics are available, free of charge, by sending a written request to the Company’s Corporate Secretary. If the Company makes any amendments to either of these Codes (other than technical, administrative, or other non-substantive amendments), or waives (explicitly or implicitly) any provision of the Code of Ethics to the benefit of its Chief Executive Officer, Chief Financial Officer or Controller, it intends to disclose the nature of the amendment or waiver, its effective date and to whom it applies in the investor relations portion of the website, or in a report on Form 8-K filed with the SEC.

13

ITEM 1A.  RISK FACTORS

The Company’s business involves a number of risks, some of which are beyond its control.  The risk and uncertainties described below are not the only ones the Company faces.  Set forth below is a discussion of the risks and uncertainties that management believes to be material to the Company.

Economic Trends

Adverse global economic conditions, when they occur, may create conditions such as a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and volatility in credit, equity and fixed income markets.  Any or all of these developments can negatively affect the Company’s business, operating results or financial condition in a number of ways.  For example, current or potential customers may be unable to fund capital spending programs, new product launches of other similar endeavors whereby they might procure services from the Company, and therefore delay, decrease or cancel purchases of services or not pay or delay paying for previously purchased services.  In addition, these conditions may cause the Company to incur increased expenses or make it more difficult either to utilize existing debt capacity or otherwise obtain financing for operations, investing activities (including the financing of any future acquisitions), or financing activities, all of which could adversely affect the Company’s business, financial condition and results of operations.

Global Epidemics

The ongoing COVID-19 pandemic, and associated initiatives to reduce its spread, have adversely affected the Company’s business and financial position, and are expected to continue to do so.  The impacts described in this risk factor as relating to COVID-19 could arise in the future with respect to any other global pandemics that may occur.

Our business has been, and we expect that it will continue to be, adversely impacted by the effects of the COVID-19 pandemic. As COVID-19 continues to present various health, business and other challenges globally, including significant impacts in the United States, we are taking a variety of measures to protect the health and safety of our employees and, especially in the healthcare segment, deploying our resources, including the talents of our employees, to help the communities we serve meet and overcome the current challenges.  However, public and private sector policies and initiatives to reduce the transmission of COVID-19, such as closures of schools, businesses and manufacturing facilities, the promotion of social distancing, the adoption of working from home by companies and institutions, and travel restrictions could continue to adversely affect demand for our services and to present challenges to us in delivering these services.  The extent to which COVID-19 impacts operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, new information which may emerge concerning the severity of the pandemic and the actions to contain COVID-19 or treat its impact, among others. These impacts on our business could have an adverse effect on our liquidity position and access to capital, including our ability to access our line of credit.  The Company can give no assurance that the line of credit will be available in the future.

These factors, in addition to delays in payment (from clients and/or clients in bankruptcy), have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results would be adversely affected if unexpected increases in the costs of labor and labor related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs and COVID-19) could not be passed on to our clients.

In addition, we believe that to maintain or improve our financial performance we must continue to obtain service agreements with new clients, retain and provide new services to existing clients, achieve modest price increases on current service agreements with existing clients and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies.  Certainly, the ongoing COVID-19 pandemic makes these objective more difficult to attain.

14

ITEM 1A.  RISK FACTORS (CONTINUED)

Government Regulations

Staffing firms and employment service providers are generally subject to one or more of the following types of government regulation: (1) regulation of the employer/employee relationship between a firm and its employees, including tax withholding or reporting, social security or retirement, benefits, workplace compliance, wage and hour, anti-discrimination, immigration and workers’ compensation; (2) registration, licensing, record keeping and reporting requirements; and (3) federal contractor compliance.  Failure to comply with these regulations could result in the Company incurring penalties and other liabilities, monetary and otherwise.

Highly Competitive Business

The staffing services and outsourcing markets are highly competitive and have limited barriers to entry.  RCM competes in global, national, regional, and local markets with numerous temporary staffing and permanent placement companies.  Price competition in the staffing industry is significant and pricing pressures from competitors and customers are increasing.  In addition, there is increasing pressure on companies to outsource certain areas of their business to low cost offshore outsourcing firms.  RCM expects that the level of competition will remain high in the future, which could limit RCM’s ability to maintain or increase its market share or profitability.  Our inability to compete successfully with our competitors could adversely affect the Company’s business, financial condition and results of operations.

Seasonality of Business

As described in “Item 1. Business,” our operating results are subject to seasonal fluctuations, with reduced demand often occurring during the first quarter of the year when clients are finalizing their engineering and IT budgets, and also during periods in which there are a substantial amount of holidays and season vacations.  In particular, one of the largest customers in our Specialty Health Care group, the New York City Department of Education, significantly reduces activity during the third quarter, when schools are closed for summer recess.  Our operating results for any given period may fluctuate as a result of the timing of holidays, vacations and other events, and if we were to experience unfavorable performance during periods in which we would otherwise expect to have high seasonal demand, we may have limited ability to make up for such performance during periods of seasonally lower demand.

Events Affecting Significant Customers

As disclosed in “Item 1. Business,” the Company’s five, ten and twenty largest customers accounted for approximately 33.4%, 46.6% and 60.7%, respectively, of revenues for the fiscal year ended January 2, 2021.  During the fiscal year ended January 2, 2021, New York City Board of Education represented 10.6% of the Company’s revenues.  No other client accounted for 10% or more of total revenues during the year.  The Company’s customers may be affected by the current state of the economy or developments in the credit markets or may engage in mergers or similar transactions.  In addition, customers may choose to reduce the business they do with RCM for other reasons or no reason.  The Company could also be materially impacted by actions of prime contractors whereby the Company derives revenues through a subcontractor relationship.  Should any significant customers experience a downturn in their business that weakens their financial condition or merge with another company or otherwise cease independent operation, or limit their relationship with us, it is possible that the business that the customer does with the Company would be reduced or eliminated, which could adversely affect the Company’s business, financial condition and results of operations.

15

ITEM 1A.  RISK FACTORS (CONTINUED)

Events Affecting Significant Customers (Continued)

The Company had a dispute with a customer that is a major utility in the United States. Both parties agreed in fiscal 2017 to resolve this dispute through binding arbitration.  Arbitration hearings with this customer started in fiscal 2018.  Essentially, the customer did not pay the balance of accounts receivable the Company believes were owed for certain disputed projects.  As of December 28, 2019, the total amount of recorded receivables from this customer on these disputed projects was $14.1 million.  Additionally, as part of the arbitration process, the customer asserted counter-claims of $10.3 million. The arbitrator rendered a decision in this dispute in April 2020, awarding the Company $7.4 million, and the arbitration award was paid during the thirteen week period ended September 26, 2020. The counter-claims asserted against the Company of $10.3 million were denied in their entirety. For the fifty-three week period ended January 2, 2021, the Company recorded a charge of $8.4 million, including $6.7 million constituting the portion of the accounts receivable relating to the disputed projects that was not awarded by the arbitrator, $0.7 million from other projects with this customer that were not part of the arbitration, $0.8 million in professional fees related to the dispute and arbitration, and $0.2 million of transit accounts receivable associated with disputed projects that were part of the arbitration. The Company decided to write off the $0.7 million of accounts receivable from other projects not part of the arbitration for business reasons.

Safety Concerns Regarding Nuclear Power Plants; Limitations on Insurance

New and existing concerns are being expressed in public forums about the safety of nuclear generating units and nuclear fuel.  Among other things, these concerns have led to, and are expected to continue to lead to, various proposals to regulators and governing bodies in some localities where nuclear facilities are located for legislative and regulatory changes that could lead to the shut-down of nuclear units, denial of license renewal applications, municipalization of nuclear units, restrictions on nuclear units or other adverse effects on owning and operating nuclear generating units.  Should these concerns or proposals lead to a diminishment of or reduced growth in the nuclear power industry, the Company’s Engineering segment, which has a focus on the nuclear power industry, could be harmed, and the Company’s business, financial condition and results of operations could be materially adversely affected.

In addition, our liability insurance does not cover accidents occurring at nuclear power facilities.  Should we be found to be responsible for such an event, we may not be able to cover relating damages, and our business would be adversely affected.

Subcontractors, Transit Accounts Receivable and Transit Accounts Payables Related to Construction Management Contracts

The Company’s Engineering segment has entered into arrangements to provide construction management and engineering services to customers under which arrangements the Company then engages subcontractors to provide the construction services.  Ultimately, as a primary contractor, the Company is responsible for the nonperformance or negligence of its subcontractors, whom the Company requires to be adequately insured and to issue performance bonds for their assignment.  Should a subcontractor not perform or act negligently and should there be inadequate insurance or performance bonds in place, the Company might not be able to mitigate its primary liability to the customer, and the Company’s business, financial condition and results of operations could be materially adversely affected.  In addition, while payments to subcontractors typically are due from the Company only after the Company receives payment from the ultimate customer, the Company faces the risk that, should a customer not pay the Company, or should a subcontractor demand payment from the Company prior to the Company’s receipt of payment from its customer, the Company’s business, financial condition and results of operations could be materially adversely affected.

16

ITEM 1A.  RISK FACTORS (CONTINUED)

Dependence Upon Personnel

The Company’s operations depend on the continued efforts of its officers and other executive management.  The loss of key officers and members of executive management may cause a significant disruption to the Company’s business.

RCM also depends on the performance and productivity of its local managers and field personnel.  The Company’s ability to attract and retain new business is significantly affected by local relationships and the quality of service rendered.  The loss of key managers and field personnel may also jeopardize existing client relationships with businesses that continue to use the Company’s services based upon past relationships with local managers and field personnel.  In order to fulfill the requirements of the Company’s customers, the Company must be able to recruit and retain appropriate personnel for client assignments.

Revolving Credit Facility and Liquidity

If the Company were unable to borrow under its Revolving Credit Facility (see “Item 7.  Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Financing Activities”), it may adversely affect liquidity, results of operations and financial condition.  The Company’s liquidity depends on its ability to generate sufficient cash flows from operations and, from time to time, borrowings under the Revolving Credit Facility with the Company’s agent lender Citizens Bank of Pennsylvania. The Company believes that Citizens Bank is liquid and is not aware of any current risk that they will become illiquid.  At January 2, 2021, the Company had $11.9 million in borrowings under the Revolving Credit Facility outstanding and $1.9 million outstanding under letters of credit, with availability for additional borrowings under the Revolving Credit Facility of $31.2 million.

The Revolving Credit Facility contains various financial and non-financial covenants.  At January 2, 2021, the Company was in compliance with the covenants and other provisions of the Credit Facility. Any failure to be in compliance could have a material adverse effect on liquidity, results of operations and financial condition.

Foreign Currency Fluctuations and Changes in Exchange Rates

The Company is exposed to risks associated with foreign currency fluctuations and changes in exchange rates.  RCM’s exposure to foreign currency fluctuations relates to operations in Canada and Serbia, principally conducted through its Canadian and Serbian subsidiaries.  Exchange rate fluctuations affect the United States dollar value of reported earnings derived from the Canadian operations as well as the carrying value of the Company’s investment in the net assets related to these operations.  The Company does not engage in hedging activities with respect to foreign operations.

17

ITEM 1A.  RISK FACTORS (CONTINUED)

Changes in Tax Laws

At any time, United States federal tax laws or the administrative interpretations of those laws may be changed.  As a result, changes in United States federal tax laws could negatively impact our operating results, financial condition and business operations, and adversely impact the Company’s shareholders.  At any time, tax laws in the Company’s other jurisdictions, Canada, Puerto Rico and Serbia, may also change.  These tax law changes may have a material impact on the Company’s income tax expense.

Workers’ Compensation and Employee Medical Insurance

The Company self-insures a portion of the exposure for losses related to workers’ compensation and employees’ medical insurance.  The Company has established reserves for workers’ compensation and employee medical insurance claims based on historical loss statistics and periodic independent actuarial valuations.  Significant differences in actual experience or significant changes in assumptions may materially affect the Company’s future financial results.

Improper Activities of Temporary Professionals Could Result in Damage to Business Reputation, Discontinuation of Client Relationships and Exposure to Liability

The Company may be subject to claims by clients related to errors and omissions, misuse of proprietary information, discrimination and harassment, theft and other criminal activity, malpractice, and other claims stemming from the improper activities or alleged activities of temporary professionals.  There can be no assurance that current liability insurance coverage will be adequate or will continue to be available in sufficient amounts to cover damages or other costs associated with such claims.

Claims raised by clients stemming from the improper actions of temporary professionals, even if without merit, could cause the Company to incur significant expense associated with rework costs or other damages related to such claims.  Furthermore, such claims by clients could damage the Company’s business reputation and result in the discontinuation of client relationships.

Acquisitions May Not Succeed

The Company reviews prospective acquisitions as an element of its growth strategy.  The failure of any acquisition to meet the Company’s expectations, whether due to a failure to successfully integrate any future acquisition or otherwise, may result in damage to the Company’s financial performance and/or divert management’s attention from its core operations or could negatively affect the Company’s ability to meet the needs of its customers promptly.

International Operations

The Company operates its business in Canada and, to a less significant extent, in Puerto Rico and Serbia. For the fiscal year ended January 2, 2021, approximately 16.1% of the Company’s revenues were generated outside the United States. There are certain risks inherent in conducting business internationally including: the imposition of trade barriers, foreign exchange restrictions, longer payment cycles, greater difficulties in accounts receivables collection, difficulties in complying with a variety of foreign laws (including without limitation the U.S. Foreign Corrupt Practices Act), changes in legal or regulatory requirements, difficulties in staffing and managing foreign operations, complex and uncertain employment environments, political instability and potentially adverse tax consequences. To the extent the Company experiences these risks, the business and results of operations could be adversely affected.

18

ITEM 1A.  RISK FACTORS (CONTINUED)

Trademarks

Management believes the RCM Technologies, Inc. name is extremely valuable and important to its business. The Company endeavors to protect its intellectual property rights and maintain certain trademarks, trade names, service marks and other intellectual property rights, including The Source of Smart Solutions®.  The Company is not currently aware of any infringing uses or other conditions that would be reasonably likely to materially and adversely affect the Company’s use of its proprietary rights.  The Company’s success depends on its ability to successfully obtain and maintain, and prevent misappropriation or infringement of, its intellectual property, maintain trade secret protection, and conduct operations without violating or infringing on the intellectual property rights of third parties.  Intellectual property litigation is expensive and time-consuming, and it is often difficult, if not impossible, to predict the outcome of such litigation.  If the Company is involved in an intellectual property litigation, its business, financial condition and results of operations could be materially adversely affected.

Data Center Capacity and Telecommunication Links

Uninterruptible Power Supply (UPS), card key access, fire suppression, and environmental control systems protect RCM’s datacenter.  All systems are monitored on a 24/7 basis with alerting capabilities via voice or email.  The telecommunications architecture at RCM utilizes managed private circuits from AT&T, which encompasses provisioning redundancy and diversity.

The Company’s ability to protect its data center against damage from fire, power loss, telecommunications failure and other disasters is critical to business operations.  In order to provide many of its services, RCM must be able to store, retrieve, process and manage large databases and periodically expand and upgrade its capabilities.  Any damage to the Company’s data centers or any failure of the Company’s telecommunication links that interrupts its operations or results in an inadvertent loss of data could adversely affect the Company’s ability to meet its customers’ needs and their confidence in utilizing the Company for future services.

RCM’s ability to protect its data, provide services and safeguard its installations, as it relates to the IT infrastructure, is in part dependent on several outside vendors with whom the Company maintains service level agreements.

Cyber Security

We are highly dependent on information technology systems to operate our business. A breakdown, invasion, corruption, destruction or interruption of critical information technology systems by employees, others with authorized access to our systems or unauthorized persons could negatively impact operations.  In the ordinary course of business, we collect, store and transmit confidential information and it is critical that we do so in a secure manner to maintain the confidentiality and integrity of such information.  Additionally, we outsource certain elements of our information technology systems to third parties.  As a result of this outsourcing, our third party vendors may or could have access to our confidential information making such systems vulnerable.  Data breaches of our information technology systems, or those of our third party vendors, may pose a risk that sensitive data may be exposed to unauthorized persons or to the public.  While we believe that we have taken appropriate security measures to protect our data and information technology systems, and have been informed by our third party vendors that they have as well, there can be no assurance that our efforts will prevent breakdowns or breaches in our systems, or those of our third party vendors, that could adversely affect our business.

19

ITEM 1B.  UNRESOLVED STAFF COMMENTS

Not applicable.

ITEM 2.  PROPERTIES

The Company provides specialty professional consulting services, principally performed at various client locations, through 26 administrative and sales offices located in the United States, Puerto Rico, Canada and Serbia.  The majority of the Company’s offices typically consist of 1,000 to 13,000 square feet and are typically leased by the Company for terms of one to five years.  Offices in larger or smaller markets may vary in size from the typical office.  The Company does not expect that it will be difficult to maintain or find suitable lease space at reasonable rates in its markets or in areas where the Company contemplates expansion.

The Company’s executive office is located at 2500 McClellan Avenue, Suite 350, Pennsauken, New Jersey 08109-4613. These premises consist of approximately 3,500 square feet and are leased at a rate of approximately $15.00 per square foot per annum for a term ending on November 30, 2025.

The Company’s operational office is located at 20 Waterview Boulevard, 4^th Floor, Parsippany, NJ 07054-1271.  These premises consist of approximately 9,200 square feet and are leased at a rate of approximately $24.95 per square foot per annum for a term ending on January 31, 2024.

20

ITEM 3.  LEGAL PROCEEDINGS

From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the ordinary business course.  These matters may relate to professional liability, tax, compensation, contract, competitor disputes, and employee-related matters and include individual and class action lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company’s employment and compensation practices. Additionally, some of the Company’s clients may also become subject to claims, governmental inquiries and investigations, and legal actions relating to the Company’s professional services. Depending upon the particular facts and circumstances, the Company may also be subject to indemnification obligations under its contracts with such clients relating to these matters.

As such, the Company is required to assess the likelihood of any adverse outcomes to these matters as well as potential ranges of losses and possible recoveries.  The Company may not be covered by insurance as it pertains to some or all of these matters.  A determination of the amount of the provision required for these commitments and contingencies, if any, which would be charged to earnings, is made after careful analysis of each matter.  The Company records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. Once established, a provision may change in the future due to new developments or changes in circumstances and could increase or decrease the Company’s earnings in the period that the changes are made. 

The Company has reserved $1.7 million for the settlement of a class action suit in California that alleges the Company did not properly pay its travel nurses overtime wages. While the Company believes it did not violate any overtime wage laws, it nevertheless decided to settle this class action lawsuit in December 2020. The Company expects to pay the $1.7 million settlement sometime during its third quarter of fiscal 2021.  The Company is exposed to other asserted claims as of January 2, 2021, but the Company does not believe any of these other claims have a probability of loss. As of January 2, 2021, the Company did not have an accrual for any such other claims.  Furthermore, even if any of these other claims do result in an unfavorable outcome or settlement, the Company believes that such matters will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations, or cash flows.

The Company had a dispute with a customer that is a major utility in the United States. Both parties agreed in fiscal 2017 to resolve this dispute through binding arbitration.  Arbitration hearings with this customer started in fiscal 2018.  Essentially, the customer did not pay the balance of accounts receivable the Company believes were owed for certain disputed projects.  As of December 28, 2019, the total amount of recorded receivables from this customer on these disputed projects was $14.1 million.  Additionally, as part of the arbitration process, the customer asserted counter-claims of $10.3 million. The arbitrator rendered a decision in this dispute in April 2020, awarding the Company $7.4 million, and the arbitration award was paid during the fifty-three week period ended January 2, 2021. The counter-claims asserted against the Company of $10.3 million were denied in their entirety. For the fifty-three week period ended January 2, 2021, the Company recorded a charge of $8.4 million, including $6.7 million constituting the portion of the accounts receivable relating to the disputed projects that was not awarded by the arbitrator, $0.7 million from other projects with this customer that were not part of the arbitration, $0.8 million in professional fees related to the dispute and arbitration, and $0.2 million of transit accounts receivable associated with disputed projects that were part of the arbitration. The Company decided to write off the $0.7 million of accounts receivable from other projects not part of the arbitration for business reasons.

The Company is also subject to other pending legal proceedings and claims that arise from time to time in the ordinary course of its business, which may not be covered by insurance.

ITEM 4.  MINE SAFETY DISCLOSURES

Not applicable.

21

PART II

ITEM 5.	MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER
	MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Shares of the Company’s common stock are traded on The NASDAQ Global Market under the Symbol “RCMT.”

Holders

As of February 12, 2021, the approximate number of holders of record of the Company’s Common Stock was 471 and the number of beneficial owners of its Common Stock was approximately 3,994.

Dividends

No dividends were declared in fiscal 2020 or fiscal 2021.  All restricted share awards contain a dividend equivalent provision entitling holders to dividends paid between the restricted stock unit grant date and ultimate share distribution date.  As of January 2, 2021, there were no accrued dividends.

While the Company, at this time, has no plans to issue any future dividends, any future payment of dividends will depend upon, among other things, the Company’s earnings, financial condition, capital requirements, level of indebtedness, contractual restrictions, and other factors that the Board of Directors deems relevant.  The Revolving Credit Facility (as discussed in Item 7 hereof) prohibits the payment of any dividends or distributions on account of the Company’s capital stock without the prior consent of the majority of the Company’s lenders. 

ITEM 6.  SELECTED FINANCIAL DATA

Not required.

22

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS

COVID-19 Considerations

The Company’s priorities during the COVID-19 pandemic are protecting the health and safety of our employees and, especially in the healthcare segment, deploying our resources, including the talents of our employees, to help the communities we serve meet and overcome the current challenges. In the future, the pandemic may continue to cause reduced demand for our services if, for example, the pandemic results in a prolonged recessionary economic environment affecting industries in which we serve; however, since certain services that we offer are essential to the daily lives of our customers, we believe that over the long term, there will continue to be demand for our services. 

Our ability to continue to operate without any significant negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees, with particular measures in place for those working in our customer facilities. For the fifty-three week period ended January 2, 2021, while our revenue, gross profit and operating income were negatively impacted, we maintained the consistency of our operations, to a substantial degree, during the onset of the COVID-19 pandemic. We intend to continue to adhere to our employee safety measures as we seek to ensure that any disruptions to our operations remain as limited as possible during the pandemic. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example, an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations. 

For additional information on risk factors related to the pandemic or other risks that could impact our results, please refer to “Risk Factors” in Part II, Item 1A of this Form 10-K. For additional information on how COVID-19 has impacted operations and our financial position, please refer to the Segment Discussion and Liquidity and Capital Resources sections in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

23

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS

Overview

RCM participates in a market that is cyclical in nature and sensitive to economic changes.  As a result, the impact of economic changes on revenue and operations can be substantial, resulting in significant volatility in the Company’s financial performance. 

In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic, which continues to present various health, business and other challenges throughout the United States. As a result, we have temporarily closed most of our office locations, with most of our workforce working from home, and have seen a reduction in customer demand, all resulting in a negative impact on Company revenue, gross profit and operating income. The duration and ultimate magnitude of the disruption remains uncertain. We experienced a negative impact in fiscal 2020 and we expect this matter to negatively impact our business, results of operations, and financial position also through at least the first half of fiscal 2021 and likely beyond.  The related financial impact cannot be reasonably estimated at this time. Please see more detailed disclosure by segment in our Segment Discussion and the impact to our consolidated financial position under Financial Activities under Liquidity and Capital Resources, all in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The Company believes it has developed and assembled an attractive portfolio of capabilities, established a proven record of performance and credibility and built an efficient pricing structure.  The Company is committed to optimizing its business model as a single-source premier provider of business and technology solutions with a strong vertical focus offering an integrated suite of services through a global delivery platform.

The Company believes that most companies recognize the importance of advanced technologies and business processes to compete in today’s business climate.  However, the process of designing, developing and implementing business and technology solutions is becoming increasingly complex.  The Company believes that many businesses today are focused on return on investment analysis in prioritizing their initiatives.  This has had an adverse impact on spending by current and prospective clients for many emerging new solutions.

Nonetheless, the Company continues to believe that businesses must implement more advanced information technology and engineering solutions to upgrade their systems, applications and processes so that they can maximize their productivity and optimize their performance in order to maintain a competitive advantage.  Although working under budgetary, personnel and expertise constraints, companies are driven to support increasingly complex systems, applications and processes of significant strategic value.  This has given rise to a demand for outsourcing.  The Company believes that its current and prospective clients are continuing to evaluate the potential for outsourcing business critical systems, applications and processes. 

The Company provides project management and consulting services, which are billed based on either agreed-upon fixed fees or hourly rates, or a combination of both.  The billing rates and profit margins for project management and solutions services are generally higher than those for professional consulting services.  The Company generally endeavors to expand its sales of higher margin solutions and project management services.  The Company also realizes revenue from client engagements that range from the placement of contract and temporary technical consultants to project assignments that entail the delivery of end-to-end solutions.  These services are primarily provided to the client at hourly rates that are established for each of the Company’s consultants based upon their skill level, experience and the type of work performed. 

24

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Overview (Continued)

The majority of the Company’s services are provided under purchase orders.  Contracts are utilized on certain of the more complex assignments where the engagements are for longer terms or where precise documentation on the nature and scope of the assignment is necessary.  Although contracts normally relate to longer-term and more complex engagements, they do not obligate the customer to purchase a minimum level of services and are generally terminable by the customer on 60 to 90 days’ notice.  The Company, from time to time, enters into contracts requiring the completion of specific deliverables.  Typically these contracts are for less than one year.  The Company recognizes revenue on these deliverables at the time the client accepts and approves the deliverables.

Costs of services consist primarily of salaries and compensation-related expenses for billable consultants and employees, including payroll taxes, employee benefits and insurance.  Selling, general and administrative expenses consist primarily of salaries and benefits of personnel responsible for business development, recruiting, operating activities, and training, and include corporate overhead expenses.  Corporate overhead expenses relate to salaries and benefits of personnel responsible for corporate activities, including the Company’s corporate marketing, administrative and financial reporting responsibilities and acquisition program.  The Company records these expenses when incurred.  Corporate overhead expenses are allocated to the segments based on revenue for the purpose of segment financial reporting.

Critical Accounting Policies and Use of Estimates

This Management's Discussion and Analysis of Financial Condition and Results of Operations is based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenue and expenses during the reporting period. In our consolidated financial statements, estimates are used for, but not limited to, accounts receivable and allowance for doubtful accounts, goodwill, long-lived intangible assets, accounting for stock options and restricted stock awards, insurance liabilities, accounting for income taxes and accrued bonuses.

Revenue Recognition

The Company records revenue under Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers.  Revenue is recognized when we satisfy a performance obligation by transferring services promised in a contract to a customer, in an amount that reflects the consideration that we expect to receive in exchange for those services.  Performance obligations in our contracts represent distinct or separate service streams that we provide to our customers.  

We evaluate our revenue contracts with customers based on the five-step model under ASC 606: (1) Identify the contract with the customer; (2) Identify the performance obligations in the contract; (3) Determine the transaction price; (4) Allocate the transaction price to separate performance obligations; and (5) Recognize revenue when (or as) each performance obligation is satisfied.

The Company derives its revenue from several sources.  The Company’s Engineering Services and Information Technology Services segments perform consulting and project solution services.  The Healthcare segment specializes in long-term and short-term staffing and placement services to hospitals, schools and long-term care facilities amongst others.  All of the Company’s segments perform staff augmentation services and derive revenue from permanent placement fees.  The majority of the Company’s revenue is invoiced on a time and materials basis.

25

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Revenue Recognition (Continued)

The following table presents our revenues disaggregated by revenue source for the fifty-three week period ended January 2, 2021 and fifty-two week period December 28, 2019:

	January 2, 2021	December 28, 2019
Engineering:
Time and Material	$43,359	$55,195
Fixed Fee	14,145	12,678
Permanent Placement Services	211	-
Total Engineering	$57,715	$67,873
Specialty Health Care:
Time and Material	$59,692	$88,057
Permanent Placement Services	789	1,291
Total Specialty Health Care	$60,481	$89,348
Information Technology:
Time and Material	$31,723	$33,384
Permanent Placement Services	490	495
Total Information Technology	$32,213	$33,879
	$150,409	$191,100

Time and Material

The Company’s IT and Healthcare segments predominantly recognize revenue through time and material work while its Engineering segment recognizes revenue through both time and material and fixed fee work. The Company’s time and material contracts are typically based on the number of hours worked at contractually agreed upon rates, therefore revenue associated with these time and materials contracts are recognized based on hours worked at contracted rates. 

Fixed fee

From time to time and predominantly in our Engineering segment, the Company will enter into contracts requiring the completion of specific deliverables.  The Company has master services agreements with many of its customers that broadly define terms and conditions. Actual services performed under fixed fee arrangements are typically delivered under purchase orders that more specifically define terms and conditions related to that fixed fee project. While these master services agreements can often span several years, the Company’s fixed fee purchase orders are typically performed over six to nine month periods.  In instances where project services are provided on a fixed-price basis, revenue is recorded in accordance with the terms of each contract.  In certain instances, revenue is invoiced at the time certain milestones are reached, as defined in the contract.  Revenue under these arrangements are recognized as the costs on these contracts are incurred.  On an infrequent basis, amounts paid in excess of revenue earned and recognized are recorded as deferred revenue, included in accounts payable and accrued expenses on the accompanying condensed balance sheets.  In other instances, revenue is billed and recorded based upon contractual rates per hour.  Additionally, some contracts contain “Performance Fees” (bonuses) for completing a contract under budget.  Performance Fees, if any, are recorded when earned.  Some contracts also limit revenue and billings to specified maximum amounts.  Provisions for contract losses, if any, are made in the period such losses are determined.  For contracts where there is a specific deliverable and the work is not complete and the revenue is not recognized, the costs incurred are deferred as a prepaid asset.  The associated costs are expensed when the related revenue is recognized.

26

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Revenue Recognition (Continued)

Permanent Placement Services

The Company earns permanent placement fees from providing permanent placement services.  These fees are typically based on a percentage of the compensation paid to the person placed with the Company’s client.

The deferred revenue balance as of January 2, 2021 and December 28, 2019 was $0.4 million. These amounts are included in accounts payable and accrued expense in the accompanying consolidated balance sheets at that date.  Revenue is recognized when the service has been performed.  Deferred revenue may be recognized over a period exceeding one year from the time it was recorded on the balance sheet, although this is an infrequent occurrence.  For the fifty-three week period ended January 2, 2021 and the fifty-two week period ended December 28, 2019, the Company recognized revenue of $0.4 million and $0.2 million, respectively, that was included in deferred revenue at the beginning of the reporting period.

Accounts Receivable and Allowance for Doubtful Accounts

The Company’s accounts receivable are primarily due from trade customers.  Credit is extended based on evaluation of customers’ financial condition and, generally, collateral is not required.  Accounts receivable payment terms vary and are stated in the financial statements at amounts due from customers net of an allowance for doubtful accounts.  Accounts outstanding longer than the payment terms are considered past due.  The Company determines its allowance by considering a number of factors, including the length of time trade accounts receivable are past due, the Company’s previous loss history, the customer’s current ability to pay its obligation to the Company, and the condition of the general economy and the industry as a whole.  The Company writes off accounts receivable when they become uncollectible, and payments subsequently received on such receivables previously written off are credited to bad debt expense.

Goodwill

Goodwill is not amortized but is subject to periodic testing for impairment in accordance with ASC Topic 350 “Intangibles - Goodwill and Other - Testing Indefinite-Lived Intangible Assets for Impairment” (“ASC Topic 350”). The Company tests goodwill for impairment on an annual basis as of the last day of the Company’s fiscal December each year or more frequently if events occur or circumstances change indicating that the fair value of the goodwill may be below its carrying amount. The Company has three reporting units.  The Company uses a market-based approach to determine the fair value of the reporting units.  This approach uses earnings/revenue multiples of similar companies recently completing acquisitions and the ability of our reporting units to generate cash flows as measures of fair value of our reporting units. The Company adopted Accounting Standards Update (“ASU”) 2017-04, “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment” effective December 29, 2018 which has eliminated Step 2 from the goodwill impairment test. Under this update, an entity should perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount.

There was no goodwill impairment in fiscal 2020 or 2019.  During all periods presented, the Company determined that the existing qualitative factors did not suggest that an impairment of goodwill exists.  There can be no assurance that future indicators of impairment and tests of goodwill impairment will not result in impairment charges for both its Engineering and Specialty Healthcare segments.

Long-Lived and Intangible Assets

The Company evaluates long-lived assets and intangible assets with definite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  When the Company determines that it is probable that undiscounted future cash flows will not be sufficient to recover an asset’s carrying amount, the asset is written down to its fair value.  Assets to be disposed of by sale, if any, are reported at the lower of the carrying amount or fair value less cost to sell.

27

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Accounting for Restricted Stock Awards

The Company uses restricted stock awards to attract, retain and reward employees for long-term service.  The Company follows Financial Accounting Standards Board (FASB), Accounting Standards Codification (ASC) Topic 718 “Compensation – Stock Compensation” which requires that the compensation cost relating to stock-based payment transactions be recognized in the financial statements.  This compensation cost is measured based on the fair value of the equity or liability instruments issued.  The Company measures stock-based compensation cost using the Black-Scholes option pricing model for stock options and the fair value of the underlying common stock at the date of grant for restricted stock awards.

Insurance Liabilities

The Company has risk participation arrangements with respect to workers compensation and health care insurance.  The Company establishes loss provisions based on historical experience and in the case of expected losses from workers compensation, considers input from third parties.  The amounts included in the Company’s costs related to this risk participation are estimated and can vary based on changes in assumptions, the Company’s claims experience or the providers included in the associated insurance programs.

Accounting for Income Taxes

In establishing the provision for income taxes and deferred income tax assets and liabilities and valuation allowances against deferred tax assets, the Company makes judgments and interpretations based on enacted tax laws, published tax guidance and estimates of future earnings.  As of January 2, 2021, the Company had both domestic and foreign net deferred tax assets of $2.9 million.  The domestic long term net deferred tax assets of $3.3 million includes $4.9 million in deferred assets offset by $1.6 million in deferred tax liabilities. The domestic deferred tax assets consist of a net operating loss carryforward of $2.6 million and various deferred expense accruals and reserves of $2.3 million. The deferred tax liabilities consist of acquisition amortization of $0.7 million, prepaid expenses of $0.6 million and advance depreciation deductions of $0.3 million.  The realization of deferred tax assets is dependent upon the likelihood that future taxable income will be sufficient to realize these benefits over time, and the effectiveness of tax planning strategies in the relevant tax jurisdictions.  If actual results differ from these estimates and assessments, valuation allowances may be required.  The Company also had $0.4 million in foreign net deferred tax liabilities as of January 2, 2021.

The Company conducts its operations in multiple tax jurisdictions in the United States, Canada, Puerto Rico and Serbia. The Company and its subsidiaries file a consolidated United States Federal income tax return and file in various states. The Company’s federal income tax returns have been examined through 2017.  The Company has no open Federal audits as of January 2, 2021.  The State of New Jersey is currently examining fiscal tax years 2009 through 2012.  Except for New Jersey and other limited exceptions, the Company is no longer subject to audits by state and local tax authorities for tax years prior to 2017.  The Company is no longer subject to audit in Canada for the tax years prior to tax year 2016.  The Company is no longer subject to audit in Puerto Rico for the tax years prior to tax year 2010.

The Company’s future effective tax rates could be adversely affected by changes in the valuation of its deferred tax assets or liabilities or changes in tax laws or interpretations thereof. In addition, the Company is subject to the examination of its income tax returns by the Internal Revenue Service and other tax authorities. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes.

28

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Accrued Bonuses

The Company pays bonuses to certain executive management, field management and corporate employees based on, or after giving consideration to, a variety of financial performance measures. Bonuses for executive management, field management and certain corporate employees are accrued throughout the year for payment during the first quarter of the following year, based in part upon anticipated annual results compared to annual budgets.  In addition, the Company pays discretionary bonuses to certain employees, which are not related to budget performance. Variances in actual results versus budgeted amounts can have a significant impact on the calculations and therefore on the estimates of the required accruals.  Accordingly, the actual earned bonuses may be materially different from the estimates used to determine the quarterly accruals.

Performance-Based Restricted Stock Awards

From time-to-time the Company issues performance-based restricted stock awards to its executives.  Performance-based restricted stock awards are typically vested based on certain multi-year performance metrics as determined by the Board of Directors Compensation Committee. The Company will reassess at each reporting date whether achievement of any performance condition is probable and would begin recognizing additional compensation cost if and when achievement of the performance condition becomes probable.  The Company will then recognize the appropriate expense cumulatively in the year performance becomes probable and recognize the remaining compensation cost over the remaining requisite service period. If at a later measurement date the Company determines that performance-based restricted stock awards deemed as likely to vest are deemed as unlikely to vest, the expense recognized will be reversed.  These performance-based restricted stock awards typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period on any stock awards that actually vest, if any.  Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying consolidated balance sheet.  Dividends for performance-based restricted stock awards that ultimately do not vest are forfeited.  

Forward-looking Information

The Company’s growth prospects are influenced by broad economic trends.  The pace of customer capital spending programs, new product launches and similar activities have a direct impact on the need for engineering and information technology services.  When the U.S., Canadian or global economies decline, the Company’s operating performance could be adversely impacted.  In addition, global events such as the ongoing COVID-19 pandemic also have a substantial impact on our operations and financial results.  The Company believes that its fiscal discipline, strategic focus on targeted vertical markets and diversification of service offerings provides some insulation from adverse trends.  However, general economic declines could result in the need for future cost reductions or changes in strategy. 

Additionally, changes in government regulations could result in prohibition or restriction of certain types of employment services or the imposition of new or additional employee benefits, licensing or tax requirements with respect to the provision of employment services that may reduce the Company’s future earnings.  There can be no assurance that the Company will be able to increase the fees charged to its clients in a timely manner and in a sufficient amount to cover increased costs as a result of any of the foregoing.

The consulting and employment services market is highly competitive with limited barriers to entry.  The Company competes in global, national, regional and local markets with numerous competitors in all of the Company’s service lines.  Price competition in the industries the Company serves is significant, and pricing pressures from competitors and customers are increasing.  The Company expects that the level of competition will remain high in the future, which could limit the Company’s ability to maintain or increase its market share or profitability.

29

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Fiscal Year Ended January 2, 2021 Compared to Fiscal Year Ended December 28, 2019

A summary of operating results for the fifty-three week period ended January 2, 2021 and the fifty-two week period ended December 28, 2019 is as follows (in thousands):

	Fiscal Years Ended
	January 2, 2021				December 28, 2019
	Amount		% of Revenue		Amount		% of Revenue
Revenues	$150,409		100.0		$191,100		100.0
Cost of services	111,554		74.2		142,508		74.6
Gross profit	38,855		25.8		48,592		25.4
Selling, general and administrative	37,551		25.0		40,390		21.1
Depreciation and amortization of property and    equipment	1,065		0.7		1,261		0.7
Amortization of acquired intangible assets	321		0.2		327		0.2
Write-off of receivables and professional fees    incurred related to arbitration	8,397		5.6		-		-
Impairment of right of use assets and related costs	2,231		1.5		-		-
Tax credit professional fees	240		0.1		47		0.0
Operating costs and expenses	49,805		33.1		42,025		22.0
Operating (loss) income	(10,950	)	(7.3	)	6,567		3.4
Other expense, net	(1,107	)	(0.7	)	(1,745	)	(0.9	)
(Loss) income before income taxes	(12,057	)	(8.0	)	4,822		2.5
Income tax (benefit) expense	(3,188	)	(2.1	)	764		0.4
Net (loss) income	($8,869	)	(5.9	)	$4,058		2.1

The Company follows a 52/53 week fiscal reporting calendar ending on the Saturday closest to December 31.  The fiscal years ended January 2, 2021 (fiscal 2020) and December 28, 2019 (fiscal 2019) consisted of fifty-three weeks and fifty-two weeks, respectively.

Revenue.  Revenue decreased 21.3%, or $40.7 million, for the fifty-three week period ended January 2, 2021 as compared to the fifty-two week period ended December 28, 2019 (the “comparable prior year period”).  Revenue decreased $10.1 million in the Engineering segment, $28.9 million in the Specialty Health Care segment and $1.7 million in the Information Technology segment.  See Segment Discussion for further information on revenue changes.

Cost of Services and Gross Profit.  Cost of services decreased 21.7%, or $31.0 million, for the fifty-three week period ended January 2, 2021 as compared to the comparable prior year period. Cost of services decreased primarily due to the decrease in revenue.  Cost of services as a percentage of revenue for the fifty-three week periods ended January 2, 2021 and the fifty-two week period ended December 28, 2019 were 74.2% and 74.6%, respectively.  See Segment Discussion for further information regarding changes in cost of services and gross profit.

30

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Fiscal Year Ended January 2, 2021 Compared to Fiscal Year Ended December 28, 2019

Selling, General and Administrative.  Selling, general and administrative (“SGA”) expenses were $37.6 million for the fifty-three week periods ended January 2, 2021 as compared to $40.4 million for the comparable prior year period.  As a percentage of revenue, SGA expenses were 25.0% for the fifty-three week period ended January 2, 2021 and 21.1% for the comparable prior year period.  See Segment Discussion for further information on SGA expense changes.

Write-off of receivables and professional fees incurred related to arbitration. The Company recorded a charge of $8.4 million during the fifty-three week period ended January 2, 2021 relating to its dispute with a customer that is a major utility in the United States.  This dispute was resolved through binding arbitration April 2020.  The charge consisted of $6.7 million for the portion of accounts receivable previously recognized by the Company that was not awarded by the arbitrator, $0.7 million from other projects with this customer that were not part of the arbitration, $0.8 million in professional fees related to the dispute and arbitration and $0.2 million of transit accounts receivable associated with disputed projects that were part of the arbitration. The Company decided to write off the $0.7 million of accounts receivable from other projects not part of the arbitration for business reasons.  For the fifty-two week period December 28, 2019, there were no such impairment charges.

Impairment of Office Leases.  In connection with the continuing developments from COVID-19, the Company has reduced its leased office space as a result of its employees moving to a remote work environment.  The Company does not believe there is an opportunity to sublet any of the vacant office space due to the current commercial rental marketplace.  This decision and reduction in the use of the office spaces resulted in a right-of-use asset impairment of $1.9 million.  This loss was determined by identifying the fair value of the impacted right-of-use assets as compared to the carrying value of the assets as of the measurement date, in accordance with Property, Plant and Equipment Topic of the FASB ASC.  The fair value of the right-of-use assets was based on the remaining term of each lease.  In addition, the Company wrote off a total of $0.3 million in other office lease costs and for obsolete equipment.   

Tax Credit Professional Fees. The Company incurred $0.2 million in tax credit professional fees in the fifty-three week period ended January 2, 2021 as compared to de minimis tax credit professional fees in the comparable prior year period.

Other Expense.  Other expense consists of interest expense, unused line fees and amortized loan costs on the Company’s line of credit, net of interest income, imputed interest on contingent consideration and gains and losses on foreign currency transactions.  Other expense, net decreased to $1.1 million as compared to $1.7 million for the comparable prior year period.  The primary component of the decrease related to interest expense, which decreased primarily due to a decreased average borrowing and a decreased borrowing rate under the Company’s line of credit.  The primary reason for the decreased average borrowing rate was change in macroeconomic borrowing rates. 

Income Tax (Benefit) Expense.  The Company recognized $3.2 million of income tax benefit for the fifty-three week period ended January 2, 2021, as compared to an income tax expense of $0.8 million for the comparable prior year period.  The consolidated effective income tax rate for the current period was 26.4% as compared to 15.8% for the comparable prior year period.  The Company considers its fiscal 2020 effective tax rate within the range of typical expectations, while its 2019 effective tax rate is comparatively low.  The primary reason for the lower 2019 effective tax rate is that the Company experienced an R&D tax credit of $0.7 million.  The effective fiscal 2020 income tax rates for the fifty-three weeks ended January 2, 2021, were 25.8%, 25.6%, and 15.8% in the United States, Canada, and Serbia, respectively. The relative income or loss generated in each jurisdiction can materially impact the overall effective income tax rate of the Company, particularly the ratio of Canadian and Serbian pretax income versus U.S. pretax income. 

Differences between the effective tax rate and the applicable U.S. federal statutory rate may arise, primarily from the effect of state and local income taxes, share-based compensation, and potential tax credits available to the Company. Actual effective tax rates may vary depending on the actual operating income earned in various jurisdictions, the potential availability of tax credits, and the exercise of stock options and vesting of share-based awards.

31

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Fiscal Year Ended January 2, 2021 Compared to Fiscal Year Ended December 28, 2019 (Continued)

Segment Discussion

Engineering

Engineering revenues of $57.7 million for the fifty-three week period ended January 2, 2021 decreased 15.0%, or $10.1 million, as compared to the comparable prior year period.  The decrease was due to decreases of $5.1 million from the Company’s Aerospace Group, $3.6 million from the Company’s Energy Services/Industrial Processing Groups and $1.5 million from the Company’s Canadian Power Systems Group.  The Company attributes these revenue declines to decreased spending on the part of several of its larger clients, a decrease in demand for power generation services, increased competition from other vendors to its Canadian Power Systems and Aerospace clients, timing of large projects from the Company’s Energy Services clients, all of which factors are impacted by COVID-19. Gross profit decreased by 10.8%, or $2.0 million, as compared to the comparable prior year period. Gross profit decreased primarily because of the decrease in revenue, offset by improvement to gross profit margin. Gross profit margin of 28.6% for the current period increased from 27.2% for the comparable prior year period. The increase in gross margin was primarily due to a concerted effort to improve utilization of the Engineering segment’s billable consultants and a focus on higher-margin project work as opposed to lower-margin staffing.  The Engineering segment experienced an operating loss of $5.8 million for the fifty-three week period ended January 2, 2021, as compared to operating income of $3.7 million for the comparable prior year period. The primary reason for the operating loss in the current period was the $8.4 million write-off of receivables and professional fees incurred related to a discrete arbitration, offset by a decrease of $0.7 million to SGA expense. The decrease in SGA expense was primarily due to a concerted effort to reduce expenses to an efficient level commensurate with current revenue and gross profit.

COVID-19 Impact to Engineering Segment

It is difficult to assess both the current and future impact from COVID-19 to the Engineering segment, due to the high degree of uncertainty around COVID-19 and the duration and extent of the pandemic. The Engineering segment has seen a decline in its field services work as its personnel has limited access to client facilities. It is difficult to determine the impact on revenue from the loss in field services work. The Company believes that an undetermined amount of field services work will eventually return as a portion of that work is mission-critical to our clients. However, given the uncertainties around COVID-19, the Company can give no assurances that it will see an increase in field services revenue.  Additionally, the Company believes that COVID-19 has had a significant adverse impact on the budgets of many of its Aerospace and Utilities clients.  Many of the Company’s Aerospace clients have seen an impact to their commercial lines of business.  A number of the Company’s Utility clients have been impacted by their customers’ inability to pay their monthly electric bills.

The Company has transitioned most of its Engineering workforce to work from home. While this has constituted a significant effort, particularly from a technology standpoint, the Company believes that this effort has been completed relatively effectively. The Company also believes that its Engineering clients have been generally supportive of these efforts and believes further that it has not lost any significant, previously awarded work. The Engineering segment continues to see new work proposals, but not at the same level as seen prior to COVID-19. The Engineering segment’s general response to the effects of COVID-19 is to continue to focus on maximizing gross margin by focusing on utilization of billable consultants and maximizing the efficiency of its SGA expense. The Engineering segment and the Company, as a whole, is focused on reducing its SGA expense in the short-term while not harming the Company in the long-term. The Company plans to refine its strategy for responding to COVID-19 as necessary as the situation develops.

32

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Segment Discussion (Continued)

Specialty Health Care

Specialty Health Care revenue of $60.5 million for the fifty-three week period ended January 2, 2021 decreased 32.3%, or $28.9 million, as compared to the comparable prior year period.  The decrease in revenue was primarily driven by school closures related to COVID-19 (see below). The Specialty Health Care segment’s gross profit decreased by 36.0%, or $7.5 million, to $13.4 million for the fifty-three week period ended January 2, 2021, as compared to $20.9 million for the prior year period. The decrease in gross profit was primarily driven by a decrease in revenue and a decrease in gross profit margin. Gross profit margin for the fifty-three week period ended January 2, 2021 decreased to 22.1% as compared to 23.4% for the comparable prior year period. The Company primarily attributes the decrease in gross profit margin to a shift in mix, as the Specialty Health Care’s non-school services typically generate lower gross margin than school services. Specialty Health Care experienced an operating loss of $2.5 million for the fifty-three week period ended January 2, 2021, as compared to operating income of $2.9 million for the comparable prior year period. The primary reason for the decrease in operating income was the decrease to revenue, gross profit, and gross profit margin, primarily resulting from sudden school closures (see below).  SGA expense decreased by $2.1 million to $15.5 million, as compared to $17.6 million in the comparable prior year period. The decrease in SGA expense was primarily due to a concerted effort to reduce SGA expense in response to the impact of COVID-19 on school services revenue, a decrease in variable SGA expense related to gross profit, and a lower allocation of corporate-generated SGA expense.

COVID-19 Impact to Specialty Health Care Segment

It is difficult to assess both the current and future impact from COVID-19 to the Specialty Health Care segment, due to the high degree of uncertainty around COVID-19 and the duration and extent of the pandemic, especially as it may impact schools where many of our personnel work. While the Company has worked to transition a portion of its Specialty Health Care workforce to work from home, this has been a difficult task. The Specialty Health Care segment has a small number of billable professionals performing services from home, in particular telehealth services. The Specialty Health Care segment’s telehealth services are primarily a new service offering. The majority of the Specialty Health Care segment’s services are historically delivered at schools and health care facilities. The Company believes that demand for much of its non-school services is very high as a result of COVID-19. However, health care professionals, such as nurses and doctors, are scarce and difficult to recruit.  Furthermore, the demand for non-COVID-19 related healthcare services has been reduced as a result of the pandemic.

The Specialty Health Care Segment has historically derived much of its revenue from school systems. Many school systems nationwide, including most of the Company’s school clients, closed down for in-person instruction in March 2020. Some have reopened partially with a combination of in-person and virtual lessons, while some have remained entirely virtual.  The Company has limited information on when, and in what manner, they will reopen in a comparable manner as to how they operated before COVID-19. Many schools are under pressure by employee unions to reduce or eliminate in-person classes. Any announced plans are subject to rapid changes. 

The Specialty Health Care's largest school clients are the New York City Department of Education, the Hawaii Department of Education, and the Chicago Public School System. There are numerous factors that could influence further decisions of these school systems on their operations. Any shift toward hybrid and remote operations has a materially negative impact on revenue generated by the Specialty Healthcare segment.

The Specialty Health Care segment generated $37.3 million in revenue from schools for the fifty-three week period ended January 2, 2021, as compared to $65.6 million for the comparable prior year period. It is difficult to estimate the impact of the school closures and reopenings on the Company’s fiscal 2021 and beyond. The Company believes that at some point in the future, its school clients will return to a normalized level of operations. However, the Company can give no assurance of when or even if this normalization will occur.

33

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Fiscal Year Ended January 2, 2021 Compared to Fiscal Year Ended December 28, 2019 (Continued)

Segment Discussion (Continued)

The Specialty Health Care segment continues to see new work proposals related to non-school related revenue streams. The Specialty Health Care segment’s general response to the effects of COVID-19 is to continue to focus on maximizing gross margin by focusing on utilization of billable personnel and maximizing the efficiency of its SGA expense. The Specialty Health Care segment has made significant reductions to its SGA cost structure. The Specialty Health Care segment and the Company, as a whole, are focused on reducing SGA expense in the short-term while not harming the Company in the long-term. The Company plans to refine its strategy for responding to COVID-19 as necessary as the situation develops.

Information Technology

Information Technology revenue of $32.2 million for the fifty-three week period ended January 2, 2021 decreased 4.9%, or $1.7 million, as compared to $33.9 million for the comparable prior year period. The Information Technology segment’s revenue declined across most of its lines of business. The Company generally attributes the decrease to the impact of COVID-19 as its runoff of backlog has not been adequately replaced with new business. Gross profit of $9.0 million for the fifty-three week period ended January 2, 2021 decreased 2.4%, or $0.2 million, as compared to $9.2 million for the comparable prior year period. The decrease in gross profit was primarily due to the decrease in revenue, partially offset by an increase in gross profit margin.  The Information Technology gross profit margin for the fifty-three week period ended January 2, 2021 was 27.9% as compared to 27.2% for the comparable prior year period.  The Company attributes the gross profit margin increase to higher utilization of the Information Technology’s fixed labor consultants and a concerted effort to increase gross profit margin. SGA expense was $9.1 million for both periods presented. The Information Technology segment experienced an operating loss of $0.2 million as compared to a small amount of operating income for the comparable prior year period.  The decrease in operating income was primarily due to the decrease in revenue and gross profit.

It is difficult to assess both the current and future impact from COVID-19 to the Information Technology segment, due to the high degree of uncertainty around COVID-19 and the duration and extent of the pandemic. The Information Technology segment has seen a decline in its field services work as its personnel has limited access to client facilities. It is difficult to determine the impact on revenue from the loss in field services work.

COVID-19 Impact to Information Technology Segment

The Company has transitioned most of its Information Technology workforce to work from home. While this has constituted a significant effort, particularly from a technology standpoint, the Company believes that this effort has been completed relatively effectively. The Company also believes that its Information Technology clients have been generally supportive of these efforts and believes further that it has not lost any significant, previously awarded work. The Information Technology segment continues to see new work proposals, but not at the same level as seen prior to COVID-19. The Information Technology segment’s general response to the effects of COVID-19 is to continue to focus on maximizing gross margin by focusing on utilization of billable consultants and maximizing the efficiency of its SGA expense. The Information Technology segment and the Company, as a whole, is focused on reducing its SGA expense in the short-term while not harming the Company in the long-term. The Company plans to refine its strategy for responding to COVID-19 as necessary as the situation develops.

34

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Fiscal Year Ended January 2, 2021 Compared to Fiscal Year Ended December 28, 2019 (Continued)

Supplemental Operating Results on a Non-GAAP Basis

The following non-GAAP measures, which adjust for the categories of expenses described below, primarily changes in contingent consideration as a result of re-measurement in the amount of contingent consideration we expect to pay with respect to past acquisitions, are non-GAAP financial measures.  Our management believes that these non-GAAP financial measures (“EBITDA” and “Adjusted EBITDA”) are useful information for investors, shareholders and other stakeholders of our company in gauging our results of operations on an ongoing basis and to enhance investors’ overall understanding of our current financial performance and period-to-period comparisons.  We believe that both EBITDA and Adjusted EBITDA are performance measures and not liquidity measures, and therefore a reconciliation between net income and EBITDA and Adjusted EBITDA has been provided.  Neither EBITDA nor Adjusted EBITDA should be considered as an alternative to net income as an indicator of performance.  In addition, neither EBITDA nor Adjusted EBITDA takes into account changes in certain assets and liabilities as well as interest and income taxes that can affect cash flows.  We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP.  These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

The following unaudited table presents the Company's GAAP Net Income measure and the corresponding adjustments used to calculate “EBITDA” and “Adjusted EBITDA” for the fifty-three week period ended January 2, 2021 and the fifty-two week period ended December 28, 2019. 

	Fifty-Three Week Period Ended January 2, 2021		Fifty-Two Week Period Ended December 28, 2019
GAAP net (loss) income	($8,869	)	$4,058
Income tax (benefit) expense	(3,188	)	764
Interest expense	778		1,695
Change in fair value of contingent consideration	145		61
Depreciation of property and equipment	1,065		1,261
Amortization of acquired intangible assets	321		327
EBITDA (non-GAAP)	($9,748	)	$8,166
Adjustments
Write-off of receivables and professional fees       incurred related to arbitration	8,397		-
Impairment of right of use assets and related costs	2,231		-
Tax credit professional fees	240		47
Gain (loss) on foreign currency transactions	184		(11	)
Adjusted EBITDA (non-GAAP)	$1,304		$8,202

35

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Liquidity and Capital Resources

The following table summarizes the major captions from the Company’s Consolidated Statements of Cash Flows ($ in thousands):

		Fiscal Years Ended
		January 2, 2021		December 28, 2019
Cash (used in) provided by:
	Operating activities	$25,203		($4,778	)
	Investing activities	($419	)	($363	)
	Financing activities	($25,632	)	$6,627

Operating Activities

Operating activities provided $25.2 million of cash for the fifty-three week period ended January 2, 2021 as compared to using $4.8 million in the comparable prior year period.  The major components of cash used in or provided by operating activities in the fifty-three week period ended January 2, 2021 and the comparable prior year period are as follows: net loss or income and changes in accounts receivable, the net of transit accounts payable and transit accounts receivable, prepaid expenses and other current assets, accounts payable and accrued expenses and accrued payroll and related costs.

For the fifty-three week period ended January 2, 2021, the Company experienced a net loss of $8.9 million as compared to net income of $4.1 million for the comparable prior year period.  A decrease in accounts receivables in the fifty-three week period ended January 2, 2021, exclusive of the impact of the arbitration resolution, provided $15.9 million of cash as compared to using $7.6 million in the comparable prior year period. The Company primarily attributes this decrease in accounts receivables for the fifty-three week period ended January 2, 2021 to the decrease in revenue for the fifty-three week period ended January 2, 2021 as compared to the fifty-two week period ended December 28, 2019 and the collection of the arbitration award. 

The Company’s transit accounts payable usually exceeds the Company’s transit accounts receivable, but absolute amounts and differences fluctuate significantly from quarter to quarter in the normal course of business.  The net of transit accounts payable and transit accounts receivable was a net payable of $2.4 million as of January 2, 2021 and as compared to a net receivable of $0.3 million as of December 28, 2019, providing $2.7 million of cash during the fifty-three week period ended January 2, 2021.  The net of transit accounts payable and transit accounts receivable was negligible as of December 29, 2018, using $0.3 million of cash during the fifty-two week period ended December 28, 2019. 

Prepaid expenses and other current assets used cash of $0.2 million for the fifty-three week period ended January 2, 2021 as compared to using $0.6 million of cash for the comparable prior year period.  The Company attributes changes to prepaid expenses and other current assets, if any, to general timing of payments in the normal course of business.

An increase in accounts payable and accrued expenses provided cash of $1.6 million for the fifty-three week period ended January 2, 2021 as compared to using $3.1 million of cash for the comparable prior year period.  The Company attributes these changes to a deliberate effort to defer payments for cash flow purposes and general timing of payments to vendors in the normal course of business.  Additionally, the Company accrued $1.7 million for the settlement of a class action suit in California that alleges the Company did not properly pay its travel nurses overtime wages.  The Company anticipates this liability will be paid during its fiscal 2021 third quarter.

36

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Liquidity and Capital Resources (Continued)

Operating Activities (Continued)

Changes in accrued payroll and related costs provided $4.6 million for the fifty-three week period ended January 2, 2021 as compared to using $1.3 million for the fifty-three week period December 28, 2019.  There are four primary factors that generally impact accrued payroll and related costs: 1) there is a general correlation to operating expenses as payroll and related costs is the Company’s largest expense group, so as operating costs increase or decrease, absent all other factors, so will the accrued payroll and related costs; 2) the Company pays the majority of its payroll every two weeks and normally has thirteen weeks in a fiscal quarter, which means that the Company normally has a major payroll on the last business day of every other quarter; 3) the timing of various payroll related payments varies in the normal course of business; and 4) most of the Company’s senior management participate in annual incentive plans and while progress advances are sometimes made during the fiscal year, these accrued bonus balances, to the extent they are projected to be achieved, generally accumulate throughout the year.  A significant portion of these incentive plan accruals are typically paid at the beginning of one fiscal year, pertaining to the prior fiscal year.  The Company’s last major payroll for the fifty-three week period ended January 2, 2021 was paid on December 31, 2020. Unique to fiscal 2020 and the primary reason for the increase in accrued payroll and related costs, as of January 2, 2021, the Company also deferred $3.3 million of employer payroll taxes under the CARES Act. These deferred payroll taxes must be paid in two equal installments at the end of calendar years 2021 and 2022.

Investing Activities

Investing activities used cash of $0.4 million for both the fifty-three week period ended January 2, 2021 and the fifty-two week period December 28, 2019.  Investing activities primarily consists of expenditures for property and equipment in both periods presented.

Financing Activities

Financing activities used $25.6 million of cash for the fifty-three week period ended January 2, 2021 as compared to providing $6.7 million in the comparable prior year period.  The Company made net repayments under its line of credit of $22.9 million during the fifty-three week period ended January 2, 2021 as compared to net borrowings of $7.2 million in the comparable prior year period.  The primary reasons for net payments during the fifty-three week period ended January 2, 2021 was the decrease of $15.9 million in accounts receivable and the $9.3 million in net cash provided by all other operating activities.  The Company generated cash of $0.2 million and $0.3 million from sales of shares from its equity plans for the current period and the comparable prior year period, respectively.  The Company also used $2.2 million to retire a note payable incurred to repurchase the Company’s common stock.  The Company paid $0.3 million of contingent consideration during the fifty-three week period ended January 2, 2021 and $0.6 million during the fifty-two week period December 28, 2019. 

Borrowings under the Revolving Credit Facility bear interest at one of two alternative rates, as selected by the Company at each incremental borrowing.  These alternatives are: (i) LIBOR (London Interbank Offered Rate), plus applicable margin, typically borrowed in fixed 30-day increments or (ii) the agent bank’s prime rate generally borrowed over shorter durations.  The Company also pays unused line fees based on the amount of the Revolving Credit Facility that is not drawn.  Unused line fees are recorded as interest expense.  The effective weighted average interest rate, including unused line fees, for the fifty-three week period ended January 2, 2021 was 2.7%.

37

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Liquidity and Capital Resources (Continued)

Financing Activities (Continued)

All borrowings under the Revolving Credit Facility are collateralized by all of the assets of the Company and its subsidiaries and a pledge of the stock of its subsidiaries.  The Revolving Credit Facility also contains various financial and non-financial covenants, such as a covenant that restricts on the Company’s ability to borrow in order to pay dividends.  As of January 2, 2021, the Company was in compliance with all covenants contained in the Revolving Credit Facility (as amended).The Company believes that it will maintain compliance with its financial covenants for the foreseeable future.   

Borrowings under the line of credit as of January 2, 2021 and December 28, 2019 were $11.9 million and $34.8 million, respectively.  At January 2, 2021 and December 28, 2019 there were letters of credit outstanding for $1.9 million and $1.6 million, respectively.  At January 2, 2021, the Company had availability for additional borrowings under the Revolving Credit Facility of $31.2 million.

On June 2, 2020, the Company entered into a stock purchase agreement with certain stockholders of the Company, whereby the Company purchased an aggregate of 1,858,139 shares of the Company’s common stock for a negotiated purchase price of $1.20 per share or $2.2 million in total. The negotiated price of $1.20 per share was less than the lowest trading price of the stock on the day of the repurchase.  The consideration paid by the Company consisted entirely of an unsecured subordinated promissory note for $2.2 million. The note accrues interest at an annual rate of 9.0%, compounded annually, payable quarterly in arrears commencing on September 1, 2020 and continuing on each December 1, March 1, June 1 and September 1 thereafter, and has a maturity date of August 10, 2023. Subject to the applicable provisions of the subordination agreement among the Company, Citizens Bank and the selling stockholders, the note was to become immediately due and payable in the event of a default by the Company.  On September 25, 2020, the Company repaid the subordinated promissory note in full.

Impact to Line of Credit from COVID-19

The Company is negatively impacted by COVID-19.  While COVID-19 is expected to continue to negatively impact revenue, gross profit, and operating income for an undetermined period of time, the Company nevertheless does not expect a material negative impact from recent results.  If the Company should experience a sudden increase to revenue and a corresponding increase to accounts receivable, the Company will likely experience negative cash flow.  In this scenario, the Company would expect to see an increase in operating income and borrowing capacity.  As a response to COVID-19, the Company, as a whole, is focused on maximizing the utilization of its billable personnel and reducing its SGA expense in the short-term while not harming the Company in the long-term. The Company plans to refine its strategy for responding to COVID-19 as the situation develops. The Company believes that its current line of credit is adequate to provide the necessary liquidity while COVID-19 impacts its operations.  The Company believes that it will be in compliance with the financial covenants in the line of credit for the foreseeable future.

Current Liquidity and Revolving Credit Facility

Liquidity is a measure of our ability to meet potential cash requirements, maintain our assets, fund our operations, and meet the other general cash needs of our business. Our liquidity is impacted by general economic, financial, competitive, and other factors beyond our control. Our liquidity requirements consist primarily of funds necessary to pay our expenses, principally labor-costs, and other related expenditures. We generally satisfy our liquidity needs through cash provided by operations and, when necessary, our revolving line of credit from Citizens Bank. The Company believes it has a great deal of flexibility to reduce its costs if it becomes necessary. The Company believes that it can satisfy its liquidity needs for at least the next twelve months.

38

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Liquidity and Capital Resources (Continued)

Current Liquidity and Revolving Credit Facility (Continued)

The Company’s liquidity and capital resources as of January 2, 2021, included accounts receivable and total current asset balances of $36.0 million and $43.9 million, respectively. Current liabilities were $28.0 million as of January 2, 2021 and were exceeded by total current assets by $15.9 million.

The Company experiences volatility in its daily cash flow and, at times, relies on the revolving line of credit to provide daily liquidity for the Company’s financial operations.  As of January 2, 2021, the Company was in compliance with all financial covenants contained in the Revolving Credit Facility.  The Company believes that it will maintain compliance with its financial covenants for the foreseeable future.   

Dividends

All restricted share awards contain a dividend equivalent provision entitling holders to dividends paid between the restricted stock unit grant date and ultimate share distribution date.  As of January 2, 2021, there were no accrued dividends.

While the Company, at this time, has no plans to issue any future dividends, any future payment of dividends will depend upon, among other things, the Company’s earnings, financial condition, capital requirements, level of indebtedness, contractual restrictions, and other factors that the Board of Directors deems relevant.  The Revolving Credit Facility (as discussed above) prohibits the payment of any dividends or distributions on account of the Company’s capital stock without the prior consent of the majority of the Company’s lenders. 

Commitments and Contingencies

The Company anticipates that its primary uses of capital in future periods will be for working capital purposes.  Funding for any long-term and short-term capital requirements as well as future acquisitions will be derived from one or more of the Revolving Credit Facility (or a replacement thereof), funds generated through operations or future financing transactions.  The Company is subject to legal proceedings and claims that arise from time to time in the ordinary course of its business, which may or may not be covered by insurance.  Were an unfavorable final outcome to occur, there exists the possibility of a material adverse impact on our financial position, liquidity, and the results of operations.

The Company’s business strategy is to achieve growth both internally through operations and externally through strategic acquisitions.  The Company from time to time engages in discussions with potential acquisition candidates. The Company has acquired numerous companies throughout its history and those acquisitions have generally included significant future contingent consideration.  As the size of the Company and its financial resources increase however, acquisition opportunities requiring significant commitments of capital may arise.  In order to pursue such opportunities, the Company may be required to incur debt or issue potentially dilutive securities in the future.  No assurance can be given as to the Company’s future acquisition and expansion opportunities or how such opportunities will be financed.

The Company has reserved $1.7 million for the settlement of a class action suit in California that alleges the Company did not properly pay its travel nurses overtime wages. While the Company believes it did not violate any overtime wage laws, it nevertheless decided to settle this class action lawsuit in December 2020.  The Company expects to pay the $1.7 million settlement sometime during its third quarter of fiscal 2021.  The Company is exposed to other asserted claims as of January 2, 2021, but the Company does not believe any of these other claims have a probability of loss. As of January 2, 2021, the Company did not have an accrual for any such other claims.  Furthermore, even if any of these other claims do result in an unfavorable outcome or settlement, the Company believes that such matters will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations, or cash flows.

39

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (CONTINUED)

Liquidity and Capital Resources (Continued)

Commitments and Contingencies (Continued)

The Company had a dispute with a customer that is a major utility in the United States. Both parties agreed in fiscal 2017 to resolve this dispute through binding arbitration.  Arbitration hearings with this customer started in fiscal 2018.  Essentially, the customer did not pay the balance of accounts receivable the Company believes were owed for certain disputed projects.  As of December 28, 2019, the total amount of recorded receivables from this customer on these disputed projects was $14.1 million.  Additionally, as part of the arbitration process, the customer asserted counter-claims of $10.3 million. The arbitrator rendered a decision in this dispute in April 2020, awarding the Company $7.4 million, and the arbitration award was paid during the thirteen week period ended September 26, 2020. The counter-claims asserted against the Company of $10.3 million were denied in their entirety. For the fifty-three week period ended January 2, 2021, the Company recorded a charge of $8.4 million, including $6.7 million constituting the portion of the accounts receivable relating to the disputed projects that was not awarded by the arbitrator, $0.7 million from other projects with this customer that were not part of the arbitration, $0.8 million in professional fees related to the dispute and arbitration, and $0.2 million of transit accounts receivable associated with disputed projects that were part of the arbitration. The Company decided to write off the $0.7 million of accounts receivable from other projects not part of the arbitration for business reasons.

The Company utilizes SAP software for its financial reporting and accounting system which was implemented in 1999 and has not undergone significant upgrades since its initial implementation.  The Company believes that it will become necessary to upgrade or replace its SAP financial reporting and accounting system.  The Company has not determined when this contemplated replacement may be necessary.  The Company estimates this upgrade or replacement of their financial reporting and accounting system will cost between $0.5 million and $1.0 million.  These estimates are subject to material change.

The Company’s current commitments consist primarily of lease obligations for office space.  The Company believes that its capital resources are sufficient to meet its present obligations and those to be incurred in the normal course of business for at least the next 12 months.

The Company leases office facilities and various equipment under non-cancelable leases expiring at various dates through November 2025.  Certain leases are subject to escalation clauses based upon changes in various factors.  The COVID-19 pandemic has had a profound impact on the Company in 2020.  This led the Company to review the guidance in ASC 360-10 to determine if an impairment of a long lived asset had occurred.  It was determined that a portion of the office space leased in a number of locations would not be utilized  through the remaining lease term.  An impairment of the right of use asset for the unused space of $2.2 million was recorded in 2020.  

Maturities of lease liabilities are as follows:

Fiscal Year Ending	Operating Leases		Finance Leases
2021	2,019		255
2022	1,505		109
2023	955		-
2024	232		-
2025	48		-
Thereafter	-		-
Total lease payments	4,759		364
Less: imputed interest	(232	)	(11	)
Total	$4,527		$353

40

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Liquidity and Capital Resources (Continued)

Future Contingent Payments

As of January 2, 2021, the Company had two active acquisition agreements whereby additional contingent consideration may be earned by the former shareholders: 1) effective October 1, 2017, the Company acquired all of the stock of PSR Engineering Solutions d.o.o. Beograd (Voždovac) (“PSR”) and 2) effective September 30, 2018 the Company acquired certain assets of Thermal Kinetics Engineering, PLLC and Thermal Kinetics Systems, LLC (together, “TKE”). The Company estimates future contingent payments at January 2, 2021 as follows:

Fiscal Year Ending	Total
January 1, 2022	500
December 31, 2022	2,358
Estimated future contingent consideration payments	$2,858

Estimates of future contingent payments are subject to significant judgment and actual payments may materially differ from estimates.  Potential future contingent payments to be made to all active acquisitions after January 2, 2021 are capped at a cumulative maximum of $3.1 million.  The Company estimates future contingent consideration payments based on forecasted performance and recorded the fair value of those expected payments as of January 2, 2021.  During the fifty-three week period ended January 2, 2021, the Company measured the intangibles acquired at fair value on a non-recurring basis.  Contingent consideration related to acquisitions are recorded at fair value (level 3) with changes in fair value recorded in other (expense) income, net.

Significant employment agreements are as follows:

Executive Severance Agreements

The Company is a party to Executive Severance Agreements (the “Executive Severance Agreements”) with Mr. Vizi, dated as of June 1, 2018, and Mr. Miller, dated as of February 28, 2014, which set forth the terms and conditions of certain payments to be made by the Company to the executive in the event, while employed by the Company, the executive experiences (a) a termination of employment unrelated to a “Change in Control” (as defined therein) or (b) there occurs a Change in Control and either (i) the executive’s employment is terminated for a reason related to the Change in Control or (ii) in the case of Mr. Miller, Mr. Miller the executive remains continuously employed with the Company for three months following the Change in Control.

Under the terms of the Executive Severance Agreement, if either (a) the executive is involuntarily terminated by the Company for any reason other than “Cause” (as defined therein), “Disability” (as defined therein) or death, or (b) the executive resigns for “Good Reason” (as defined therein), and, in each case, the termination is not a “Termination Related to a Change in Control” (as defined below), the executive will receive the following severance payments: (i) an amount equal to 1.5 times the sum of (a) the executive’s annual base salary as in effect immediately prior to the termination date (before taking into account any reduction that constitutes Good Reason) (“Annual Base Salary”) and (b) the highest annual bonus paid to the executive in any of the three fiscal years immediately preceding the executive’s termination date (“Bonus”), to be paid in installments over the twelve month period following the executive’s termination date; and (ii) for a period of eighteen months following the executive’s termination date, a monthly payment equal to the monthly COBRA premium that the executive is required to pay to continue medical, vision, and dental coverage, for himself and, where applicable, his spouse and eligible dependents.  

41

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

Liquidity and Capital Resources (Continued)

Future Contingent Payments (Continued)

Executive Severance Agreements (Continued)

Notwithstanding the above, if the executive has a termination as described above and can reasonably demonstrate that such termination would constitute a Termination Related to a Change in Control, and a Change in Control occurs within 120 days following the executive’s termination date, the executive will be entitled to receive the payments set forth below for a Termination Related to a Change in Control, less any amounts already paid to the executive, upon consummation of the Change in Control.

Under the terms of the Executive Severance Agreement, if a Change in Control occurs and (a) the executive experiences a Termination Related to a Change in Control on account of (i) an involuntary termination by the Company for any reason other than Cause, death, or Disability, (ii) an involuntary termination by the Company within a specified period of time following a Change in Control (12 months for Mr. Vizi and three months for Mr. Miller) on account of Disability or death, or (iii) a resignation by the executive with Good Reason; or (b) in the case of Mr. Miller, the executive resigns, with or without Good Reason, which results in a termination date that is the last day of the three month period following the Change in Control, then the executive will receive the following severance payments: (1) a lump sum payment equal to two times the sum of the executive’s (a) Annual Base Salary and (b) Bonus; and (2) a lump sum payment equal to 24 multiplied by the monthly COBRA premium cost, as in effect immediately prior to the executive’s termination date, for the executive to continue medical, dental and vision coverage, as applicable, in such Company plans for himself and, if applicable, his spouse and eligible dependents.  Upon the occurrence of a Change in Control, the Company shall establish an irrevocable rabbi trust and contribute to the rabbi trust the applicable amounts due under the Executive Severance Agreement.  If Mr. Miller receives the Change in Control Payment following his resignation at the end of the three month period following the Change in Control, he will not be eligible to receive any severance payments under his Executive Severance Agreement.

Mr. Miller’s Executive Severance Agreement provides that if Mr. Miller remains continuously employed for three months following a Change in Control and is employed by the Company on the last day of such specified period, Mr. Miller will receive a lump sum payment equal to two times the sum of his (a) Annual Base Salary and (b) Bonus (the “Change in Control Payment”).  If Mr. Miller receives the Change in Control Payment, he will not be eligible to receive any severance payments under his Executive Severance Agreement.

Mr. Saks, along with several other members of the Company’s senior management (not including Mr. Vizi and Mr. Miller), is covered by our Change in Control Plan for Selected Executive Management (the “CIC Plan”).

Off-Balance Sheet Arrangements

None.

Impact of Inflation

Consulting, staffing, and project services are generally priced based on mark-ups on prevailing rates of pay, and as a result are able to generally maintain their relationship to direct labor costs.  Permanent placement services are priced as a function of salary levels of the job candidates.

The Company’s business is labor intensive; therefore, the Company has a high exposure to increasing health care benefit costs.  The Company attempts to compensate for these escalating costs in its business cost models and customer pricing by passing along some of these increased health care benefit costs to its customers and employees, however, the Company has not been able to pass on all increases.  The Company is continuing to review its options to further control these costs, which the Company does not believe are representative of general inflationary trends.  Otherwise, inflation has not been a meaningful factor in the Company’s operations.

42

ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
	RESULTS OF OPERATIONS (CONTINUED)

New Accounting Standards

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326). The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities.  In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842), which amends the effective date of the original pronouncement for smaller reporting companies.  ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022.  The Company believes the adoption will modify the way the Company analyzes financial instruments, but it does not anticipate a material impact on results of operations. The Company is in the process of determining the effects the adoption will have on its condensed consolidated financial statements.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This standard only applies to contracts and other transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform.  This guidance provides temporary optional expedients and exceptions to accounting guidance on contract modifications and hedge accounting to ease entities’ financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. The Company may elect to apply the amendments prospectively through December 31, 2022.  The Company is currently evaluating the impact this guidance will have on its condensed consolidated financial statements and related disclosures.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company’s exposure to market risk for changes in interest rates relates primarily to the Company’s investment portfolio and debt instruments, which primarily consist of the Revolving Credit Facility. The Company does not have any derivative financial instruments in its portfolio.  The Company places its investments in instruments that meet high credit quality standards.  The Company is adverse to principal loss and ensures the safety and preservation of its invested funds by limiting default risk, market risk and reinvestment risk.  As of September 26, 2020, the Company’s investments consisted of cash and money market funds.  The Company does not use interest rate derivative instruments to manage its exposure to interest rate changes.  Based on the Company’s variable-rate line of credit balances during the fifty-three week period ended January 2, 2021, if the interest rate on the Company’s variable-rate line of credit (using an incremental borrowing rate) during the period had been 1.0% higher, the Company’s interest expense on an annualized basis would have increased by $0.2 million.  The Company does not expect any material loss with respect to its investment portfolio.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The financial statements, together with the report of the Company’s Independent Registered Public Accounting Firm, begins on page F-1.

ITEM 9.	CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
	FINANCIAL DISCLOSURE

None.

43

ITEM 9A. CONTROLS AND PROCEDURES

The Company’s management, under the supervision and with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report.  Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that those disclosure controls and procedures as of the end of the period covered by this report were effective to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

A controls system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

As management prepares and executes a virtual financial close process, for the first time, there could be related implications on the internal controls performed specifically in conjunction with the preparation, review, and filing of this report. There is a risk that moving to a virtual environment in response to COVID-19 could result in certain controls (e.g., financial closing and reporting controls) being overridden or performed less frequently, or that management could be designing and implementing new controls in response to new risks. In addition, in instances where relevant controls fail, and there are no compensating controls in place, there may be fewer opportunities to timely identify or remediate control deficiencies.  There were otherwise no changes in the Company’s internal control over financial reporting during the fiscal year ended January 2, 2021, that materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our system of internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

Management performed an assessment of the effectiveness of our internal control over financial reporting as of January 2, 2021 based upon criteria in Internal Control-Integrated Framework issued and updated in fiscal 2013 by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on this assessment, management determined that the Company’s internal control over financial reporting was effective as of January 2, 2021, based on the criteria in Internal Control-Integrated Framework issued by COSO.

There have been no changes in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter and that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

44

ITEM 9B. OTHER INFORMATION

On March 29, 2021, the Compensation Committee of the Company’s Board of Directors approved a grant, under the Company's 2014 Omnibus Equity Compensation Plan (as amended and restated, the “2014 Plan”), of a target amount of 90,000 performance stock units (“PSUs”) to Bradley S. Vizi, the Company's Executive Chairman and President. The number of PSUs that will ultimately be earned and vested shall be determined as follows:  50% based on the level of achievement of established levels of EBITDA and 50% based on the level of achievement with respect to certain individual performance goals established by the Compensation Committee, both during a performance period beginning on January 3, 2021 and ending on January 1, 2022.   With respect to the both the EBITDA and individual performance goals, threshold, target and maximum levels of performance have been established, with the following number of PSUs to be earned with respect to each such level: threshold – 22,500; target – 45,000; maximum – 62,500.  The grant is subject to accelerated vesting in the event of a Change in Control (as defined in the 2014 Plan) prior to the end of the performance period.

45

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information required by Item 10 shall be included in the 2021 Proxy Statement and is incorporated herein by reference.

ITEM 11. EXECUTIVE COMPENSATION

The information required by Item 11 shall be included in the 2021 Proxy Statement and is incorporated herein by reference.

ITEM 12.	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
	AND RELATED STOCKHOLDER MATTERS

Except as set forth below, the information required by Item 12 shall be included in the 2021 Proxy Statement and is incorporated herein by reference.

The table below presents certain information concerning securities issuable in connection with equity compensation plans that have been approved by the Company’s shareholders and that have not been approved by the Company’s shareholders.

Plan category	Number of securities to be potentially issued upon realization of restricted stock awards	Weighted-average exercise price of outstanding options, warrants and rights	Number of securities remaining available for issuance under equity compensation plans, excluding securities reflected in column (a)
	(a)	(b)	(c)
Equity compensation plans approved by security holders	709,805(1)	N/A	520,929
Equity compensation plans not approved by security holders	____________________	____________________	____________________
Total	709,805(1)	N/A	520,929

⁽¹⁾  Includes time-based restricted stock units of 352,661 and time-based restricted stock awards of 357,144, none of which have an exercise price.

ITEM 13.	CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
	INDEPENDENCE

The information required by Item 13 shall be included in the 2021 Proxy Statement and is incorporated herein by reference.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information required by Item 14 shall be included in the 2021 Proxy Statement and is incorporated herein by reference.

46

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)	1. and 2. Financial Statement Schedules -- See “Index to Financial Statements and Schedules” on F-1.
	3. See Item (b) below.
(b)	Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this report (unless otherwise indicated, the file number with respect to each filed document is 1-10245):
		(3)(a)	Articles of Incorporation, as amended; incorporated by reference to Exhibit 3(a) to the Registrant’s Annual Report on Form 10-K for the fiscal year ended October 31, 1994, filed with the Securities and Exchange Commission on January 4, 1995.
		(3)(b)	Certificate of Amendment of Articles of Incorporation; incorporated by reference to Exhibit A to the Registrant’s Proxy Statement, dated February 6, 1996, filed with the Securities and Exchange Commission on January 29, 1996.
		(3)(c)	Certificate of Amendment of Articles of Incorporation; incorporated by reference to Exhibit B to the Registrant’s Proxy Statement, dated February 6, 1996, filed with the Securities and Exchange Commission on January 29, 1996.
		(3)(d)	Amended and Restated Bylaws; incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 23, 2014 (the “January 2014 8-K”).
		(3)(e)	Certificate of Designation of Series A-3 Junior Participating Preferred Stock of RCM Technologies, Inc.; incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 22, 2020 (the “May 2020 8-K”).
		(4)(a)	Description of Capital Stock. (Filed herewith)
		(4)(b)	Rights Agreement, dated as of May 22, 2020, by and between RCM Technologies, Inc. and American Stock Transfer & Trust Company, LLC, as rights agent; incorporated by reference to Exhibit 4.1 to the May 2020 8-K.
	*	(10)(a)	RCM Technologies, Inc. 2000 Employee Stock Incentive Plan, dated January 6, 2000; incorporated by reference to Exhibit A to the Registrant’s Proxy Statement, dated March 3, 2000, filed with the Securities and Exchange Commission on February 28, 2000.
	*	(10)(b)	The RCM Technologies, Inc. 2007 Omnibus Equity Compensation Plan; incorporated by reference to Annex A to the Registrant’s Proxy Statement, dated April 20, 2007, filed with the Securities and Exchange Commission on April 19, 2007.
	*	(10)(c)	Executive Severance Agreement between RCM Technologies, Inc. and Kevin Miller dated December 27, 2012; incorporated by reference to Exhibit 99.2 to the Registrant’s Current Report on Form 8-K dated December 27, 2012, filed with the Securities and Exchange Commission on December 28, 2012.
	*	(10)(d)	Amendment No. 1 to Executive Severance Agreement between RCM Technologies, Inc. and Kevin Miller dated December 26, 2017; incorporated by reference to Exhibit 10(x) to the Registrant’s Annual Report on Form 10-K for this fiscal year ended December 28, 2019, filed with the Securities and Exchange Commission on March 8, 2018.

47

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES (CONTINUED)

(b)	Exhibits (Continued)
	*	(10)(e)	RCM Technologies, Inc. Amended and Restated 2014 Omnibus Equity Compensation Plan (as amended through December 17, 2020); incorporated by reference to Exhibit 99.1 to the Company’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on December 18, 2020.
	*	(10)(f)	Form of Stock Unit Agreement; incorporated by reference to Exhibit 99.2 to the December 2014 8-K.
	*	(10)(g)	RCM Technologies, Inc. Change in Control Plan for Selected Executive Management (filed as an exhibit to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 12, 2015 and incorporated herein by reference).
	*	(10)(h)	Amendment 2015-3 to the RCM Technologies, Inc. 2001 Employee Stock Purchase Plan; incorporated by reference to Exhibit A to the Registrant’s Definitive Proxy Statement for the 2015 Annual Meeting filed with the Securities and Exchange Commission on October 30, 2015.
	*	(10)(i)	Amendment 2018-4 to the RCM Technologies, Inc. 2001 Employee Stock Purchase Plan; incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on December 18, 2018.
	*	(10)(j)	Executive Severance Agreement, dated as of June 1, 2018, by and between the Company and Bradley S. Vizi; incorporated by reference to Exhibit 99.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on June 7, 2018.
		(10)(k)	Third Amended & Restated Loan and Security Agreement, dated as of August 9, 2018, by and among the Company and all of its subsidiaries, Citizens Bank of Pennsylvania, a Pennsylvania state chartered bank, in its capacity as administrative agent and arranger, and Citizens Bank of Pennsylvania, as lender; incorporated by reference to Exhibit 10(d) to the Registrant’s Quarterly Report on Form 10-Q for this fiscal quarter ended June 30, 2018, filed with the Securities and Exchange Commission on August 14, 2018.
		(10)(l)	First Amendment to Third Amended and Restated Loan Agreement, dated as of August 9, 2018, by and among the Company and all of its subsidiaries, and Citizens Bank, N.A., a national banking association (as successor by merger to Citizens Bank of Pennsylvania), in its capacities as lender and as administrative agent and arranger; incorporated by reference to Exhibit 99 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 22, 2019.
		(10)(m)	Amendment No. 2 to Third Amended and Restated Loan Agreement, dated as of June 2, 2020, by and among the Company and all of its subsidiaries, and Citizens Bank, N.A., a national banking association (as successor by merger to Citizens Bank of Pennsylvania), in its capacities as lender and as administrative agent and arranger; incorporated by reference to Exhibit 10.4 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on June 2, 2020.
		(10)(n)	Amendment No. 3 to Third Amended and Restated Loan Agreement, dated as of September 29, 2020, by and among the Company and all of its subsidiaries, and Citizens Bank, N.A., a national banking association (as successor by merger to Citizens Bank of Pennsylvania), in its capacities as lender and as administrative agent and arranger; incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 1, 2020.

48

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES (CONTINUED)

(b)	Exhibits (Continued)
		(21)	Subsidiaries of the Registrant.  (Filed herewith)
		(23.1)	Consent of Macias, Gini & O’Connell, LLP.  (Filed herewith)
		(31.1)	Certifications of Chief Executive Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.  (Filed herewith)
		(31.2)	Certifications of Chief Financial Officer Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.  (Filed herewith)
		(32.1)	Certifications of Chief Executive Officer Required by Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended.  (This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section.  Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)  (Furnished herewith)
		(32.2)	Certifications of Chief Financial Officer Required by Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended.  (This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section.  Further, this exhibit shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.)  (Furnished herewith)
		101.INS	XBRL Instance Document (Filed herewith)
		101.SCH	XBRL Taxonomy Extension Schema Document (Filed herewith)
		101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document (Filed herewith)
		101.LAB	XBRL Taxonomy Extension Label Linkbase Document (Filed herewith)
		101.PRE	XBRL Taxonomy Extension Presentation Linkbase Documents (Filed herewith)
		101.DEF	XBRL Taxonomy Definition Linkbase Document (Filed herewith)
	*	Constitutes a management contract or compensatory plan or arrangement.
	+	The Registrant will furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request.

ITEM 16. FORM 10-K SUMMARY

None.

49

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	RCM Technologies, Inc.
Date:  April 2, 2021	By:	/s/ Bradley S. Vizi
		Bradley S. Vizi
		Executive Chairman and President
Date:  April 2, 2021	By:	/s/ Kevin D. Miller
		Kevin D. Miller
		Chief Financial Officer, Treasurer and Secretary

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Date:  April 2, 2021	By:	/s/ Bradley S. Vizi
		Bradley S. Vizi
		Executive Chairman and President
Date:  April 2, 2021	By:	/s/ Kevin D. Miller
		Kevin D. Miller
		Chief Financial Officer, Treasurer and Secretary (Principal Financial and Accounting Officer)
Date:  April 2, 2021	By:	/s/ Roger H. Ballou
		Roger H. Ballou
		Director
Date:  April 2, 2021	By:	/s/ Richard A. Genovese
		Richard A. Genovese
		Director
Date:  April 2, 2021	By:	/s/ Swarna Kakodkar
		Swarna Kakodkar
		Director
Date:  April 2, 2021	By:	/s/ Jayanth S. Komarneni
		Jayanth S. Komarneni
		Director

50

RCM TECHNOLOGIES, INC.

FORM 10-K

INDEX TO FINANCIAL STATEMENTS AND SCHEDULES

	Page
Consolidated Balance Sheets, January 2, 2021 and December 28, 2019	F-2
Consolidated Statements of Operations, Fiscal Years Ended January 2, 2021 and      December 28, 2019	F-3
Consolidated Statements of Comprehensive (Loss) Income, Fiscal Years Ended      January 2, 2021 and December 28, 2019	F-4
Consolidated Statements of Changes in Stockholders’ Equity, Fiscal Years Ended      January 2, 2021 and December 28, 2019	F-5
Consolidated Statements of Cash Flows, Fiscal Years Ended January 2, 2021 and      December 28, 2019	F-6
Notes to Consolidated Financial Statements	F-7
Report of Independent Registered Public Accounting Firm	F-41

F-1

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

January 2, 2021 and December 28, 2019

(Amounts in thousands, except share and per share amounts, unless otherwise indicated)

			January 2,	December 28,
			2021	2019
Current assets:
	Cash and cash equivalents		$734	$1,847
	Accounts receivable, net		36,007	59,760
	Transit accounts receivable		2,494	4,906
	Prepaid expenses and other current assets		4,699	4,144
		Total current assets	43,934	70,657
Property and equipment, net			2,078	2,717
Other assets:
	Deposits		169	209
	Deferred tax assets, net, domestic		3,300	-
	Goodwill		16,354	16,354
	Operating right of use asset		2,409	5,820
	Intangible assets, net		95	416
		Total other assets	22,327	22,799
		Total assets	$68,339	$96,173

Current liabilities:
	Accounts payable and accrued expenses			$7,895		$6,220
	Transit accounts payable			4,900		4,552
	Accrued payroll and related costs			12,877		7,713
	Finance lease payable			247		315
	Income taxes payable			436		130
	Operating right of use liability			1,886		2,134
	Liability for contingent consideration from acquisitions			500		344
			Total current liabilities	28,741		21,408
Deferred tax liability, foreign				365		382
Deferred tax liability, net, domestic				-		395
Finance lease payable				106		189
Liability for contingent consideration from acquisitions				2,358		2,714
Operating right of use liability, net of current position				2,641		3,921
Borrowings under line of credit				11,890		34,761
		Total liabilities		46,101		63,770
Stockholders’ equity:
	Preferred stock, $1.00 par value; 5,000,000 shares authorized;
			no shares issued or outstanding	-		-
	Common stock, $0.05 par value; 40,000,000 shares authorized;
			16,224,191 shares issued and 11,542,880 shares outstanding at January 2, 2021 and 15,826,891 shares issued and 13,003,719 shares outstanding at December 28, 2019	811		791
			Stock subscription receivable	(420	)	-
	Additional paid-in capital			109,588		108,452
	Accumulated other comprehensive loss			(2,550)		(2,748	)
	Accumulated deficit			(67,974	)	(59,105	)
	Treasury stock (4,681,311 shares at January 2, 2021 and 2,823,172 at December 28, 2019) at cost			(17,217	)	(14,987	)
			Stockholders’ equity	22,238		32,403
			Total liabilities and stockholders’ equity	$68,339		$96,173

The accompanying notes are an integral part of these consolidated financial statements.

F-2

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

Fiscal Years Ended January 2, 2021 and December 28, 2019

(Dollars in thousands, except per share amounts, unless otherwise indicated)

		January 2, 2021		December 28, 2019
Revenues		$150,409		$191,100
Cost of services		111,554		142,508
Gross profit		38,855		48,592
Operating costs and expenses
	Selling, general and administrative	37,551		40,390
	Depreciation and amortization of property and equipment	1,065		1,261
	Amortization of acquired intangible assets	321		327
	Write-off of receivables and professional fees    incurred related to arbitration	8,397		-
	Impairment of right of use assets and related costs	2,231		-
	Tax credit professional fees	240		47
	Operating costs and expenses	49,805		42,025
Operating (loss) income		(10,950	)	6,567
Other (expense) income
	Interest expense and other, net	(778	)	(1,695	)
	Change in fair value of contingent consideration	(145	)	(61	)
	(Loss) gain on foreign currency transactions	(184	)	11
	Other expense, net	(1,107	)	(1,745	)
(Loss) income before income taxes		(12,057	)	4,822
Income tax (benefit) expense		(3,188	)	764
Net (loss) income		($8,869	)	$4,058
Basic and diluted net (loss) income per share		($0.73	)	$0.31

The accompanying notes are an integral part of these consolidated financial statements.

F-3

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

 Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands unless otherwise indicated)

	January 2,		December 28,
	2021		2019
Net (loss) income	($8,869	)	$4,058
Other comprehensive income	198		7
Total comprehensive (loss) income	($8,671	)	$4,065

The accompanying notes are an integral part of these consolidated financial statements.

F-4

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Amounts in thousands, except share amounts, unless otherwise indicated)

	Common Stock		Stock Subscription Receivable		Additional Paid-in Capital		Accumulated Other Comprehensive Loss		Accumulated Deficit		Treasury Stock			Total
	Issued Shares	Amount									Shares	Amount
Balance, December 29, 2018	15,578,345	$778	-		$107,326		($2,755	)	($63,163	)	2,823,172	($14,987	)	$27,199
Issuance of stock under    employee stock purchase plan	118,526	6	-		315		-		-		-	-		321
Translation adjustment	-	-	-		-		7		-		-	-		7
Issuance of stock upon vesting    of restricted share awards	130,020	7	-		(7	)	-		-		-	-		-
Share based compensation expense	-	-	-		806		-		-		-	-		806
Accrued dividends forfeited	-	-	-		12		-		-		-	-		12
Net income	-	-	-		-		-		$4,058		-	-		$4,058
Balance, December 28, 2019	15,826,891	$791	-		$108,452		($2,748	)	($59,105	)	2,823,172	($14,987	)	$32,403
			-
Issuance of stock under    employee stock purchase plan	117,983	6	-		202		-		-		-	-		208
Stock subscription receivable	-	-	(420	)	420		-		-		-	-		-
Translation adjustment	-	-	-		-		198		-		-	-		198
Issuance of stock upon vesting    of restricted share awards	279,317	14	-		(14	)	-		-		-	-		-
Equity compensation expense from    awards issued	-	-	-		528		-		-		-	-		528
Purchase of treasury stock	-	-	-		-		-		-		1,858,139	(2,230	)	(2,230	)
Net loss	-	-	-		-		-		(8,869	)	-	-		(8,869	)
Balance, January 2, 2021	16,224,191	$811	($420	)	$109,588		($2,550	)	($67,974	)	4,681,311	($17,217	)	$22,238

The accompanying notes are an integral part of these consolidated financial statements.

F-5

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands unless otherwise indicated)

				January 2, 2021		December 28, 2019
Cash flows from operating activities:
	Net (loss) income			($8,869	)	$4,058
	Adjustments to reconcile net income to net cash provided by (used in)   operating activities:
		Depreciation and amortization		1,386		1,588
		Change in fair value of contingent consideration		145		61
		Impairment of right of use assets and related costs		2,231		-
		Equity compensation expense		1,108		806
		Provision for losses on accounts receivable		7,911		322
		Deferred income tax (benefit) expense		(3,712	)	1,104
		Changes in assets and liabilities:
			Accounts receivable	15,947		(7,626		)
			Prepaid expenses and other current assets	(162	)	(645		)
			Net of transit accounts receivable and payable	2,757		(293		)
			Accounts payable and accrued expenses	1,639		(3,085		)
			Accrued payroll and related costs	4,557		(1,342		)
			Right of use assets	1,490		(5,820		)
			Right of use liabilities	(1,529	)	6,056
			Income taxes payable	304		38
	Total adjustments			34,072		(8,836		)
	Net cash provided by (used in) operating activities			25,203		(4,778		)
Cash flows from investing activities:
	Property and equipment acquired			(460	)	(367		)
	Decrease in deposits			41		4
	Net cash used in investing activities			(419	)	(363		)
Cash flows from financing activities:
	Borrowings under line of credit			73,238		95,554
	Repayments under line of credit			(96,109	)	(88,332		)
	Issuance of stock for employee stock purchase plan			208		321
	Changes in finance lease obligations			(394	)	(318		)
	Contingent consideration paid			(345	)	(598		)
	Payment of note payable for treasury stock			(2,230	)	-
	Net cash (used in) provided by financing activities			(25,632	)	6,627
Effect of exchange rate changes on cash and cash equivalents				(265	)	(121		)
(Decrease) increase in cash and cash equivalents				(1,113	)	1,365
Cash and cash equivalents at beginning of period				1,847		482
Cash and cash equivalents at end of period				$734		$1,847
Supplemental cash flow information:
	Cash paid for:
		Interest		$1,026		$1,657
		Income taxes		$264		$290
Non-cash financing activities:
	Equity awards issued			$492			$436
	Dividend forfeited on unvested restricted share awards			$     -			$  12
	Software purchase under finance leases			$258			$126

The accompanying notes are an integral part of these consolidated financial statements.

F-6

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Description of Business and Basis of Presentation

RCM Technologies, Inc. (the “Company” or “RCM”) is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced engineering and information technology services.  Additionally, the Company provides specialty health care staffing services through its Specialty Health Care Services group.  RCM’s offices are primarily located in major metropolitan centers throughout North America.

The consolidated financial statements are comprised of the accounts of the Company and its wholly owned subsidiaries.  All significant intercompany accounts and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

The Company considers its holdings of highly liquid money-market instruments and certificates of deposits to be cash equivalents if the securities mature within 90 days from the date of acquisition.  These investments are carried at cost, which approximates fair value.  The Company’s cash balances are maintained in accounts held by major banks and financial institutions.  The majority of these balances may exceed federally insured amounts.  The Company held $42 and $56 of cash and cash equivalents in Canadian banks as of January 2, 2021 and December 28, 2019, respectively, which was held principally in Canadian dollars.  The Company held $246 and $129 of cash and cash equivalents in Serbian banks as of January 2, 2021 and December 28, 2019, respectively, which was held in various currencies. 

Fair Value of Financial Instruments

The Company’s carrying value of financial instruments, consisting primarily of accounts receivable, transit accounts receivable, accounts payable and accrued expenses, and transit accounts payable and borrowings under line of credit approximates fair value due to their liquidity or their short-term nature and the line of credit’s variable interest rate.  The Company does not have derivative products in place to manage risks related to foreign currency fluctuations for its foreign operations or for interest rate changes.

Accounts Receivable and Allowance for Doubtful Accounts

The Company’s accounts receivable are primarily due from trade customers.  Credit is extended based on evaluation of customers’ financial condition and, generally, collateral is not required.  Accounts receivable payment terms vary and are stated in the financial statements at amounts due from customers net of an allowance for doubtful accounts.  Accounts outstanding longer than the payment terms are considered past due. The Company determines its allowance by considering a number of factors, including the length of time trade accounts receivable are past due, the Company’s previous loss history, the customer’s current ability to pay its obligation to the Company, and the condition of the general economy and the industry as a whole.  The Company writes off accounts receivable when they become uncollectible, and payments subsequently received on such receivables previously written off are credited to bad debt expense.

F-7

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Accrued and Unbilled Accounts Receivable and Work-in-Process

Unbilled receivables primarily represent revenues earned whereby those services are ready to be billed as of the balance sheet ending date.  Work-in-process primarily represents revenues earned under contracts which the Company is contractually precluded from invoicing until future dates as project milestones are realized.  See Note 4 for further details.

Transit Receivables and Transit Payables

From time to time, the Company’s Engineering segment enters into agreements to provide, among other things, construction management and engineering services.  Pursuant to these agreements, the Company a) may engage subcontractors to provide construction or other services; b) typically earns a fixed percentage of the total project value; and c) assumes no ownership or risks of inventory.  In such situations, the Company acts as an agent under the provisions of FASB ASC 606 “Revenue from Contracts with Customers” and therefore recognizing revenue on a “net-basis.”  The Company records revenue on a “net” basis on relevant engineering and construction management projects, which require subcontractor/procurement costs or transit costs. In those situations, the Company charges the client a negotiated fee, which is reported as net revenue when earned. 

Under the terms of the agreements, the Company is typically not required to pay the subcontractor until after the corresponding payment from the Company’s end-client is received. Upon invoicing the end-client on behalf of the subcontractor or staffing agency the Company records this amount simultaneously as both a “transit account receivable” and “transit account payable” as the amount when paid to the Company is due to and generally paid to the subcontractor within a few days. The Company typically does not pay a given transit account payable until the related transit account receivable is collected. The Company is typically obligated to pay the subcontractor or staffing agency whether or not the client pays the Company.  The Company’s transit accounts payable generally exceeds the Company’s transit accounts receivable but absolute amounts and spreads fluctuate significantly from quarter to quarter in the normal course of business.

Property and Equipment

Property and equipment are stated at cost and are depreciated on the straight-line method at rates calculated to provide for retirement of assets at the end of their estimated useful lives.  The annual rates are 20% for computer hardware and software as well as furniture and office equipment.  Leasehold improvements are amortized over the shorter of the estimated life of the asset or the lease term.

F-8

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Intangible Assets

The Company’s intangible assets have been generated through acquisitions.  The Company maintains responsibility for valuing and determining the useful life of intangible assets.  As a general rule, the Company amortizes restricted covenants over four years and customer relationships over six years.  However, circumstances may dictate other amortization terms as determined by the Company and assisted by their third party advisors.

Canadian Sales Tax

The Company is required to charge and collect sales tax for all Canadian clients and remits invoiced sales tax monthly to the Canadian taxing authorities whether collected or not.  The Company does not collect the sales tax from its clients until they have paid their respective invoices.  The Company includes uncollected Canadian sales tax invoiced to clients in its prepaid and other current assets.

Goodwill

Goodwill is not amortized but is subject to periodic testing for impairment in accordance with FASB ASC 350 “Intangibles - Goodwill and Other.”  The Company tests goodwill for impairment on an annual basis as of the last day of the Company’s fiscal December each year or more frequently if events occur or circumstances change indicating that the fair value of the goodwill may be below its carrying amount. The Company has three reporting units.  The Company uses a market-based approach to determine the fair value of the reporting units.  This approach uses earnings/revenue multiples of similar companies recently completing acquisitions and the ability of our reporting units to generate cash flows as measures of fair value of our reporting units. The Company adopted Accounting Standards Update (“ASU”) 2017-04, “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment” effective December 28, 2019 which has eliminated Step 2 from the goodwill impairment test. Under this update, an entity should perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount.

The Company did not record a goodwill impairment charge in fiscal years ended January 2, 2021 and December 28, 2019.  There can be no assurance that future indicators of impairment and tests of goodwill impairment will not result in an impairment charge.

F-9

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Long-Lived and Intangible Assets

The Company evaluates long-lived assets and intangible assets with definite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  When the Company determines that it is probable that undiscounted future cash flows will not be sufficient to recover an asset’s carrying amount, the asset is written down to its fair value.  Assets to be disposed of by sale, if any, are reported at the lower of the carrying amount or fair value less cost to sell.  The Company’s intangible assets consist of customer relationships and non-compete agreements. 

Software

In accordance with FASB ASC 350-40 “Accounting for Internal Use Software,” certain costs related to the development or purchase of internal-use software are capitalized and amortized over the estimated useful life of the software.  During the fiscal years ended January 2, 2021 and December 28, 2019, the Company capitalized $305 and $139, respectively, for software costs.  The net balance after accumulated depreciation for all software costs capitalized as of January 2, 2021 and December 28, 2019 was $1,389 and $1,726, respectively.

Income Taxes

The Company makes judgments and interpretations based on enacted tax laws, published tax guidance, as well as estimates of future earnings.  These judgments and interpretations affect the provision for income taxes, deferred tax assets and liabilities and the valuation allowance.  The Company evaluated the deferred tax assets and determined on the basis of objective factors that the net assets will be realized through future years’ taxable income.  In the event that actual results differ from these estimates and assessments, additional valuation allowances may be required.  The Company did not have any valuation allowance as of January 2, 2021 or December 28, 2019.

The Company accounts for income taxes in accordance with FASB ACS 740 “Income Taxes” (FASB ASC 740) which requires an asset and liability approach of accounting for income taxes.  FASB ASC 740 requires assessment of the likelihood of realizing benefits associated with deferred tax assets for purposes of determining whether a valuation allowance is needed for such deferred tax assets.  Deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that such tax rate changes are enacted.  The Company measures its deferred tax assets and liabilities using the tax rates that the Company believes will apply in the years in which the temporary differences are expected to be recovered or paid.  The Company and its wholly owned United States subsidiaries file a consolidated federal income tax return.  The Company also files tax returns in Canada, Puerto Rico and Serbia.

The Company also follows the provisions of FASB ASC 740 which prescribes a model for the recognition and measurement of a tax position taken or expected to be taken in a tax return, and provides guidance on derecognition, classification, interest and penalties, disclosure and transition.  The Company’s policy is to record interest and penalty, if any, as interest expense.

F-10

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Revenue Recognition

The Company records revenue under Accounting Standards Codification ("ASC") Topic 606, Revenue from Contracts with Customers.  Revenue is recognized when we satisfy a performance obligation by transferring services promised in a contract to a customer, in an amount that reflects the consideration that we expect to receive in exchange for those services.  Performance obligations in our contracts represent distinct or separate service streams that we provide to our customers.  

We evaluate our revenue contracts with customers based on the five-step model under ASC 606: (1) Identify the contract with the customer; (2) Identify the performance obligations in the contract; (3) Determine the transaction price; (4) Allocate the transaction price to separate performance obligations; and (5) Recognize revenue when (or as) each performance obligation is satisfied.

The Company derives its revenue from several sources.  The Company’s Engineering Services and Information Technology Services segments perform consulting and project solution services.  The Healthcare segment specializes in long-term and short-term staffing and placement services to hospitals, schools and long-term care facilities amongst others.  All of the Company’s segments perform staff augmentation services and derive revenue from permanent placement fees.  The majority of the Company’s revenue is invoiced on a time and materials basis.

The following table presents our revenues disaggregated by revenue source for the fifty-three week period ended January 2, 2021 and the fifty-two week period December 28, 2019:

	January 2, 2021	December 28, 2019
Engineering:
Time and Material	$43,359	$55,195
Fixed Fee	14,145	12,678
Permanent Placement Services	211	-
Total Engineering	$57,715	$67,873
Specialty Health Care:
Time and Material	$59,692	$88,057
Permanent Placement Services	789	1,291
Total Specialty Health Care	$60,481	$89,348
Information Technology:
Time and Material	$31,723	$33,384
Permanent Placement Services	490	495
Total Information Technology	$32,213	$33,879
	$150,409	$191,100

F-11

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Revenue Recognition (Continued)

Time and Material

The Company’s IT and Healthcare segments predominantly recognize revenue through time and material work while its Engineering segment recognizes revenue through both time and material and fixed fee work. The Company’s time and material contracts are typically based on the number of hours worked at contractually agreed upon rates, therefore revenue associated with these time and materials contracts are recognized based on hours worked at contracted rates. 

Fixed fee

From time to time and predominantly in our Engineering segment, the Company will enter into contracts requiring the completion of specific deliverables.  The Company has master services agreements with many of its customers that broadly define terms and conditions. Actual services performed under fixed fee arrangements are typically delivered under purchase orders that more specifically define terms and conditions related to that fixed fee project. While these master services agreements can often span several years, the Company’s fixed fee purchase orders are typically performed over six to nine month periods.  In instances where project services are provided on a fixed-price basis, revenue is recorded in accordance with the terms of each contract.  In certain instances, revenue is invoiced at the time certain milestones are reached, as defined in the contract.  Revenue under these arrangements are recognized as the costs on these contracts are incurred.  On an infrequent basis, amounts paid in excess of revenue earned and recognized are recorded as deferred revenue, included in accounts payable and accrued expenses on the accompanying condensed balance sheets.  In other instances, revenue is billed and recorded based upon contractual rates per hour.  Additionally, some contracts contain “Performance Fees” (bonuses) for completing a contract under budget.  Performance Fees, if any, are recorded when earned.  Some contracts also limit revenue and billings to specified maximum amounts.  Provisions for contract losses, if any, are made in the period such losses are determined.  For contracts where there is a specific deliverable and the work is not complete and the revenue is not recognized, the costs incurred are deferred as a prepaid asset.  The associated costs are expensed when the related revenue is recognized.

Permanent Placement Services

The Company earns permanent placement fees from providing permanent placement services.  Fees for placements are recognized at the time the candidate commences employment.  The Company guarantees its permanent placements on a prorated basis for 90 days.  In the event a candidate is not retained for the 90-day period, the Company will provide a suitable replacement candidate.  In the event a replacement candidate cannot be located, the Company will provide a prorated refund to the client.  An allowance for refunds, based upon the Company’s historical experience, is recorded in the financial statements.  Permanent placement revenue was $1.5 million for the fiscal year ended January 2, 2021 and $1.8 million for the fiscal year ended December 28, 2019.

The deferred revenue balance as of both January 2, 2021 and December 28, 2019 was $0.4 million. These amounts are included in accounts payable and accrued expense in the accompanying consolidated balance sheets at that date.  Revenue is recognized when the service has been performed.  Deferred revenue may be recognized over a period exceeding one year from the time it was recorded on the balance sheet, although this is an infrequent occurrence.  For the fifty-three week period ended January 2, 2021 and the fifty-two week period ended December 28, 2019, the Company recognized revenue of $0.4 million and $0.2 million, respectively, that was included in deferred revenue at the beginning of the reporting period.

F-12

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Revenue Recognition (Continued)

Transit Receivables and Transit Payables

From time to time, the Company’s Engineering segment enters into agreements to provide, among other things, construction management and engineering services.  Pursuant to these agreements, the Company a) may engage subcontractors to provide construction or other services; b) typically earns a fixed percentage of the total project value; and c) assumes no ownership or risks of inventory.  Under the terms of the agreements, the Company is typically not required to pay the subcontractor until after the corresponding payment from the Company’s end-client is received. Upon invoicing the end-client on behalf of the subcontractor or staffing agency the Company records this amount simultaneously as both a “transit account receivable” and “transit account payable” as the amount when paid to the Company is due to and generally paid to the subcontractor within a few days. The Company typically does not pay a given transit account payable until the related transit account receivable is collected. The Company is typically obligated to pay the subcontractor or staffing agency whether or not the client pays the Company.  The Company’s transit accounts payable generally exceeds the Company’s transit accounts receivable but absolute amounts and spreads fluctuate significantly from quarter to quarter in the normal course of business.  The transit accounts receivable was $2.5 million and related transit accounts payable was $4.9 million, for a net payable of $2.4 million, as of January 2, 2021.  The transit accounts receivable was $4.9 million and related transit accounts payable was $4.6 million, for a net receivable of $0.3 million, as of December 28, 2019. 

Concentration

During the fiscal year ended January 2, 2021, New York City Board of Education represented 10.6% of the Company’s revenues.  No other client accounted for 10% or more of total revenues during the year.  As of January 2, 2021, the following clients represented more than 10.0% of the Company’s accounts receivable, net: New York City Board of Education was 11.8% and Hawaii Department of Education was 10.6%.  No other customer accounted for 10% or more of the Company’s accounts receivable, net. The Company’s five, ten and twenty largest customers accounted for approximately 33.4%, 46.6% and 60.7%, respectively, of the Company’s revenues for the fiscal year ended January 2, 2021.

During the fiscal year ended December 28, 2019, New York City Board of Education and Hawaii Department of Education represented 17.6% and 11.1% of the Company’s revenues, respectively.  No other client accounted for 10% or more of total revenues during the year.  As of December 28, 2019, the following clients represented more than 10.0% of the Company’s accounts receivable, net: New York Power Authority was 24.6%, New York City Board of Education was 17.6% and Hawaii Department of Education was 12.7%.  As of December 28, 2019, New York Power Authority total accounts receivable balance (including transit accounts receivable) was 27.3% of the total of accounts receivable, net and transit accounts receivable.  No other customer accounted for 10% or more of the Company’s accounts receivable, net or total accounts receivable balance (including transit accounts receivable). The Company’s five, ten and twenty largest customers accounted for approximately 43.5%, 57.0% and 69.2%, respectively, of the Company’s revenues for the fiscal year ended December 28, 2019.

F-13

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Foreign Currency Translation

The functional currency of the Company’s Canadian and Serbian subsidiaries is the local currency.  Assets and liabilities are translated at period-end exchange rates.  Income and expense items are translated at weighted average rates of exchange prevailing during the year.  Any translation adjustments are included in the accumulated other comprehensive income account in stockholders’ equity.  Transactions executed in different currencies resulting in exchange adjustments are translated at spot rates and resulting foreign exchange transaction gains and losses are included in the results of operations.

Comprehensive Income

Comprehensive income consists of net income and foreign currency translation adjustments.

Per Share Data

Basic net income per share is calculated using the weighted-average number of common shares outstanding during the period.  Diluted net income per share is calculated using the weighted-average number of common shares plus dilutive potential common shares outstanding during the period.  Potential dilutive common shares consist of stock options and other stock-based awards under the Company’s stock compensation plans, when their impact is dilutive.  Because of the Company’s capital structure, all reported earnings pertain to common shareholders and no other adjustments are necessary.

Share - Based Compensation

The Company recognizes share-based compensation over the vesting period of an award based on fair value at the grant date determined using the Black-Scholes option pricing model.  Certain assumptions are used to determine the fair value of stock-based payment awards on the date of grant and require subjective judgment.  Because employee stock options have characteristics significantly different from those of traded options, and because changes in the input assumptions can materially affect the fair value estimate, the existing models may not provide a reliable single measure of the fair value of the employee stock options.  Management assesses the assumptions and methodologies used to calculate estimated fair value of stock-based compensation when share-based awards are granted.  Circumstances may change and additional data may become available over time, which could result in changes to these assumptions and methodologies and thereby materially impact our fair value determination.  See Note 11 for additional share-based compensation information.

Restricted share awards are recognized at their fair value.  The amount of compensation cost is measured on the grant date fair value of the equity instrument issued.  The compensation cost of the restricted share awards is recognized over the vesting period of the restricted share awards on a straight-line basis.  Restricted share awards typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period assuming the grantee’s restricted stock unit fully vests.  Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying consolidated balance sheet.  Dividends for restricted share awards that ultimately do not vest are forfeited.

F-14

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

1.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Advertising Costs

Advertising costs are expensed as incurred.  Total advertising expense was $800 and $855 for the fiscal years ended January 2, 2021 and December 28, 2019, respectively.

Fair Value Measurements

The Company values its financial assets and liabilities based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  In order to increase consistency and comparability in fair value measurements, a fair value hierarchy was established that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:

Level 1:  Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.  The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2:  Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in inactive markets; or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data.

Level 3:  Unobservable inputs are used when little or no market data is available.  The fair value hierarchy gives the lowest priority to Level 3 inputs.

In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.

Reclassification

Certain prior year amounts have been reclassified to conform with the current year presentation.  These classifications had no effect on the previously reported results of operations.

2. FISCAL YEAR

The Company follows a 52/53 week fiscal reporting calendar ending on the Saturday closest to December 31.  The fiscal year ended January 2, 2021 (fiscal 2020) was a 53-week reporting year.  The fiscal year ended December 28, 2019 (fiscal 2019) was a 52-week reporting year. 

F-15

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

3. USE OF ESTIMATES AND UNCERTAINTIES

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expenses and disclosure of contingent assets and liabilities.  Actual results could differ from those estimates.

The Company uses estimates to calculate an allowance for doubtful accounts on its accounts receivables, adequacy of reserves, goodwill impairment, if any, equity compensation, the tax rate applied and the valuation of certain assets and liability accounts.  These estimates can be significant to the operating results and financial position of the Company.  The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-19.  Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.

The Company has risk participation arrangements with respect to workers compensation and health care insurance.  The amounts included in the Company’s costs related to this risk participation are estimated and can vary based on changes in assumptions, the Company’s claims experience or the providers included in the associated insurance programs.

The Company can be affected by a variety of factors including uncertainty relating to the performance of the general economy, competition, demand for the Company’s services, adverse litigation and claims and the hiring, training and retention of key employees.

Fair Value of Financial Instruments

The Company’s carrying value of financial instruments, consisting primarily of accounts receivable, transit accounts receivable, accounts payable and accrued expenses, and transit accounts payable and borrowings under line of credit approximates fair value due to their liquidity or their short-term nature and the line of credit’s variable interest rate.  The Company does not have derivative products in place to manage risks related to foreign currency fluctuations for its foreign operations or for interest rate changes.

The Company re-measures the fair value of the contingent consideration at each reporting period and any change in the fair value from either the passage of time or events occurring after the acquisition date, is recorded in earnings in the accompanying consolidated statement of operations.

4. ACCOUNTS RECEIVABLE, TRANSIT ACCOUNTS RECEIVABLE AND TRANSIT ACCOUNTS PAYABLE

The Company’s accounts receivable are comprised as follows:

	January 2, 2021		December 28, 2019
Billed	$25,926		$29,214
Accrued and unbilled	8,219		13,824
Work-in-progress	3,612		4,352
Accounts receivable subject to arbitration	-		14,095
Allowance for sales discounts and doubtful accounts	(1,750	)	(1,725	)
Accounts receivable, net	$36,007		$59,760

F-16

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

4. ACCOUNTS RECEIVABLE, TRANSIT ACCOUNTS RECEIVABLE AND TRANSIT ACCOUNTS PAYABLE (CONTINUED)

Unbilled receivables primarily represent revenue earned whereby those services are ready to be billed as of the balance sheet ending date.  Work-in-progress primarily represents revenue earned under contracts which the Company contractually invoices at future dates.

From time to time, the Company’s Engineering segment enters into agreements to provide, among other things, construction management and engineering services.  Pursuant to these agreements, the Company a) may engage subcontractors to provide construction or other services; b) typically earns a fixed percentage of the total project value; and c) assumes no ownership or risks of inventory.  Under the terms of the agreements, the Company is typically not required to pay the subcontractor until after the corresponding payment from the Company’s end-client is received. Upon invoicing the end-client on behalf of the subcontractor or staffing agency the Company records this amount simultaneously as both a “transit account receivable” and “transit account payable” as the amount when paid to the Company is due to and generally paid to the subcontractor within a few days. The Company typically does not pay a given transit account payable until the related transit account receivable is collected. The Company is typically obligated to pay the subcontractor or staffing agency whether or not the client pays the Company.  The Company’s transit accounts payable generally exceeds the Company’s transit accounts receivable but absolute amounts and spreads fluctuate significantly from quarter to quarter in the normal course of business. The transit accounts receivable was $2.5 million and related transit accounts payable was $4.9 million, for a net payable of $2.4 million, as of January 2, 2021.  The transit accounts receivable was $4.9 million and related transit accounts payable was $4.6 million, for a net receivable of $0.3 million, as of December 28, 2019. 

The Company had a dispute with a customer that is a major utility in the United States. Both parties agreed in fiscal 2017 to resolve this dispute through binding arbitration.  Arbitration hearings with this customer started in fiscal 2018.  Essentially, the customer did not pay the balance of accounts receivable the Company believes were owed for certain disputed projects.  As of December 28, 2019, the total amount of recorded receivables from this customer on these disputed projects was $14.1 million.  Additionally, as part of the arbitration process, the customer asserted counter-claims of $10.3 million. The arbitrator rendered a decision in this dispute in April 2020, awarding the Company $7.4 million, and the arbitration award was paid during the fifty-three week period ended January 2, 2021. The counter-claims asserted against the Company of $10.3 million were denied in their entirety. For the fifty-three week period ended January 2, 2021, the Company recorded a charge of $8.4 million, including $6.7 million constituting the portion of the accounts receivable relating to the disputed projects that was not awarded by the arbitrator, $0.7 million from other projects with this customer that were not part of the arbitration, $0.8 million in professional fees related to the dispute and arbitration, and $0.2 million of transit accounts receivable associated with disputed projects that were part of the arbitration. The Company decided to write off the $0.7 million of accounts receivable from other projects not part of the arbitration for business reasons.

5.    PROPERTY AND EQUIPMENT

Property and equipment are stated at cost and are depreciated on the straight-line method at rates calculated to provide for retirement of assets at the end of their estimated useful lives.  The annual rates are 20% for computer hardware and software as well as furniture and office equipment.  Leasehold improvements are amortized over the shorter of the estimated life of the asset or the lease term. 

F-17

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

5.    PROPERTY AND EQUIPMENT (CONTINUED)

Property and equipment are comprised of the following:

	January 2, 2021	December 28, 2019
Equipment and furniture	$264	$319
Computers and systems	4,686	5,628
Leasehold improvements	236	308
	5,185	6,255
Less: accumulated depreciation and amortization	3,107	3,538
Property and equipment, net	$2,078	$2,717

The Company periodically writes off fully depreciated and amortized assets.  The Company wrote off fully depreciated and amortized assets of $1,529 and $2,781 during the fiscal years ended January 2, 2021 and December 28, 2019, respectively.  For the fiscal years ended January 2, 2021 and December 28, 2019, depreciation and amortization expense for property and equipment was $1,065 and $1,261, respectively.

6.    ACQUISITIONS

The purchase method of accounting in accordance with FASB ASC 805, “Business Combination,” was applied for all acquisitions.  This requires the cost of an acquisition to be allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their respective fair values at the date of acquisition with the excess cost accounted for as goodwill.  Goodwill arising from the acquisitions is attributable to expected sales synergies from combining the operations of the acquired business with those of the Company.

Future Contingent Payments

As of January 2, 2021, the Company had two active acquisition agreements whereby additional contingent consideration may be earned by the former shareholders: 1) effective October 1, 2017, the Company acquired all of the stock of PSR Engineering Solutions d.o.o. Beograd (Voždovac) (“PSR”) and 2) effective September 30, 2018, the Company acquired certain assets of Thermal Kinetics Engineering, PLLC and Thermal Kinetics Systems, LLC (together, “TKE”). The Company estimates future contingent payments at January 2, 2021 as follows:

Fiscal Year Ending	Total
January 1, 2022	500
December 31, 2022	2,358
Estimated future contingent consideration payments	$2,858

Estimates of future contingent payments are subject to significant judgment and actual payments may materially differ from estimates.  Potential future contingent payments to be made to all active acquisitions after January 2, 2021 are capped at a cumulative maximum of $3.1 million.  The Company estimates future contingent consideration payments based on forecasted performance and recorded the fair value of those expected payments as of January 2, 2021.  During the fifty-three week period ended January 2, 2021, the Company measured contingent consideration at fair value on a non-recurring basis.  Contingent consideration related to acquisitions are recorded at fair value level 3 due to the lack of observable market inputs. Changes in fair value are recorded in other (expense) income, net.

F-18

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

6.    ACQUISITIONS (CONTINUED)

For acquisitions that involve contingent consideration, the Company records a liability equal to the fair value of the estimated contingent consideration obligation as of the acquisition date. The Company determines the acquisition date fair value of the contingent consideration based on the likelihood of paying the additional consideration. The fair value is estimated using projected future operating results and the corresponding future earn-out payments that can be earned upon the achievement of specified operating objectives and financial results by acquired companies using Level 3 inputs and the amounts are then discounted to present value. These liabilities are measured quarterly at fair value, and any change in the fair value of the contingent consideration liability is recognized in the consolidated statements of comprehensive (loss) income. During the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed with the corresponding adjustment to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recognized in the consolidated statements of comprehensive (loss) income.

The Company paid contingent consideration of $0.3 million and $0.6 million during the fifty-three week period ended January 2, 2021 and the fifty-two week period ended December 28, 2019, respectively. 

The changes in the liability for contingent consideration from acquisitions for the fifty-three week period ended January 2, 2021 and the fifty-two week period ended December 28, 2019 are as follows:

Balance as of December 29, 2018	$4,773
Contingent payments made	(598	)
Increase to contingent payment estimates	(1,178	)
Changes in fair value of contingent payments	61
Balance as of December 28, 2019	$3,058
Contingent payments made	(345	)
Changes in fair value of contingent consideration	145
Balance as of January 2, 2021	$2,858

F-19

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

7.    GOODWILL

Goodwill represents the premium paid over the fair value of the net tangible and intangible assets acquired in business combinations.  The Company tests goodwill for impairment on an annual basis as of the last day of the Company's fiscal year or more frequently if events occur or circumstances change indicating that the fair value of goodwill may be below the carrying amount.  During the fifty-three week period ended January 2, 2021, the Company reviewed the carrying value of goodwill due to the events and circumstances surrounding the COVID-19 pandemic.  While COVID-19 has negatively impacted the Company, and the Company expects this negative impact to continue at least through the first half of fiscal 2021 and likely beyond, the Company did not conclude in such review that this negative impact is permanent.  The Company has determined that no other indicators of impairment of goodwill existed during the fifty-three week period ended January 2, 2021 and fifty-two week period ended December 28, 2019.  As such, no impairment loss on the Company’s goodwill during the fifty-three week period ended January 2, 2021 or the fifty-two week period ended December 28, 2019 was recorded as a result of such review. 

The changes in the carrying amount of goodwill for the fifty-three week period ended January 2, 2021 and the fifty-two week period ended December 28, 2019 are as follows:

	Engineering		Specialty Health Care	Information Technology	Total
Balance as of December 29, 2018	$13,096		$2,398	$2,038	$17,532
Adjustment to final TKE purchase price	(1,178	)	-	-	(1,178	)
Balance as of December 28, 2019	$11,918		$2,398	$2,038	$16,354
No change in fiscal 2020	-		-	-	-
Balance as of January 2, 2021	$11,918		$2,398	$2,038	$16,354

8.    INTANGIBLE ASSETS

The Company evaluates long-lived assets and intangible assets with definite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  When the Company determines that it is probable that undiscounted future cash flows will not be sufficient to recover an asset’s carrying amount, the asset is written down to its fair value.  Assets to be disposed of by sale, if any, are reported at the lower of the carrying amount or fair value less cost to sell.  The Company’s intangible assets consist of customer relationships and non-compete agreements.  During the fifty-three week period ended January 2, 2021 and the fifty-two week period ended December 28, 2019, the Company reviewed the carrying value of its intangible assets due to the events and circumstances surrounding the COVID-19 pandemic.  While COVID-19 has negatively impacted the Company, and the Company expects this negative impact to continue at least through the first half of fiscal 2021 and likely beyond, the Company does not believe at this time that this negative impact is permanent. As such, no impairment loss on the Company’s intangible assets during the fifty-three week period ended January 2, 2021 and the fifty-two week period ended December 28, 2019 was recorded as a result of such review.

All of the Company’s intangible assets are associated with the Engineering segment.  Intangible assets other than goodwill are amortized over their useful lives.  Intangible assets are carried at cost, less accumulated amortization.

F-20

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

8.    INTANGIBLE ASSETS (CONTINUED)

Details of intangible assets by class at January 2, 2021 and December 28, 2019:

	January 2, 2021	December 28, 2019
Restricted covenants	$12	$28
Customer relationships	83	388
Total intangible assets	$95	$416

Amortization of acquired intangible assets for the fifty-three week period ended January 2, 2021 and the fifty-two week period ended December 28, 2019 was $321 and $327, respectively.  The remaining intangible asset balance will be amortized during fiscal 2021.

9. LINE OF CREDIT

The Company and its subsidiaries amended and restated its Revolving Credit Facility with Citizens Bank of Pennsylvania on October 18, 2019.  As amended and restated, the Revolving Credit Facility provides for a $45.0 million revolving credit facility, has no sub-limit for letters of credit, and expires on August 8, 2023.

On September 29, 2020, the Company entered into an amendment to its Revolving Credit Facility. The amendment (i) modifies certain aspects of the financial covenants under the Loan Agreement, including the manner in which the measurement periods for certain components of the financial covenants are determined, (ii) modifies the required compliance levels for certain ratios under the Loan Agreement, and (iii) permitted the repayment of $2.2 million of indebtedness to a third party incurred in connection with the previously disclosed June 2020 repurchase of stock.

Borrowings under the Revolving Credit Facility bear interest at one of two alternative rates, as selected by the Company at each incremental borrowing.  These alternatives are: (i) LIBOR (London Interbank Offered Rate), plus applicable margin, typically borrowed in fixed 30-day increments or (ii) the agent bank’s prime rate generally borrowed over shorter durations.  The Company also pays unused line fees based on the amount of the Revolving Credit Facility that is not drawn.  Unused line fees are recorded as interest expense.  The effective weighted average interest rate, including unused line fees, for the fifty-three week period ended January 2, 2021 and fifty-two week period ended December 28, 2019 were 2.7% and 4.4%, respectively.

All borrowings under the Revolving Credit Facility are collateralized by all of the assets of the Company and its subsidiaries and a pledge of the stock of its subsidiaries.  The Revolving Credit Facility also contains various financial and non-financial covenants, such as a covenant that restricts on the Company’s ability to borrow in order to pay dividends.  As of January 2, 2021, the Company was in compliance with all covenants contained in the Revolving Credit Facility (as amended).The Company believes that it will maintain compliance with its financial covenants for the foreseeable future.   

Borrowings under the line of credit as of January 2, 2021 and December 28, 2019 were $11.9 million and $34.8 million, respectively.  At January 2, 2021 and December 28, 2019 there were letters of credit outstanding for $1.9 million and $1.6 million, respectively.  At January 2, 2021, the Company had availability for additional borrowings under the Revolving Credit Facility of $31.2 million.

F-21

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

9. LINE OF CREDIT (CONTINUED)

Impact to Line of Credit from COVID-19

The Company is negatively impacted by COVID-19 as more fully described in Footnote 19 as well as the Segment Discussion, and Liquidity and Capital Resources sections in Management’s Discussion and Analysis of Financial Condition and Results of Operations. The Company believes that its current line of credit is adequate to provide the necessary liquidity while COVID-19 impacts its operations.  While the Company does expect to be in compliance with its financial covenants in the line of credit for the foreseeable future, the Company can give no assurance that the line of credit will be available to the Company.

10.  PER SHARE DATA

The Company uses the treasury stock method to calculate the weighted-average shares used for diluted earnings per share.  The number of common shares used to calculate basic and diluted earnings (loss) per share for the fiscal years ended January 2, 2021 and December 28, 2019 was determined as follows:

	Fiscal Years Ended
	January 2, 2021	December 28, 2019
Basic weighted average shares outstanding	12,152,042	12,913,912
Dilutive effect of outstanding restricted share awards	-	58,241
Weighted average dilutive shares outstanding	12,152,042	12,972,153

Because the year ended January 2, 2021 recorded a net loss, the otherwise dilutive effect of 46,873 outstanding restricted share awards has not been included in the weighted average diluted shares outstanding.  For the years ended January 2, 2021 and December 28, 2019, there were no anti-dilutive shares not included in the calculation of common stock equivalents.

Unissued shares of common stock were reserved for the following purposes:

	January 2, 2021	December 28, 2019
Time-based restricted stock awards outstanding	459,805	151,725
Unvested subscription restricted share awards	250,000	-
Performance-based restricted stock awards outstanding	-	240,000
Future grants of options or shares	520,929	268,326
Shares reserved for employee stock purchase plan	149,894	267,877
Total	1,380,628	927,928

F-22

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

11.   SHARE BASED COMPENSATION

At January 2, 2021, the Company had two share-based employee compensation plans.  The Company measures the fair value of share-based awards, if and when granted, based on the Black-Scholes method and using the closing market price of the Company’s common stock on the date of grant.  Awards typically vest over periods ranging from one to three years and expire within 10 years of issuance.  The Company may also issue immediately vested equity awards.  Share-based compensation expense related to time-based awards is amortized in accordance with applicable vesting periods using the straight-line method.  The Company expenses performance-based awards only when the performance metrics are likely to be achieved and the associated awards are therefore likely to vest.  Performance-based share awards that are likely to vest are also expensed on a straight-line basis over the vesting period but may vest on a retroactive basis or be reversed, depending on when it is determined that they are likely to vest, or in the case of a reversal when they are later determined to be unlikely to vest. 

Share-based compensation expense of $1,109 and $806 was recognized for the fiscal years ended January 2, 2021 and December 28, 2019, respectively.  Fiscal year ended January 2, 2021 did not include any expense associated with performance-based awards.  Share based compensation for the fiscal year ended December 28, 2019 included estimated expense of $228 for performance-based awards.  As of January 2, 2021, there were no performance-based restricted stock awards outstanding.

As of January 2, 2021, the Company had $1.1 million of total unrecognized compensation cost related to all time-based non-vested share-based awards outstanding. The Company expects to recognize this expense over approximately two years.  These amounts do not include a) the cost of any additional share-based awards granted in future periods or b) the impact of any potential changes in the Company’s forfeiture rate. 

2014 Omnibus Equity Compensation Plan (the 2014 Plan)

The 2014 Plan, approved by the Company’s shareholders in December 2014, initially provided for the issuance of up to 625,000 shares of the Company’s common stock to officers, non-employee directors, employees of the Company and its subsidiaries, or consultants and advisors utilized by the Company.  In fiscal 2016 and fiscal 2020, the Company amended and restated the 2014 Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance under the Plan by an additional 500,000 and 850,000 shares, respectively, so that the total number of shares of stock reserved for issuance under the Plan is 1,975,000 shares.  The expiration date of the Plan is December 17, 2030, unless the 2014 Plan is terminated earlier by the Board or is extended by the Board with the approval of the stockholders.  The Compensation Committee of the Board of Directors determines the vesting period at the time of grant. 

As of January 2, 2021, under the 2014 Plan, 709,805 time-based shares were outstanding, there were no performance-based restricted share awards outstanding and 520,929 shares were available for awards thereunder.

The market value of equity grants for the fifty-three week period ended January 2, 2021 and the fifty-two week period ended December 28, 2019 was $1.5 million and $1.1 million respectively.

Employee Stock Purchase Plan

The Company implemented the 2001 Employee Stock Purchase Plan (the “Purchase Plan”) with shareholder approval, effective January 1, 2001.  Under the Purchase Plan, employees meeting certain specific employment qualifications are eligible to participate and can purchase shares of common stock semi-annually through payroll deductions at the lower of 85% of the fair market value of the stock at the commencement or end of the offering period.  The purchase plan permits eligible employees to purchase shares of common stock through payroll deductions for up to 10% of qualified compensation, subject to maximum purchases in any one fiscal year of 3,000 shares. 

F-23

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

11.   SHARE BASED COMPENSATION (CONTINUED)

Employee Stock Purchase Plan (Continued)

In fiscal 2015, the Company amended the Purchase Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance or transfer under the Plan by an additional 300,000 shares so that the total number of shares of stock reserved for issuance or transfer under the Plan shall be 1,100,000 shares and to extend the expiration date of the Plan to December 31, 2025.  In fiscal 2018, the Company amended the Purchase Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance or transfer under the Plan by an additional 300,000 shares so that the total number of shares of stock reserved for issuance or transfer under the Plan shall be 1,400,000 shares.

The Company has two offering periods in the Purchase Plan coinciding with the Company’s first two fiscal quarters and the last two fiscal quarters.  Actual shares are issued on the first business day of the subsequent offering period for the prior offering period payroll deductions.  During the fiscal years ended January 2, 2021 and December 28, 2019, there were 117,983 and 118,526 shares issued under the Purchase Plan for net proceeds of $208 and $321, respectively.  As of January 2, 2021, there were 149,894 shares available for issuance under the Purchase Plan.  Compensation expense, representing the discount to the quoted market price, for the Purchase Plan for the fiscal years ended January 2, 2021 and December 28, 2019 was $44 and $91, respectively.

Time-Based Restricted Stock Awards / Stock Subscription Receivable

From time-to-time the Company issues time-based restricted stock awards.  These time-based restricted stock awards typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period assuming the grantee’s restricted stock award fully vests.  Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying condensed consolidated balance sheet.  As of January 2, 2021, there were no accrued dividends.  Dividends for time-based restricted stock awards that ultimately do not vest are forfeited.   

The following summarizes the activity in the time-based restricted stock awards under the 2014 Plan during the fifty-three week period ended January 2, 2021:

	Number of Time-Based Restricted Stock Awards		Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at December 28, 2019	151,725		$3.64
Granted	719,805		$1.88
Vested	(139,225	)	$3.61
Forfeited or expired	(22,500	)	$1.55
Outstanding non-vested at January 2, 2021	709,805		$1.92

Based on the closing price of the Company’s common stock of $2.07 per share on December 31, 2020 (the last trading day prior to January 2, 2021), the intrinsic value of the time-based non-vested restricted stock awards at January 2, 2021 was approximately $1.5 million.  As of January 2, 2021, there was approximately $1.1 million of total unrecognized compensation cost related to time-based restricted stock awards, which is expected to be recognized over the vesting period of the restricted stock awards.

F-24

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

11.   SHARE BASED COMPENSATION (CONTINUED)

Time-Based Restricted Stock Awards / Stock Subscription Receivable (Continued)

In December 2020, the Company granted senior management a one-time restricted stock award of 250,000 shares in exchange for a stock subscription receivable.  The shares will be acquired by senior management through repayment of the stock subscription receivable over twelve months beginning in January 2021 and ending in December 2021. 

During fiscal 2020, the Company awarded 100,092 immediately vested share awards at an average price of $1.33.

Performance-Based Restricted Stock Awards

From time-to-time the Company issues performance-based restricted stock awards to its executives.  Performance-based restricted stock awards are typically vested based on certain multi-year performance metrics as determined by the Board of Directors Compensation Committee. These performance-based restricted stock awards typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period on any stock awards that actually vest, if any.  Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying condensed consolidated balance sheet.  As of January 2, 2021, there were no accrued dividends.  Dividends for performance-based restricted stock awards that ultimately do not vest are forfeited.  

To date, the Company has issued performance-based restricted stock awards only under the 2014 Plan.  The following summarizes the activity in the performance-based restricted stock awards during the fifty-three week period ended January 2, 2021:

	Number of Performance- Based Restricted Stock Awards		Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at December 28, 2019	240,000		$4.81
Granted	-		-
Vested	(40,000	)	$4.38
Forfeited or expired	(200,000	)	$4.89
Outstanding non-vested at January 2, 2021	-		-

As of January 2, 2021,there were no outstanding performance-based restricted stock awards. The Company will reassess at each reporting date whether achievement of any performance condition is probable and would begin recognizing additional compensation cost if and when achievement of the performance condition becomes probable.  The Company will then recognize the appropriate expense cumulatively in the year performance becomes probable and recognize the remaining compensation cost over the remaining requisite service period. If at a later measurement date the Company determines that performance-based restricted stock awards deemed as likely to vest are deemed as unlikely to vest, the expense recognized will be reversed. 

F-25

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

11.   SHARE BASED COMPENSATION (CONTINUED)

	Number of Restricted Stock Awards		Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at December 29, 2018	347,372		$4.74
Granted – time-based vesting	99,225		$3.02
Granted – performance-based vesting	167,148		$4.35
Vested	(130,020	)	$3.91
Forfeited or expired	(92,000	)	$4.98
Outstanding non-vested at December 28, 2019	391,725		$4.36
Granted – time-based vesting	719,805		$1.88
Granted – performance-based vesting	-		-
Vested	(179,225	)	$3.78
Forfeited or expired	(222,500	)	$4.55
Outstanding non-vested at January 2, 2021	709,805		$1.92

Based on the closing price of the Company’s common stock of $2.07 per share on December 31, 2020, the intrinsic value of all restricted share awards at January 2, 2021 was $1.5 million.  This amount does not include any intrinsic value that may be associated with the performance-based restricted share awards that are deemed unlikely to vest.

12. TREASURY STOCK TRANSACTIONS

On June 2, 2020, the Company entered into a stock purchase agreement with certain stockholders of the Company, whereby the Company purchased an aggregate of 1,858,139 shares of the Company’s common stock for a negotiated purchase price of $1.20 per share or $2.2 million in total. The negotiated price of $1.20 per share was less than the lowest trading price of the stock on the day of the repurchase.  The consideration paid by the Company consisted entirely of an unsecured subordinated promissory note for $2.2 million. The note accrues interest at an annual rate of 9.0%, compounded annually, payable quarterly in arrears commencing on September 1, 2020 and continuing on each December 1, March 1, June 1 and September 1 thereafter, and initially had a maturity date of August 10, 2023. On September 25, 2020, the Company repaid the subordinated promissory note in the amount of $2.2 million.

The shares repurchased on June 2, 2020 were not purchased under a stock repurchase plan.  The Company did not repurchase any shares in the comparable prior year period.

On January 13, 2021, the Company’s Board of Directors authorized a program to repurchase shares of the Company’s common stock constituting, in the aggregate, up to an amount not to exceed $7.5 million, consistent with the maximum limitation set forth by the Company’s revolving line of credit.  The program is designed to provide the Company with enhanced flexibility over the long term to optimize its capital structure.  Shares of the common stock may be repurchased in the open market or through negotiated transactions.  The program may be terminated or suspended at any time at the discretion of the Company. 

F-26

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

13. NEW ACCOUNTING STANDARDS

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326). The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities.  In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842), which amends the effective date of the original pronouncement for smaller reporting companies.  ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022.  The Company believes the adoption will modify the way the Company analyzes financial instruments, but it does not anticipate a material impact on results of operations. The Company is in the process of determining the effects the adoption will have on its condensed consolidated financial statements.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This standard only applies to contracts and other transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform.  This guidance provides temporary optional expedients and exceptions to accounting guidance on contract modifications and hedge accounting to ease entities’ financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. The Company may elect to apply the amendments prospectively through December 31, 2022.  The Company is currently evaluating the impact this guidance will have on its condensed consolidated financial statements and related disclosures.

F-27

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

14.   SEGMENT INFORMATION

The Company follows “Disclosures about Segments of an Enterprise and Related Information,” which establishes standards for companies to report information about operating segments, geographic areas and major customers.  The accounting policies of each segment are the same as those described in the summary of significant accounting policies (see Note 1 to these Consolidated Financial Statements.)

Segment operating income includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments.  The following tables reflect the results of the segments consistent with the Company’s management system:

Fiscal Year Ended January 2, 2021	Engineering		Specialty Health Care		Information Technology		Corporate		Total
Revenue	$57,715		$60,481		$32,213		$   -		$150,409
Cost of services	41,227		47,116		23,211		-		111,554
Gross profit	16,488		13,365		9,002		-		38,855
Selling, general and administrative	12,931		15,504		9,116		-		37,551
Depreciation and amortization of    property and equipment	638		319		108		-		1,065
Amortization of acquired intangible assets	321		-		-		-		321
Write-off of receivables and    professional fees incurred    related to arbitration	8,397		-		-		-		8,397
Impairment of right of use assets and    related costs	-		-		-		2,231		2,231
Tax credit professional fees	-		-		-		240		240
Operating income (loss)	($5,799	)	($2,458	)	($222	)	($2,471	)	($10,950	)
Total assets as of January 2, 2021	$33,782		$19,141		$7,498		$7,918		$68,339
Capital expenditures	$26		$36		$48		$350		$460

F-28

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

14.   SEGMENT INFORMATION (CONTINUED)

Fiscal Year Ended December 28, 2019	Engineering	Specialty Health Care	Information Technology	Corporate		Total
Revenue	$67,873	$89,348	$33,879	$     -		$191,100
Cost of services	49,395	68,464	24,649	-		142,508
Gross profit	18,478	20,884	9,230	-		48,592
Selling, general and administrative	13,648	17,643	9,099	-		40,390
Depreciation and amortization of    property and equipment	841	336	84	-		1,261
Amortization of acquired intangible assets	327	-	-	-		327
Tax credit professional fees	-	-	-	47		47
Operating income (loss)	$3,662	$2,905	$47	($47	)	$6,567
Total assets as of December 28, 2019	$52,342	$29,781	$8,178	$5,872		$96,173
Capital expenditures	$82	$121	$69	$95		$367

The Company derives a majority of its revenue from offices in the United States.  Revenues reported for each operating segment are all from external customers.  The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Serbia. Revenues by geographic area for the fiscal years ended January 2, 2021 and December 28, 2019 are as follows: 

		Fiscal Year Ended
		January 2,	December 28,
		2021	2019
Revenues
	United States	$126,238	$166,750
	Canada	15,310	16,822
	Puerto Rico	5,702	4,942
	Serbia	3,159	2,586
		$150,409	$191,100

F-29

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

14.   SEGMENT INFORMATION (CONTINUED)

Total assets by geographic area as of the reported periods are as follows:

		Fiscal Year Ended
		January 2,	December 28,
		2021	2019
Total Assets
	United States	$56,308	$82,110
	Canada	7,067	9,638
	Puerto Rico	1,483	1,103
	Serbia	3,481	3,322
		$68,339	$96,173

15.   INCOME TAXES

Generally, the Company’s relative income or loss generated in each of its jurisdictions can materially impact the consolidated effective income tax rate of the Company, particularly the ratio of Canadian and Serbian pretax income, versus United States pretax income.  The consolidated effective income tax rate for fiscal 2020 was 26.4% as compared to 15.8% for the comparable prior year period.  The Company’s United States Federal statutory tax rate for the fifty-three week period ended January 2, 2021 and the comparable prior year period, before any adjustments, was 21.0%.  The income tax provisions reconciled to the tax computed at the United States Federal statutory rate for both fiscal 2020 and 2019 are as follows:

	January 2, 2021		December 28, 2019
Federal statutory rate	21.0	%	21.0	%
Tax expense on taxable (loss)    income at federal statutory rate	($2,532	)	$1,013
State and Puerto Rico income taxes,    net of Federal income tax benefit	(535	)	305
Prior year United States R&D tax credits in current year	-		(668	)
Permanent differences	154		77
Foreign income tax rates	(21	)	(101	)
Adjustments to NOL and repatriation taxes	(53	)	154
Other	(201	)	(16	)
Total income tax expense	($3,188	)	$764

F-30

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

15.   INCOME TAXES (CONTINUED)

The Company did not experience any significant adjustments that impacted its 2020 income tax benefit of $3.2 million.  The Company experienced the following significant adjustments for the 2019 fiscal year that impacted its net income tax expense of $0.8 million: prior year United States R&D tax credits of $0.7 million recognized in fiscal 2019, and expense from changes to its United States net operating loss carryforward and repatriation taxes of $0.2 million.

The components of income tax expense are as follows:

		Fiscal Years Ended
		January 2, 2021		December 28, 2019
Current
	Federal	($32	)	($688	)
	State and local	174		181
	Foreign	382		166
		524		(341	)
Deferred
	Federal	(2,844	)	892
	State	(851	)	229
	Foreign	(17	)	(16	)
		(3,755	)	1,105
Total		($3,188	)	$764

The components of earnings before income taxes by United States and foreign jurisdictions were as follows:

	Fiscal Years Ended
	January 2, 2021		December 28, 2019
United States	($13,898	)	$3,626
Foreign jurisdictions	1,841		1,196
	($12,057	)	$4,822

F-31

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

15.   INCOME TAXES (CONTINUED)

The Company accounts for penalties or interest related to uncertain tax positions as part of its provision for income taxes and records such amounts to interest expense.  The Company recorded no expense for penalties or interest in the fiscal years ended January 2, 2021 and December 28, 2019.

At January 2, 2021 and December 28, 2019, deferred tax assets and liabilities consist of the following:

	January 2, 2021		December 28, 2019
Deferred tax assets:
Allowance for doubtful accounts	$455		$432
Federal and state net operating loss carryforward	2,634		330
Reserves and accruals	1,491		255
Other	318		185
Total deferred tax assets	4,898		1,202
Deferred tax liabilities:
Acquisition amortization, net	(716	)	(569	)
Prepaid expense deferral	(602	)	(701	)
Bonus depreciation to be reversed	(280	)	(327	)
Canada deferred tax liability, net	(365	)	(382	)
Total deferred tax liabilities	(1,963	)	(1,979	)
Total deferred tax assets (liabilities), net	$2,935		($777	)

The Company has gross net operating losses of $8.4 million and $13.6 million to be applied to the net income of future federal and state tax returns, respectively. The principal amount of the federal net operating loss has an unlimited life. The Company conducts business in many states. Net operating losses in these states expire at differing periods but the majority of these expire from 2038 through 2040.

The Company accounts for penalties or interest related to uncertain tax positions as part of its provision for income taxes and records such amounts to interest expense. The Company recorded no expense for penalties or interest in the fiscal years ended January 2, 2021 and December 28, 2019.

The Company conducts its operations in multiple tax jurisdictions in the United States, Canada, Puerto Rico and Serbia. The Company and its subsidiaries file a consolidated United States Federal income tax return and file in various states. The Company’s federal income tax returns have been examined through 2017.  The Company has no open federal audits as of January 2, 2021.  The State of New Jersey is currently examining fiscal tax years 2009 through 2012.  Except for New Jersey and other limited exceptions, the Company is no longer subject to audits by state and local tax authorities for tax years prior to 2017.  The Company is no longer subject to audit in Canada for the tax years prior to tax year 2016.  The Company is no longer subject to audit in Puerto Rico for the tax years prior to tax year 2010.

Differences between the effective tax rate and the applicable U.S. federal statutory rate may arise, primarily from the effect of state and local income taxes, share-based compensation, and potential tax credits available to the Company.

F-32

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

16. CONTINGENCIES

From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the ordinary business course.  These matters may relate to professional liability, tax, compensation, contract, competitor disputes, and employee-related matters and include individual and class action lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company’s employment and compensation practices. Additionally, some of the Company’s clients may also become subject to claims, governmental inquiries and investigations, and legal actions relating to the Company’s professional services. Depending upon the particular facts and circumstances, the Company may also be subject to indemnification obligations under its contracts with such clients relating to these matters.

As such, the Company is required to assess the likelihood of any adverse outcomes to these matters as well as potential ranges of losses and possible recoveries.  The Company may not be covered by insurance as it pertains to some or all of these matters.  A determination of the amount of the provision required for these commitments and contingencies, if any, which would be charged to earnings, is made after careful analysis of each matter.  The Company records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. Once established, a provision may change in the future due to new developments or changes in circumstances and could increase or decrease the Company’s earnings in the period that the changes are made. 

The Company has reserved $1.7 million for the settlement of a class action suit in California that alleges the Company did not properly pay its travel nurses overtime wages. While the Company believes it did not violate any overtime wage laws, it nevertheless decided to settle this class action lawsuit in December 2020.  The Company expects to pay the $1.7 million settlement sometime during its third quarter of fiscal 2021.  The Company is exposed to other asserted claims as of January 2, 2021, but the Company does not believe any of these other claims have a probability of loss. As of January 2, 2021, the Company did not have an accrual for any such other claims.  Furthermore, even if any of these other claims do result in an unfavorable outcome or settlement, the Company believes that such matters will not, either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations, or cash flows.

The Company had a dispute with a customer that is a major utility in the United States. Both parties agreed in fiscal 2017 to resolve this dispute through binding arbitration.  Arbitration hearings with this customer started in fiscal 2018.  Essentially, the customer did not pay the balance of accounts receivable the Company believes were owed for certain disputed projects.  As of December 28, 2019, the total amount of recorded receivables from this customer on these disputed projects was $14.1 million.  Additionally, as part of the arbitration process, the customer asserted counter-claims of $10.3 million. The arbitrator rendered a decision in this dispute in April 2020, awarding the Company $7.4 million, and the arbitration award was paid during the fifty-three week period ended January 2, 2021. The counter-claims asserted against the Company of $10.3 million were denied in their entirety. For the fifty-three week period ended January 2, 2021, the Company recorded a charge of $8.4 million, including $6.7 million constituting the portion of the accounts receivable relating to the disputed projects that was not awarded by the arbitrator, $0.7 million from other projects with this customer that were not part of the arbitration, $0.8 million in professional fees related to the dispute and arbitration, and $0.2 million of transit accounts receivable associated with disputed projects that were part of the arbitration. The Company decided to write off the $0.7 million of accounts receivable from other projects not part of the arbitration for business reasons.

F-33

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

17.   RETIREMENT PLANS

Profit Sharing Plans

The Company maintains a 401(k) profit sharing plan for the benefit of eligible employees in the United States and other similar plans in Canada, Puerto Rico and Serbia (the “Retirement Plans”).  The 401(k) plan includes a cash or deferred arrangement pursuant to Section 401(k) of the Internal Revenue Code sponsored by the Company to provide eligible employees an opportunity to defer compensation and have such deferred amounts contributed to the 401(k) plan on a pre-tax basis, subject to certain limitations.  The Company, at the discretion of the Board of Directors, may make contributions of cash to match deferrals of compensation by participants in the Retirement Plans.  Contributions to the Retirement Plans charged to operations by the Company for the fiscal years ended January 2, 2021 and December 28, 2019 were $217 and $296, respectively.

18.   COMMITMENTS

Executive Severance Agreements

The Company is a party to Executive Severance Agreement (the “Executive Severance Agreement”) each of Bradley S. Vizi, the Company's Executive Chairman and President (dated as of June 1, 2018), and Kevin Miller, the Company’s Chief Financial Officer (dated as of February 28, 2014, as amended), which set forth the terms and conditions of certain payments to be made by the Company to the executive in the event, while employed by the Company, such executive experiences (a) a termination of employment unrelated to a “Change in Control” (as defined therein) or (b) there occurs a Change in Control and either (i) the executive’s employment is terminated for a reason related to the Change in Control or (ii) in the case of Mr. Miller, the executive remains continuously employed with the Company for a period of three months following the Change in Control.  Each Executive Severance Agreement also provide for certain payments, if either (a) the executive is involuntarily terminated by the Company for any reason other than “Cause” (as defined therein), “Disability” (as defined therein) or death, or (b) the executive resigns for “Good Reason” (as defined therein), and, in each case, the termination is not a “Termination Related to a Change in Control” (as defined therein).

Leases

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), which requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases with terms greater than 12 months and requires disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting applied by a lessor is largely unchanged from that applied under the prior standard. After the issuance of Topic 842, the FASB clarified the guidance through several ASUS; hereinafter the collection of lease guidance is referred to as “ASC 842”.

In connection with the continuing developments from COVID-19, the Company has reduced its leased office space as a result of its employees moving to a remote work environment.  The Company does not believe there is an opportunity to sublet any of the vacant office space due to the current commercial rental marketplace.  This decision and reduction in the use of the office spaces resulted in a right-of-use asset impairment of $1.9 million.  This loss was determined by identifying the fair value of the impacted right-of-use assets as compared to the carrying value of the assets as of the measurement date, in accordance with Property, Plant and Equipment Topic of the FASB ASC.  The fair value of the right-of-use assets was based on the remaining term of each lease.  In addition, the Company wrote off a total of $0.3 million in other office lease costs and obsolete equipment.   

F-34

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

18.   COMMITMENTS (CONTINUED)

Leases (Continued)

On December 30, 2018, the Company adopted ASC 842 using the modified retrospective method for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning December 30, 2018 are presented under ASC 842, while prior period amounts were not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 840, Leases. The standard had a material impact on the Company’s Consolidated Condensed Balance Sheet but did not have a significant impact on the Company’s consolidated net earnings and cash flows. The most significant impact was the recognition of right of use assets and lease liabilities for operating leases, while the accounting for finance leases remained substantially unchanged. For leases that commenced before the effective date of ASC 842, the Company elected the permitted practical expedients to not reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases.  Consequently, financial information will not be updated, and the disclosures required under the new standard will not be provided for dates before December 30, 2018.

As a result of the cumulative impact of adopting ASC 842, the Company recorded operating lease right of use assets of $3.9 million and operating lease liabilities of $4.1 million as of December 30, 2018, primarily related to real estate and office equipment leases, based on the present value of the future lease payments on the date of adoption.

The Company determines if an arrangement is a lease at inception. For leases where the Company is the lessee, right of use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. Right of use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The right of use asset also consists of any lease incentives received. The lease terms used to calculate the right of use asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest method of recognition. The Company has lease agreements which require payments for lease and non-lease components.  The Company has elected to account for these as a single lease component with the exception of its real estate leases.

F-35

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

18.   COMMITMENTS (CONTINUED)

Leases (Continued)

The components of lease expense were as follows:

		Fifty-Three Week Period Ended January 2, 2021	Fifty-Two Week Period Ended December 28, 2019
Operating lease cost		$2,524	$2,314
	Amortization of right of use assets	$366	$305
	Interest on lease liabilities	10	8
Total finance lease cost		$376	$313

Supplemental Cash Flow information related to leases was as follows:

		Fifty-Three Week Period Ended January 2, 2021	Fifty-Two Week Period Ended December 28, 2019
Cash paid for amounts included in the measurement of lease liabilities
	Operating cash flows from operating leases	$2,589	$2,290
	Operating cash flows from finance leases	$7	$8
	Financing cash flows from finance leases	$402	$310
Right of use assets obtained in exchange for lease obligations
	Operating leases	$1,257	$7,894
	Finance leases	$258	$126

F-36

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

18.   COMMITMENTS (CONTINUED)

Leases (Continued)

Supplemental Balance Sheet information as of January 2, 2021 related to leases was as follows:

		Fifty-Three Week Period Ended January 2, 2021		Fifty-Two Week Period Ended December 28, 2019
Operating leases
	Operating lease right of use assets	$2,409		$5,820
	Operating right of use liability - current	($1,886	)	($2,134	)
	Operating right of use liability - non-current	(2,641	)	(3,921	)
	Total operating lease liabilities	($4,527	)	($6,055	)
Finance leases
	Property and equipment - (right of use assets)	$1,140		$985
	Accumulated depreciation	(746	)	(475	)
	Property and equipment, net	$394		$510
	Other current liabilities	($247	)	($315	)
	Other long term liabilities	(106	)	(189	)
	Total finance lease liabilities	($353	)	($504	)
Weighted average remaining lease term
	Operating leases	2.03 Years		2.54 Years
	Finance leases	1.45 Years		1.62 Years
Weighted average discount rate
	Operating leases	4.06	%	4.11	%
	Finance leases	2.63	%	1.78	%

F-37

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

18.   COMMITMENTS (CONTINUED)

Leases (Continued)

Maturities of lease liabilities are as follows:

Fiscal Year Ending	Operating Leases		Finance Leases
2021	2,019		255
2022	1,505		109
2023	955		-
2024	232		-
2025	48		-
Thereafter	-		-
Total lease payments	4,759		364
Less: imputed interest	(232	)	(11	)
Total	$4,527		$353

19.   RELATED PARTY TRANSACTIONS

There have been no related party transactions during the time periods presented.

F-38

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fiscal Years Ended January 2, 2021 and December 28, 2019

 (Dollars in thousands, except share and per share amounts, unless otherwise indicated)

20.  STOCKHOLDER RIGHTS PLAN

On May 22, 2020, the Board of Directors of the Company approved a stockholder rights plan (the “Rights Plan”) and declared a dividend distribution to stockholders of record as of the close of business on June 2, 2020 of one preferred stock purchase right (a “Right”) for each outstanding share of Common Stock of the Company.  Each Right entitles the holder to purchase from the Company a unit consisting of one one-hundredth of a share (a “Unit”) of a newly-authorized series of junior participating preferred stock of the Company, upon the occurrence of certain events, as more fully described below, at a purchase price of $5.60 per Unit.

In connection with the adoption of the stockholder rights plan, the Company designated 250,000 shares of the Company’s authorized shares of Preferred Stock, par value $1.00, as Series A-3 Junior Participating Preferred Shares, none of which are issued and outstanding. As provided in the Certificate of Designation filed by the Company with the Department of State of the State of Nevada, each Series A-3 Preferred Share shall entitle the holder 100 votes on all matters submitted to a vote of the stockholders of the Company, subject to adjustment for future dividends and combinations of common stock.  The holders of Series A-3 Preferred Shares and the holders of shares of Common Stock shall vote together as one class on all matters submitted to a vote of stockholders of the Company.  The Series A-3 Preferred Shares shall, after issuance, be entitled to receive quarterly dividends in an amount equal to the greater of $50.00 per share or an amount per share, subject to adjustment, equal to 100 times the aggregate per share amount of all non-cash dividends or other distributions other than a dividend payable in shares of common stock or a subdivision of the outstanding shares of common stock declared on the common stock since the immediately preceding quarterly dividend payment date of the Series A-3 Preferred Shares, or, with respect to the first such quarterly dividend payment date, since the first issuance of any share or fraction of a share of the Series A-3 Preferred Shares.  The Series A-3 Preferred Shares shall rank junior to all other series of the Company’s Preferred Stock as to the payment of dividends and the distribution of assets, unless the terms of any such series shall provide otherwise.  The Series A-3 Preferred Shares shall not be redeemable.  In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Series A-3 Preferred Shares shall be entitled to receive the greater of $100.00 per share, plus accrued dividends, or an amount per share, subject to adjustment, equal to 100 times the aggregate amount to be distributed per share to holders of Common Stock. In the event the Company shall enter into any consolidation, merger, combination or other transaction in which the shares of Common Stock are exchanged for or changed into other stock or securities, cash and/or any other property, then in any such event the Series A-3 Preferred Shares shall at the same time be similarly exchanged or changed in an amount per share, subject to adjustment, equal to 100 times the aggregate amount of stock, securities, cash and/or any other property (payable in kind), as the case may be, into which or for which each share of Common Stock is changed or exchanged. These preferences are protected by customary anti-dilution provisions.

Initially, the Rights are not exercisable and are attached to each existing outstanding share of the Company’s Common Stock. The Rights will separate and become exercisable if a person or group acquires 10% or more of the Company’s Common Stock in a transaction, including the open market purchase of shares, not approved by our Board. If a person or group acquires 10%, each Right will entitle its holder (other than such person or members of such group) to purchase, at the Right’s exercise price (subject to adjustment as provided in the Rights Plan), a number of shares of the Company’s Common Stock having a then-current market value of twice the exercise price. The Rights Plan will cause substantial dilution to a person or group that attempts to acquire control of the Company on terms or in a manner not approved by our Board. 

F-39

RCM TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share amounts, unless otherwise indicated)

20.  STOCKHOLDER RIGHTS PLAN (CONTINUED)

The initial issuance of the Rights as a dividend had no financial accounting or reporting impact. The fair value of the Rights was nominal because the Rights were not exercisable when issued and no value is attributable to them. Additionally, the Rights do not meet the definition of a liability under generally accepted accounting principles in the United States and are therefore not accounted for as a long-term obligation.  Accordingly, unless the Rights become exercisable as discussed above, the Rights Plan has no impact on the Company’s Condensed Consolidated Financial Statements. 

The Company’s Board of Directors may redeem the Rights for $0.001 per Right at any time before an event that causes the Rights to become exercisable. The Rights will expire on May 22, 2021, unless the Rights have previously been redeemed by the Board of Directors.

The Rights Plan is not intended to interfere with any merger, tender or exchange offer or other business combination approved by our Board.  Nor does the Rights Plan prevent our Board from considering any offer that it considers to be in the best interest of its stockholders.

21.   COVID-19

In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) as a pandemic, which continues to present various health, business and other challenges throughout the United States. As a result, we have temporarily closed most of our office locations, with most of our workforce working from home, and have seen a reduction in customer demand, all resulting in a negative impact on Company revenue, gross profit, and operating income. The duration and ultimate magnitude of the disruption remains uncertain. Therefore, while we experienced a negative impact during 2020, we expect this matter to continue to impact negatively our business, results of operations, and financial position at least through the first half of fiscal 2021 and likely beyond, and the related financial impact cannot be reasonably estimated at this time. Please see more detailed disclosure by segment in our Segment Discussion and the impact to our condensed consolidated financial position under Financial Activities under Liquidity and Capital Resources, all in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

F-40

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of

RCM Technologies, Inc. and Subsidiaries

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of RCM Technologies, Inc. and Subsidiaries (the “Company") as of January 2, 2021 and December 28, 2019, and the related consolidated statements of operations, comprehensive income (loss), changes in stockholders’ equity, and cash flows for the years ended January 2, 2021 and December 28, 2019, and the related notes (collectively referred to as the “financial statements”).  In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of January 2, 2021 and December 28, 2019, and the results of its operations and its cash flows for the years ended January 2, 2021 and December 28, 2019, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Company’s management.  Our responsibility is to express an opinion on the Company’s financial statements based on our audits.  We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB.  Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.  The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting.  Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks.  Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.  Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.  We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Realizability of deferred tax assets

Description of the Matter

As discussed in Note 15 to the financial statements, the Company had gross deferred tax assets of $4.9 million, of which $2.6 million related to net operating loss carryforwards as of January 2, 2021. The assessment of the realizability of these deferred tax assets is based on the Company’s evaluation of available evidence to determine whether sufficient future taxable income will be generated to allow for the realization of such deferred tax assets. The Company records a valuation allowance to reduce its deferred tax assets to an amount that is more than 50% likely of being realized.

F-41

We identified the evaluation of the realizability of deferred tax assets as a critical audit matter. A high degree of auditor judgment was necessary to assess the evidence used by the Company to evaluate the realizability of deferred tax assets relating to the net operating loss carryforwards. Specifically, assessing the Company’s determination of the reversal of existing taxable temporary differences, cumulative pre-tax losses and the relevance of such losses to forecasted future taxable income required subjective auditor judgment. In addition, specialized skills were required to evaluate the Company’s application of income tax regulations.

How We Addressed the Matter in Our Audit

We evaluated the design and obtained an understanding of certain internal controls related to the Company’s income tax process. This included controls related to the application of income tax regulations and the Company’s consideration of available evidence to determine whether sufficient future taxable income will be generated to allow for the realization of existing deferred tax assets. We involved income tax professionals with specialized skills and knowledge, who assisted in evaluating the Company’s application of income tax regulations used in its realizability analysis. This included evaluating the scheduling of the reversal of existing taxable temporary differences to assess the utilization of net operating loss carryforwards in each tax jurisdiction before their scheduled expiration. We evaluated the Company’s consideration of cumulative pre-tax losses and the net deferred tax position in assessing whether deferred tax assets were more than 50% likely of being realized.

/s/ Macias, Gini & O’Connell LLP

We have served as the Company’s auditor since 2019.

Macias, Gini & O’Connell, LLP

San Diego, California

April 2, 2021

F-42

EXHIBIT 21

SUBSIDIARIES OF THE REGISTRANT

Cataract, Inc.

PSR Engineering Solutions d.o.o. Beograd (Voždovac)

RCM Technologies Canada Corp.

RCM Technologies (USA), Inc.

RCM Technologies Netherlands B.V.

RCMT Delaware, Inc.

RCMT Europe Holdings, Inc.

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements of RCM Technologies, Inc. on Form S-8 (Nos. 333-251516, 333-222151, 333-200826, 333-165482, 333-145904, 333-61306, 333-80590, 333-48089, 333-52206 and 333-52480) and on Form S-3 (No. 333-252148) of our report dated April 2, 2021, related to our audits of the consolidated financial statements of RCM Technologies, Inc. as of January 2, 2021 and December 28, 2019, and for the years then ended, which report appears in this Annual Report on Form 10-K.

/s/ Macias, Gini & O’Connell, LLP

Macias, Gini & O’Connell, LLP

San Diego, California

April 2, 2021

EXHIBIT 31.1

CERTIFICATION REQUIRED BY

RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934

I, Bradley S. Vizi, certify that:

1.I have reviewed this annual report on Form 10-K of RCM Technologies, Inc. (the “registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this  report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 2, 2021	/s/	Bradley S. Vizi
		Bradley S. Vizi Executive Chairman and President

EXHIBIT 31.2

CERTIFICATION REQUIRED BY

RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934

I, Kevin D. Miller, certify that:

1.I have reviewed this annual report on Form 10-K of RCM Technologies, Inc. (the “registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 2, 2021	/s/	Kevin D. Miller
		Kevin D. Miller Chief Financial Officer, Treasurer and Secretary

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of RCM Technologies, Inc. (the “Company”) for the fiscal year ended January 2, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bradley S. Vizi, Executive Chairman and President of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1)The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended (15 U.S.C. section 78m (a)); and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/	Bradley S. Vizi
	Bradley S. Vizi Executive Chairman and President April 2, 2021

A signed original of this written statement required by Section 906 has been provided to RCM Technologies, Inc. and will be retained by RCM Technologies, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of RCM Technologies, Inc. (the “Company”) for the fiscal year ended January 2, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kevin D. Miller, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1)The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended (15 U.S.C. section 78m (a)); and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/	Kevin D. Miller
	Kevin D. Miller Chief Financial Officer, Treasurer and Secretary April 2, 2021

A signed original of this written statement required by Section 906 has been provided to RCM Technologies, Inc. and will be retained by RCM Technologies, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-4.A

Exhibit (4)

DESCRIPTION OF CAPITAL STOCK

The following description of the terms of the common stock of RCM Technologies, Inc. (the “Company,” “we,” “our” or “us”) sets forth certain general terms and provisions of our common stock. This section also summarizes relevant provisions of Nevada law. The following summary of the terms of our common stock does not purport to be complete and is subject to, and is qualified in its entirety by reference to, the applicable provisions of Nevada law and our Articles of Incorporation, as amended (the “Articles of Incorporation”) and our Amended and Restated Bylaws, as amended (the “Bylaws”), copies of which are filed with, or incorporated by reference into, our Annual Reports on Form 10-K.

Capital Stock

Our authorized capital stock currently consists of 40,000,000 shares of common stock, $0.05 par value per share, and 5,000,000 shares of preferred stock, $1.00 par value per share.

Common Stock

The holders of our common stock are entitled to one vote for every share standing in the name of the stockholder in the books of the Company on any matter submitted to the stockholders, including the election of directors. Holders of the common stock do not have any preemptive rights so long as the common stock remains registered pursuant to section 12 of the Securities Exchange Act of 1934, as amended.  Holders of the common stock do not have any cumulative voting rights. The holders of our common stock are entitled to receive dividends when, as and if declared by our board of directors out of legally available funds. Upon our liquidation or dissolution, the holders of common stock will be entitled to share ratably in those of our assets that are legally available for distribution to stockholders after payment of liabilities and subject to the prior rights of any holders of preferred stock then outstanding. All of the outstanding shares of common stock are fully paid and nonassessable. The rights, preferences and privileges of holders of common stock are subject to the rights of the holders of shares of any series of preferred stock that may be issued in the future.

Preferred Stock

We are authorized to issue up to 5,000,000 shares of preferred stock. Subject to limitations prescribed by Nevada law and the Articles of Incorporation, the Preferred Stock shall be divided into and from time to time may be issued in classes and in series within any class and our board of directors is hereby authorized to make such division into classes and series, to determine the number of shares of any such class or series, and to determine the designation,  voting rights, preferences, limitations and special rights, if any, of the shares of each such class or series. The issuance of preferred stock may have the effect of delaying, deferring or preventing a change in control of our Company and may adversely affect the voting and other rights of the holders of our common stock, which could have an adverse impact on the market price of our common stock.

Certain Articles of Incorporation, Bylaws and Statutory Provisions

The provisions of the Articles of Incorporation and Bylaws and of the Nevada Business Corporation Act summarized below may have an anti-takeover effect and may delay, defer or prevent a tender offer or takeover attempt that a stockholder might consider in such stockholder’s best interest, including an attempt that might result in the receipt of a premium over the market price for our shares.

Limitation of Liability of Officers and Directors

Nevada law currently provides that our directors will not be personally liable to our Company or our stockholders for monetary damages for any act or omission as a director other than in the following circumstances:

• the director breaches his fiduciary duty to our Company or our stockholders and this breach involves intentional misconduct, fraud or a knowing violation of law; or

• our Company makes an unlawful payment of a dividend or unlawful stock purchases, redemptions or other distributions.

As a result, neither we nor our stockholders have the right, through stockholders’ derivative suits on our behalf, to recover monetary damages against a director for breach of fiduciary duty as a director, including breaches resulting from grossly negligent behavior, except in the situations described above. Nevada law allows the articles of incorporation of a corporation to provide for greater liability of the corporation’s directors. Our Articles of Incorporation do not provide for such expanded liability.

Special Meetings of Stockholders

The Bylaws provide that special meetings of stockholders may be called only by a majority of the members of our board orupon the written request of stockholders, in accordance with, and subject to, the provisions of the Bylaws, from stockholders who hold, in the aggregate, not less than twenty percent (20%) of the voting power of our outstanding shares.

Stockholder Action; Advance Notice Requirements for Stockholder Proposals and Director Nominations

The Articles of Incorporation provide that stockholders may take action by written consent if such consent is signed by the holders of record of the outstanding shares of the Company having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted, and otherwise may only take action at duly called annual or special meetings. In addition, our Bylaws establish advance notice procedures for:

• stockholders to nominate candidates for election as a director; and

• stockholders to propose topics for consideration at stockholders’ meetings.

Stockholders must notify our corporate secretary in writing prior to the meeting at which the matters are to be acted upon or directors are to be elected. The notice must contain the information specified in our Bylaws. To be timely, the notice must be delivered to, or mailed and received at, the principal executive offices of the Company not less than ninety (90) days nor more than one hundred twenty (120) days prior to the one-year anniversary of the immediately preceding year’s annual meeting; provided, however, that in the event that no annual meeting was held in the previous year or the date of the annual meeting is called for a date that is more than thirty (30) days before or more than sixty (60) days after such anniversary date, notice by the stockholder to be timely must be so delivered, or mailed and received, not later than the ninetieth (90th) day prior to such annual meeting or, if later, the tenth (10th) day following the day on which public disclosure of the date of such annual meeting was first made. In the case of a special meeting of stockholders called to elect directors, the stockholder notice must be delivered to, or mailed and received by, the Secretary of the Company at its principal executive offices not earlier than the one hundred twentieth (120th) day prior to such special meeting and not later than the ninetieth (90th) day prior to such special meeting or, if later, the tenth (10th) day following the day on which public disclosure (as defined in Section 3.13(h)) of the date of such special meeting was first made. These provisions may preclude some stockholders from bringing matters before the stockholders at an annual or special meeting or from nominating candidates for director at an annual or special meeting.

Election and Removal of Directors

Our board of directors is elected each year by our stockholders for a term expiring at the next annual meeting of stockholders. Our stockholders may remove directors with our without cause by the affirmative vote of the holders of two-thirds (2/3) of the combined voting power of all the then issued and outstanding shares of stock of all classes and series of the Company entitled to vote generally for the election of Directors, thereon, voting together as a single class. Our board of directors may elect a director to fill a vacancy created by the expansion of the board of directors.

Nevada Anti-Takeover Statutes

Business Combinations Act

We are subject to Nevada’s anti-takeover law under the Nevada Business Corporation Act, known as the Business Combinations Act. This law provides that specified persons who, together with affiliates and associates, own, or, with respect to affiliates or associates of ours who within two years did own, 10% or more of the outstanding voting stock of a corporation cannot engage in specified business combinations with the corporation for a period of two years after the date on which the person became an interested stockholder. The law defines the term “business combination” to encompass a wide variety of transactions with or caused by an interested stockholder, including mergers, asset sales and other transactions in which the interested stockholder receives or could receive a benefit on other than a pro rata basis with other stockholders. This provision would then have an anti-takeover effect for transactions not approved in advance by our board of directors, including discouraging takeover attempts that might result in a premium over the market price for the shares of our common stock.

Control Shares Act

The Nevada Business Corporation Act provides that, in certain circumstances, a stockholder who acquires a controlling interest in a corporation, defined in the statute as an interest in excess of a 1/5, 1/3 or 1/2 interest, has no voting rights in the shares acquired that caused the stockholder to exceed any such threshold, unless the corporation’s other stockholders, by majority vote, grant voting rights to such shares. We may opt out of this act by amending our by-laws either before or within ten days after the relevant acquisition of shares. Presently, our amended and restated by-laws do not opt out of this act.

Transfer Agent and Registrar

The transfer agent and registrar for the common stock is American Stock Transfer & Trust Company, LLC. Its address is 59 Maiden Lane, New York, New York 10005.

Listing

Our common stock is listed on the NASDAQ Capital Market under the symbol “RCMT.”

Shareholder Rights (Poison Pill)

On May 22, 2020, our Board of Directors, approved and adopted a Rights Agreement, dated as of May 22, 2020 (the “Rights Agreement”), by and between the Company and American Stock Transfer & Trust Company, LLC, as Rights Agent (the “Rights Agent”). Pursuant to the Rights Agreement, the Board declared a dividend of one preferred share purchase right (each, a “Right”) for each outstanding share of common stock (in the context of the Rights and the Rights Agreement, each a “Common Share” and, collectively, the “Common Shares”). The Rights were distributable to stockholders of record as of the close of business on June 2, 2020 (the “Record Date”). One Right will also be issued together with each Common Share issued by the Company after June 2, 2020, but before the Distribution Date (as defined below) (or the earlier redemption or expiration of the Rights) and, in certain circumstances, after the Distribution Date.

Generally, the Rights Agreement works by imposing a significant penalty upon any person or group that acquires beneficial ownership of ten percent (10%) or more of the Common Shares without the approval of the Board. As a result, the overall effect of the Rights Agreement and the issuance of the Rights may be to render more difficult or discourage a merger, tender or exchange offer or other business combination involving the Company that is not approved by the Board. The Rights Agreement is not intended to interfere with any merger, tender or exchange offer or other business combination approved by the Board. Nor does the Rights Agreement prevent the Board from considering any offer that it considers to be in the best interest of its stockholders.

The following is a summary description of the Rights and material terms and conditions of the Rights Agreement. This summary is intended to provide a general description only, does not purport to be complete and is qualified in its entirety by reference to the complete text of the Rights Agreement, a copy of which is filed as Exhibit 4.1 to the Company’s Registration Statement on Form 8-A filed with the Securities and Exchange Commission (the “SEC”) on May 22, 2020 (the “Form 8-A”) and is incorporated herein by reference. All capitalized terms used herein but not defined herein shall have the meanings ascribed to such terms in the Rights Agreement.

The Rights

Subject to the terms, provisions and conditions of the Rights Agreement, if the Rights become exercisable, each Right would initially represent the right to purchase from the Company one one-hundredth of a share of a newly-designated series of preferred stock, Series A-3 Junior Participating Preferred Stock, par value $1.00 per share, of the Company (each, a “Series A-3 Preferred Share” and, collectively, the “Series A-3 Preferred Shares”), at an exercise price of $5.60 per one one-hundredth of a Series A-3 Preferred Share, subject to adjustment (the “Exercise Price”). If issued, each one one-hundredth of a Series A-3 Preferred Share would give the stockholder approximately the same dividend, voting and liquidation rights as does one Common Share. However, prior to exercise, a Right does not give its holder any rights as a stockholder of the Company, including, without limitation, any dividend, voting or liquidation rights. A copy of the Certificate of Designation of Series A-3 Junior Participating Preferred Stock (the “Series A-3 Certificate of Designation”) that the Company intends to file with the Secretary of State of the State of Nevada on May 22, 2020 to designate the Series A-3 Preferred Shares is filed as Exhibit 4.2 to the Form 8-A and is incorporated herein by reference.

Initial Exercisability

Initially, the Rights will not be exercisable, certificates will not be sent to stockholders and the Rights will automatically trade with the Common Shares. Until the Rights separate from the Common Shares and become exercisable (or the earlier redemption or expiration of the Rights), the Rights will be evidenced by Common Share certificates, Rights relating to any uncertificated Common Shares that are registered in book entry form will be represented by a notation in book entry on the records of the Company, and the surrender for transfer of any Common Shares will also constitute the transfer of the associated Rights.

Subject to certain exceptions specified in the Rights Agreement, the Rights will separate from the Common Shares and become exercisable following the earlier to occur of (i) the tenth (10th) business day (or such later date as may be determined by the Board) after the day on which a public announcement or filing with the SEC is made indicating that a person has become an Acquiring Person (as defined below) or that discloses information which reveals the existence of an Acquiring Person (the “Shares Acquisition Date”), or (ii) the tenth (10th) business day (or such later date as may be determined by the Board) after the commencement by any person (other than certain exempted persons) of, or the first public announcement of the intent of any person (other than certain exempted persons) to commence, a tender or exchange offer by or on behalf of a person, the successful consummation of which would result in any person (other than certain exempted persons) becoming an Acquiring Person, irrespective of whether any shares are actually purchased or exchanged pursuant to such offer (the earlier of these dates is called the “Distribution Date”).

After the Distribution Date, separate rights certificates will be issued and the Rights may be transferred other than in connection with the transfer of the underlying Common Shares unless and until the Board has determined to effect an exchange pursuant to the Rights Agreement (as described below).

Acquiring Person

Under the Rights Agreement, an Acquiring Person is any person who or which, together with all Affiliates and Associates (as defined in the Rights Agreement) of such person, from and after the first public announcement by the Company of the adoption of the Rights Agreement, is or becomes the beneficial owner of ten percent (10%) or more of the Common Shares outstanding, subject to various exceptions. For purposes of the Rights Agreement, beneficial ownership is defined to include the ownership of derivative securities.

The Rights Agreement provides that an Acquiring Person does not include the Company, any subsidiary of the Company, any employee benefit plan of the Company or any subsidiary of the Company, or any person organized, appointed, or established to hold Common Shares pursuant to any employee benefit plan of the Company or for the purpose of funding any such plan.

The Rights Agreement also provides that the following persons shall not be deemed an Acquiring Person thereunder: (i) any person who becomes the beneficial owner of ten percent (10%) or more of the shares of Common Stock of the Company then outstanding solely as a result of the initial grant or vesting of any options, warrants, rights or similar interests (including restricted shares and restricted stock units) by the Company to its directors, officers and employees pursuant to any employee benefit or stock ownership plan of the Company, or the acquisition of shares of Common Stock of the Company upon the exercise or conversion of any such securities so granted; (ii) any person who as the result of an acquisition of shares of Common Stock by the Company (or any subsidiary of the Company, or any person organized, appointed, established or holding shares of Common Stock of the Company for or pursuant to the terms of any such plan) which, by reducing the number of shares of Common Stock of the Company outstanding, increases the proportionate number of shares of Common Stock of the Company beneficially owned by such person to ten percent (10%) or more of the Common Shares then outstanding; (iii) any person who or which became the beneficial owner of ten percent (10%) or more of the Common Shares then outstanding as a result of the acquisition of Common Shares directly from the Company; or (iv) any person who or which would otherwise be an Acquiring Person who or which the Board determines had become such inadvertently (including, without limitation, because (A) such person was unaware that it beneficially owned a percentage of the Common Shares that would otherwise cause such person to be an “Acquiring Person,” or (B) such person was aware of the extent of its beneficial ownership of Common Shares but had no actual knowledge of the consequences of such beneficial ownership under the Rights Agreement), and who or which thereafter within five (5) business days of being requested by the Company, reduces such person’s beneficial ownership to less than ten percent (10%) of the Common Shares then outstanding.

“Grandfathering” of Existing Holders

The Rights Agreement also provides that any person who or which, together with all Related Persons of such Person, would be deemed an Acquiring Person as of the time immediately prior to the first public announcement by the Company of the adoption of the Rights Agreement (each a “Grandfathered Person”), shall not be deemed to be an “Acquiring Person” for purposes of the Rights Agreement unless and until a Grandfathered Person becomes the beneficial owner of one or more additional Common Shares after the first public announcement by the Company of the adoption of the Rights Agreement (other than pursuant to a dividend or distribution paid or made by the Company on the outstanding Common Shares, pursuant to a split, reclassification or subdivision of the outstanding Common Shares or pursuant to the acquisition of beneficial ownership of Common Shares upon the vesting or exercise of any option, warrants or other rights, or upon the initial grant or vesting of restricted stock, granted or issued by the Company to its directors, officers and employees, pursuant to a compensation or benefits plan or arrangement adopted by the Board). However, if upon acquiring beneficial ownership of one or more additional Common Shares at any time after the first public announcement by the Company of the adoption of the Rights Agreement, the Grandfathered Person does not, at such time, beneficially own ten percent (10%) or more of the Common Shares then outstanding, the  Grandfathered Person will not be treated as an “Acquiring Person” for purposes of the Rights Agreement.

Flip-In Trigger

If a person becomes an Acquiring Person, then, following the occurrence of the Distribution Date and subject to the terms, provisions and conditions of the Rights Agreement, each Right will entitle the holder thereof to purchase from the Company, upon payment of the Exercise Price, in lieu of a number of one one-hundredths of a Series A-3 Preferred Share, a number of Common Shares (or, in certain circumstances, cash, property or other securities of the Company) having a then-current market value of twice the Exercise Price. However, the Rights are not exercisable until such time as the Rights are no longer redeemable by the Company, as further described below.

Following the occurrence of an event set forth in the preceding paragraph, all Rights that are or, under certain circumstances specified in the Rights Agreement, were beneficially owned by an Acquiring Person or certain of its transferees will become null and void and nontransferable.

Flip-Over Trigger

If, after an Acquiring Person obtains beneficial ownership of ten percent (10%) or more of the Common Shares, (i) the Company merges into another entity, (ii) an acquiring entity merges into the Company, or (iii) the Company sells or transfers more than fifty percent (50%) of its assets, cash flow or earning power, then each Right (except for Rights that have previously been voided as set forth above) will entitle the holder thereof to purchase, upon payment of the Exercise Price, in accordance with the terms of the Rights Agreement, a number of shares of common stock of the person engaging in the transaction having a then-current market value of twice the Exercise Price.

Redemption of the Rights

At any time until the close of business on the tenth (10th) business day after the Shares Acquisition Date (or, if the tenth (10th) business day after the Shares Acquisition Date occurs before the Record Date, the close of business on the Record Date), or thereafter under certain circumstances, the Company may redeem the Rights in whole, but not in part, at a price of $0.001 per Right (the “Redemption Price”). The Redemption Price may be paid in cash, Common Shares or other forms of consideration, as determined by the Board, in the exercise of its sole discretion. The redemption of the Rights may be made effective at such time, on such basis and subject to such conditions as the Board in its sole discretion may establish. Immediately upon any redemption of the Rights, the right to exercise the Rights will terminate and the only right of the holders of Rights will be to receive the Redemption Price without any interest thereon.

Exchange of the Rights

At any time after any person becomes an Acquiring Person, and prior to the acquisition by any person of beneficial ownership of fifty percent (50%) or more of the Common Shares, the Board may, at its option, cause the Company to exchange all or part of the then outstanding and exercisable Rights (other than Rights held by the Acquiring Person or any Affiliate or Associate thereof, which would have become null and void and nontransferable in accordance with the terms of the Rights Agreement), in whole or in part, for Common Shares at an exchange ratio (subject to adjustment) of one Common Share for each Right.

In any exchange of the Rights pursuant to the Rights Agreement, the Company, at its option, may, and to the extent there are an insufficient number of authorized Common Shares not reserved for any other purpose to exchange for all of the outstanding Rights, shall, substitute preferred stock or other securities of the Company for some or all of the Common Shares exchangeable for Rights such that the aggregate value received by a holder of Rights in exchange for each Right is substantially the same value as one Common Share. The exchange of the Rights by the Board may be made effective at such time, on such basis, and subject to such conditions as the Board in its sole discretion may establish. Immediately upon the action of the Board authorizing the exchange of the Rights, the right to exercise the Rights will terminate, and the only right of the holders of Rights will be to receive the Common Shares or other consideration issuable in connection with the exchange.

Expiration of the Rights

The Rights and the Rights Agreement will expire upon the earliest to occur of (i) 5:00 p.m., New York City time, on May 22, 2021, (ii) the date on which all of the Rights are redeemed, and (iii) the date on which the Rights are exchanged.

Amendment of Rights Agreement

Except as otherwise provided in the Rights Agreement, the Company, by action of the Board, may from time to time, in its sole and absolute discretion, supplement or amend any provision of the Rights Agreement in any respect without the approval of any holders of Rights, including, without limitation, in order to (i) cure any ambiguity in the Rights Agreement, (ii) correct or supplement any provision contained in the Rights Agreement that may be defective or inconsistent with any other provisions contained therein, (iii) shorten or lengthen any time period in the Rights Agreement, or (iv) otherwise change, amend, or supplement any provisions in the Rights Agreement in any manner that the Company may deem necessary or desirable; provided, however, that from and after such time as any person becomes an Acquiring Person, the Rights Agreement may not be supplemented or amended in any manner that would adversely affect the interests of the holders of Rights (other than Rights that have become null and void pursuant to the Rights Agreement) as such or cause the Rights Agreement to become amendable other than in accordance with the terms of the Rights Agreement. Without limiting the foregoing, the Company, by action of the Board, may at any time before any person becomes an Acquiring Person amend the Rights Agreement to make the provisions of the Rights Agreement inapplicable to a particular transaction by which a person might otherwise become an Acquiring Person or to otherwise alter the terms and conditions of the Rights Agreement as they may apply with respect to any such transaction.

Rights of Holders

Until a Right is exercised, a Right does not give its holder any rights as a stockholder of the Company, including, without limitation, any dividend, voting or liquidation rights.

Anti-Dilution Provisions

The Board may adjust the Exercise Price, the number of Series A-3 Preferred Shares issuable and the number of outstanding Rights to prevent dilution that may occur from a stock dividend, a stock split or a reclassification of the Series A-3 Preferred Shares or Common Shares.

With certain exceptions, no adjustments to the Exercise Price will be made until the cumulative adjustments amount to at least one percent (1%) of the Exercise Price. No fractional Series A-3 Preferred Shares will be issued other than fractions which are integral multiples of one one-hundredth of a share and, in lieu thereof, an adjustment in cash will be made based on the current market price of the Series A-3 Preferred Shares.

Tax Consequences

The adoption of the Rights Agreement and the subsequent distribution of the Rights to stockholders should not be a taxable event for the Company or its stockholders under presently existing U.S. federal income tax laws. However, if the Rights become exercisable or if the Rights are redeemed, stockholders may recognize taxable income, depending on the circumstances then existing.

Accounting Treatment

The distribution of the Rights as a dividend to the Company’s stockholders is not expected to have any financial accounting or reporting impact. The fair value of the Rights is expected to be zero when they are distributed because the Rights will be “out of the money” when distributed and no value should be attributable to them. Additionally, the Rights do not meet the definition of a liability under generally accepted accounting principles in the United States and are therefore not accounted for as a long-term obligation.

Authority of the Board

When evaluating decisions relating to the redemption of the Rights or any amendment to the Rights Agreement to delay or prevent the Rights from detaching and becoming exercisable as a result of a particular transaction, pursuant to the Rights Agreement, the Board, or any future board of directors, would not be subject to restrictions such as those commonly known as “dead-hand,” “slow-hand,” “no-hand,” or similar provisions.

Certain Anti-Takeover Effects

The Rights are not intended to prevent a takeover of the Company and should not interfere with any merger or other business combination approved by the Board. However, the Rights may cause substantial dilution to a person or group that acquires beneficial ownership of ten percent (10%) or more of the issued and outstanding Common Shares (which includes for this purpose stock referenced in derivative transactions and securities) without the approval of the Board.

SEC Registration

Since the Rights are not exercisable immediately, registration with the SEC of the Series A-3 Preferred Shares issuable upon exercise of the Rights is not required until the Rights become exercisable.

EX-21

EXHIBIT 21

SUBSIDIARIES OF THE REGISTRANT

Cataract, Inc.

PSR Engineering Solutions d.o.o. Beograd (Voždovac)

RCM Technologies Canada Corp.

RCM Technologies (USA), Inc.

RCM Technologies Netherlands B.V.

RCMT Delaware, Inc.

RCMT Europe Holdings, Inc.

EX-23.1

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements of RCM Technologies, Inc. on Form S-8 (Nos. 333-251516, 333-222151, 333-200826, 333-165482, 333-145904, 333-61306, 333-80590, 333-48089, 333-52206 and 333-52480) and on Form S-3 (No. 333-252148) of our report dated April 2, 2021, related to our audits of the consolidated financial statements of RCM Technologies, Inc. as of January 2, 2021 and December 28, 2019, and for the years then ended, which report appears in this Annual Report on Form 10-K.

/s/ Macias, Gini & O’Connell, LLP

Macias, Gini & O’Connell, LLP

San Diego, California

April 2, 2021

EX-31.1

EXHIBIT 31.1

CERTIFICATION REQUIRED BY

RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934

I, Bradley S. Vizi, certify that:

1.I have reviewed this annual report on Form 10-K of RCM Technologies, Inc. (the “registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this  report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 2, 2021	/s/	Bradley S. Vizi
		Bradley S. Vizi Executive Chairman and President

EX-31.2

EXHIBIT 31.2

CERTIFICATION REQUIRED BY

RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934

I, Kevin D. Miller, certify that:

1.I have reviewed this annual report on Form 10-K of RCM Technologies, Inc. (the “registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 2, 2021	/s/	Kevin D. Miller
		Kevin D. Miller Chief Financial Officer, Treasurer and Secretary

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of RCM Technologies, Inc. (the “Company”) for the fiscal year ended January 2, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bradley S. Vizi, Executive Chairman and President of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1)The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended (15 U.S.C. section 78m (a)); and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/	Bradley S. Vizi
	Bradley S. Vizi Executive Chairman and President April 2, 2021

A signed original of this written statement required by Section 906 has been provided to RCM Technologies, Inc. and will be retained by RCM Technologies, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of RCM Technologies, Inc. (the “Company”) for the fiscal year ended January 2, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kevin D. Miller, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1)The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended (15 U.S.C. section 78m (a)); and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/	Kevin D. Miller
	Kevin D. Miller Chief Financial Officer, Treasurer and Secretary April 2, 2021

A signed original of this written statement required by Section 906 has been provided to RCM Technologies, Inc. and will be retained by RCM Technologies, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document And Entity Information - USD ($) $ in Millions	12 Months Ended
	Jan. 02, 2021	Apr. 01, 2021	Jun. 27, 2020
Document Information [Line Items]
Entity Registrant Name	RCM TECHNOLOGIES, INC.
Entity Central Index Key	0000700841
Trading Symbol	rcmt
Current Fiscal Year End Date	--01-02
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding (in shares)		11,485,310
Entity Public Float			$ 9.6
Entity Shell Company	false
Document Type	10-K
Document Period End Date	Jan. 02, 2021
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Amendment Flag	false
Title of 12(b) Security	Common Stock, par value $0.05 per share

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 02, 2021	Dec. 28, 2019
Current assets:
Cash and cash equivalents	$ 734	$ 1,847
Accounts receivable, net	36,007	59,760
Transit accounts receivable	2,494	4,906
Prepaid expenses and other current assets	4,699	4,144
Total current assets	43,934	70,657
Property and equipment, net	2,078	2,717
Other assets:
Deposits	169	209
Deferred tax assets, net, domestic	3,300
Goodwill	16,354	16,354
Operating right of use asset	2,409	5,820
Intangible assets, net	95	416
Total other assets	22,327	22,799
Total assets	68,339	96,173
Current liabilities:
Accounts payable and accrued expenses	7,895	6,220
Transit accounts payable	4,900	4,552
Accrued payroll and related costs	12,877	7,713
Finance lease payable	247	315
Income taxes payable	436	130
Operating right of use liability	1,886	2,134
Liability for contingent consideration from acquisitions	500	344
Total current liabilities	28,741	21,408
Finance lease payable	106	189
Liability for contingent consideration from acquisitions	2,358	2,714
Operating right of use liability, net of current position	2,641	3,921
Borrowings under line of credit	11,890	34,761
Total liabilities	46,101	63,770
Stockholders’ equity:
Preferred stock, $1.00 par value; 5,000,000 shares authorized; no shares issued or outstanding
Common stock, $0.05 par value; 40,000,000 shares authorized; 16,224,191 shares issued and 11,542,880 shares outstanding at January 2, 2021 and 15,826,891 shares issued and 13,003,719 shares outstanding at December 28, 2019	811	791
Stock subscription receivable	(420)
Additional paid-in capital	109,588	108,452
Accumulated other comprehensive loss	(2,550)	(2,748)
Accumulated deficit	(67,974)	(59,105)
Treasury stock (4,681,311 shares at January 2, 2021 and 2,823,172 at December 28, 2019) at cost	(17,217)	(14,987)
Stockholders’ equity	22,238	32,403
Total liabilities and stockholders’ equity	68,339	96,173
Foreign Tax Authority [Member]
Current liabilities:
Deferred tax liability	365	382
Domestic Tax Authority [Member]
Current liabilities:
Deferred tax liability		$ 395

XML

Consolidated Balance Sheets (Parentheticals) - $ / shares	Jan. 02, 2021	Dec. 28, 2019
Preferred stock par value (in dollars per share)	$ 1	$ 1
Preferred stock, authorized (in shares)	5,000,000	5,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.05	$ 0.05
Common stock, authorized (in shares)	40,000,000	40,000,000
Common stock, issued (in shares)	16,224,191	15,826,891
Common stock, outstanding (in shares)	11,542,880	13,003,719
Treasury stock, shares (in shares)	4,681,311	2,823,172

XML

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Revenues	$ 150,409	$ 191,100
Cost of services	111,554	142,508
Gross profit	38,855	48,592
Operating costs and expenses
Selling, general and administrative	37,551	40,390
Depreciation and amortization of property and equipment	1,065	1,261
Amortization of acquired intangible assets	321	327
Write-off of receivables and professional fees incurred related to arbitration	8,397
Impairment of right of use assets and related costs	2,231
Tax credit professional fees	240	47
Operating costs and expenses	49,805	42,025
Operating (loss) income	(10,950)	6,567
Other (expense) income
Interest expense and other, net	(778)	(1,695)
Change in fair value of contingent consideration	(145)	(61)
(Loss) gain on foreign currency transactions	(184)	11
Other expense, net	(1,107)	(1,745)
(Loss) income before income taxes	(12,057)	4,822
Income tax (benefit) expense	(3,188)	764
Net (loss) income	$ (8,869)	$ 4,058
Basic and diluted net (loss) income per share (in dollars per share)	$ (0.73)	$ 0.31

XML

Consolidated Statements of Comprehensive (Loss) Income - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Net (loss) income	$ (8,869)	$ 4,058
Other comprehensive income	198	7
Total comprehensive (loss) income	$ (8,671)	$ 4,065

XML

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Stock Subscriptions Receivable [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Total
Balance (in shares) at Dec. 29, 2018	15,578,345					2,823,172
Balance at Dec. 29, 2018	$ 778		$ 107,326	$ (2,755)	$ (63,163)	$ (14,987)	$ 27,199
Issuance of stock under employee stock purchase plan (in shares)	118,526
Issuance of stock under employee stock purchase plan	$ 6		315				321
Translation adjustment				7			7
Issuance of stock upon vesting of restricted share awards (in shares)	130,020
Issuance of stock upon vesting of restricted share awards	$ 7		(7)
Equity compensation expense from awards issued			806				806
Accrued dividends forfeited			12				12
Net income (loss)					4,058		4,058
Balance (in shares) at Dec. 28, 2019	15,826,891					2,823,172
Balance at Dec. 28, 2019	$ 791		108,452	(2,748)	(59,105)	$ (14,987)	32,403
Issuance of stock under employee stock purchase plan (in shares)	117,983
Issuance of stock under employee stock purchase plan	$ 6		202				208
Translation adjustment				198			198
Issuance of stock upon vesting of restricted share awards (in shares)	279,317
Issuance of stock upon vesting of restricted share awards	$ 14		(14)
Equity compensation expense from awards issued			528				528
Net income (loss)					(8,869)		(8,869)
Stock subscription receivable (in shares)
Stock subscription receivable		(420)	420
Purchase of treasury stock (in shares)						1,858,139
Purchase of treasury stock						$ (2,230)	(2,230)
Balance (in shares) at Jan. 02, 2021	16,224,191					4,681,311
Balance at Jan. 02, 2021	$ 811	$ (420)	$ 109,588	$ (2,550)	$ (67,974)	$ (17,217)	$ 22,238

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Cash flows from operating activities:
Net (loss) income	$ (8,869)	$ 4,058
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	1,386	1,588
Change in fair value of contingent consideration	145	61
Impairment of right of use assets and related costs	2,231
Equity compensation expense	1,108	806
Provision for losses on accounts receivable	7,911	322
Deferred income tax (benefit) expense	(3,712)	1,104
Changes in assets and liabilities:
Accounts receivable	15,947	(7,626)
Prepaid expenses and other current assets	(162)	(645)
Net of transit accounts receivable and payable	2,757	(293)
Accounts payable and accrued expenses	1,639	(3,085)
Accrued payroll and related costs	4,557	(1,342)
Right of use assets	1,490	(5,820)
Right of use liabilities	(1,529)	6,056
Income taxes payable	304	38
Total adjustments	34,072	(8,836)
Net cash provided by (used in) operating activities	25,203	(4,778)
Cash flows from investing activities:
Property and equipment acquired	(460)	(367)
Decrease in deposits	41	4
Net cash used in investing activities	(419)	(363)
Cash flows from financing activities:
Borrowings under line of credit	73,238	95,554
Repayments under line of credit	(96,109)	(88,332)
Issuance of stock for employee stock purchase plan	208	321
Changes in finance lease obligations	(394)	(318)
Contingent consideration paid	(345)	(598)
Payment of note payable for treasury stock	(2,230)
Net cash (used in) provided by financing activities	(25,632)	6,627
Effect of exchange rate changes on cash and cash equivalents	(265)	(121)
(Decrease) increase in cash and cash equivalents	(1,113)	1,365
Cash and cash equivalents at beginning of period	1,847	482
Cash and cash equivalents at end of period	734	1,847
Supplemental cash flow information:
Interest	1,026	1,657
Income taxes	264	290
Non-cash financing activities:
Equity awards issued	492	436
Dividend forfeited on unvested restricted share awards		12
Software purchase under finance leases	$ 258	$ 126

XML

Note 1 - Summary of Significant Accounting Policies

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Description of Business and Basis of Presentation

RCM Technologies, Inc. (the “Company” or “RCM”) is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced engineering and information technology services. Additionally, the Company provides specialty health care staffing services through its Specialty Health Care Services group. RCM's offices are primarily located in major metropolitan centers throughout North America.

The consolidated financial statements are comprised of the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

The Company considers its holdings of highly liquid money-market instruments and certificates of deposits to be cash equivalents if the securities mature within

90

days from the date of acquisition.  These investments are carried at cost, which approximates fair value.  The Company's cash balances are maintained in accounts held by major banks and financial institutions.  The majority of these balances

may

exceed federally insured amounts.  The Company held

$42

and

$56

of cash and cash equivalents in Canadian banks as of

January 2, 2021

and

December 28, 2019,

respectively, which was held principally in Canadian dollars.  The Company held

$246

and

$129

of cash and cash equivalents in Serbian banks as of

January 2, 2021

and

December 28, 2019,

respectively, which was held in various currencies. 

Fair Value of Financial Instruments

The Company's carrying value of financial instruments, consisting primarily of accounts receivable, transit accounts receivable, accounts payable and accrued expenses, and transit accounts payable and borrowings under line of credit approximates fair value due to their liquidity or their short-term nature and the line of credit's variable interest rate. The Company does

not

have derivative products in place to manage risks related to foreign currency fluctuations for its foreign operations or for interest rate changes.

Accounts Receivable and Allowance for Doubtful Accounts

The Company's accounts receivable are primarily due from trade customers. Credit is extended based on evaluation of customers' financial condition and, generally, collateral is

not

required. Accounts receivable payment terms vary and are stated in the financial statements at amounts due from customers net of an allowance for doubtful accounts. Accounts outstanding longer than the payment terms are considered past due. The Company determines its allowance by considering a number of factors, including the length of time trade accounts receivable are past due, the Company's previous loss history, the customer's current ability to pay its obligation to the Company, and the condition of the general economy and the industry as a whole. The Company writes off accounts receivable when they become uncollectible, and payments subsequently received on such receivables previously written off are credited to bad debt expense.

Accrued and Unbilled Accounts Receivable and Work-in-Process

Unbilled receivables primarily represent revenues earned whereby those services are ready to be billed as of the balance sheet ending date. Work-in-process primarily represents revenues earned under contracts which the Company is contractually precluded from invoicing until future dates as project milestones are realized. See Note

4

for further details.

Transit Receivables and Transit Payables

From time to time, the Company's Engineering segment enters into agreements to provide, among other things, construction management and engineering services.  Pursuant to these agreements, the Company a)

may

engage subcontractors to provide construction or other services; b) typically earns a fixed percentage of the total project value; and c) assumes

no

ownership or risks of inventory.  In such situations, the Company acts as an agent under the provisions of FASB ASC

606

“Revenue from Contracts with Customers” and therefore recognizing revenue on a “net-basis.”  The Company records revenue on a “net” basis on relevant engineering and construction management projects, which require subcontractor/procurement costs or transit costs. In those situations, the Company charges the client a negotiated fee, which is reported as net revenue when earned. 

Under the terms of the agreements, the Company is typically

not

required to pay the subcontractor until after the corresponding payment from the Company's end-client is received. Upon invoicing the end-client on behalf of the subcontractor or staffing agency the Company records this amount simultaneously as both a “transit account receivable” and “transit account payable” as the amount when paid to the Company is due to and generally paid to the subcontractor within a few days. The Company typically does

not

pay a given transit account payable until the related transit account receivable is collected. The Company is typically obligated to pay the subcontractor or staffing agency whether or

not

the client pays the Company. The Company's transit accounts payable generally exceeds the Company's transit accounts receivable but absolute amounts and spreads fluctuate significantly from quarter to quarter in the normal course of business.

Property and Equipment

Property and equipment are stated at cost and are depreciated on the straight-line method at rates calculated to provide for retirement of assets at the end of their estimated useful lives. The annual rates are

20%

for computer hardware and software as well as furniture and office equipment. Leasehold improvements are amortized over the shorter of the estimated life of the asset or the lease term.

Intangible Assets

The Company's intangible assets have been generated through acquisitions. The Company maintains responsibility for valuing and determining the useful life of intangible assets. As a general rule, the Company amortizes restricted covenants over

four

years and customer relationships over

six

years. However, circumstances

may

dictate other amortization terms as determined by the Company and assisted by their

third

party advisors.

Canadian Sales Tax

The Company is required to charge and collect sales tax for all Canadian clients and remits invoiced sales tax monthly to the Canadian taxing authorities whether collected or

not.

The Company does

not

collect the sales tax from its clients until they have paid their respective invoices. The Company includes uncollected Canadian sales tax invoiced to clients in its prepaid and other current assets.

Goodwill

Goodwill is

not

amortized but is subject to periodic testing for impairment in accordance with FASB ASC

350

“

Intangibles - Goodwill and Other.

” The Company tests goodwill for impairment on an annual basis as of the last day of the Company's fiscal

December

each year or more frequently if events occur or circumstances change indicating that the fair value of the goodwill

may

be below its carrying amount. The Company has

three

reporting units. The Company uses a market-based approach to determine the fair value of the reporting units. This approach uses earnings/revenue multiples of similar companies recently completing acquisitions and the ability of our reporting units to generate cash flows as measures of fair value of our reporting units. The Company adopted Accounting Standards Update (“ASU”)

2017

-

04,

“Intangibles - Goodwill and Other (Topic

350

): Simplifying the Test for Goodwill Impairment” effective

December 28, 2019

which has eliminated Step

2

from the goodwill impairment test. Under this update, an entity should perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount.

The Company did

not

record a goodwill impairment charge in fiscal years ended

January 2, 2021

and

December 28, 2019.

There can be

no

assurance that future indicators of impairment and tests of goodwill impairment will

not

result in an impairment charge.

Long-Lived and Intangible Assets

The Company evaluates long-lived assets and intangible assets with definite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset

may

not

be recoverable. When the Company determines that it is probable that undiscounted future cash flows will

not

be sufficient to recover an asset's carrying amount, the asset is written down to its fair value. Assets to be disposed of by sale, if any, are reported at the lower of the carrying amount or fair value less cost to sell. The Company's intangible assets consist of customer relationships and non-compete agreements.

Software

In accordance with FASB ASC

350

-

40

“Accounting for Internal Use Software,” certain costs related to the development or purchase of internal-use software are capitalized and amortized over the estimated useful life of the software. During the fiscal years ended

January 2, 2021

and

December 28, 2019,

the Company capitalized

$305

and

$139,

respectively, for software costs. The net balance after accumulated depreciation for all software costs capitalized as of

January 2, 2021

and

December 28, 2019

was

$1,389

and

$1,726,

respectively.

Income Taxes

The Company makes judgments and interpretations based on enacted tax laws, published tax guidance, as well as estimates of future earnings. These judgments and interpretations affect the provision for income taxes, deferred tax assets and liabilities and the valuation allowance. The Company evaluated the deferred tax assets and determined on the basis of objective factors that the net assets will be realized through future years' taxable income. In the event that actual results differ from these estimates and assessments, additional valuation allowances

may

be required. The Company did

not

have any valuation allowance as of

January 2, 2021

or

December 28, 2019.

The Company accounts for income taxes in accordance with FASB ACS

740

“Income Taxes” (FASB ASC

740

) which requires an asset and liability approach of accounting for income taxes.  FASB ASC

740

requires assessment of the likelihood of realizing benefits associated with deferred tax assets for purposes of determining whether a valuation allowance is needed for such deferred tax assets.  Deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that such tax rate changes are enacted. The Company measures its deferred tax assets and liabilities using the tax rates that the Company believes will apply in the years in which the temporary differences are expected to be recovered or paid. The Company and its wholly owned United States subsidiaries file a consolidated federal income tax return.  The Company also files tax returns in Canada, Puerto Rico and Serbia.

The Company also follows the provisions of FASB ASC

740

which prescribes a model for the recognition and measurement of a tax position taken or expected to be taken in a tax return, and provides guidance on derecognition, classification, interest and penalties, disclosure and transition.  The Company's policy is to record interest and penalty, if any, as interest expense.

Revenue Recognition

The Company records revenue under Accounting Standards Codification ("ASC") Topic

606,

 

Revenue from Contracts with Customers

. Revenue is recognized when we satisfy a performance obligation by transferring services promised in a contract to a customer, in an amount that reflects the consideration that we expect to receive in exchange for those services. Performance obligations in our contracts represent distinct or separate service streams that we provide to our customers.

We evaluate our revenue contracts with customers based on the

five

-step model under ASC

606:

(

1

) Identify the contract with the customer; (

2

) Identify the performance obligations in the contract; (

3

) Determine the transaction price; (

4

) Allocate the transaction price to separate performance obligations; and (

5

) Recognize revenue when (or as) each performance obligation is satisfied.

The Company derives its revenue from several sources. The Company's Engineering Services and Information Technology Services segments perform consulting and project solution services. The Healthcare segment specializes in long-term and short-term staffing and placement services to hospitals, schools and long-term care facilities amongst others. All of the Company's segments perform staff augmentation services and derive revenue from permanent placement fees. The majority of the Company's revenue is invoiced on a time and materials basis.

The following table presents our revenues disaggregated by revenue source for the

fifty-three

week period ended

January 2, 2021

and the

fifty-two

week period

December 28, 2019:

	January 2, 2021		December 28, 2019
Engineering:
Time and Material	$	43,359	$	55,195
Fixed Fee		14,145		12,678
Permanent Placement Services		211		-
Total Engineering	$	57,715	$	67,873
Specialty Health Care:
Time and Material	$	59,692	$	88,057
Permanent Placement Services		789		1,291
Total Specialty Health Care	$	60,481	$	89,348
Information Technology:
Time and Material	$	31,723	$	33,384
Permanent Placement Services		490		495
Total Information Technology	$	32,213	$	33,879
	$	150,409	$	191,100

Time and Material

The Company's IT and Healthcare segments predominantly recognize revenue through time and material work while its Engineering segment recognizes revenue through both time and material and fixed fee work. The Company's time and material contracts are typically based on the number of hours worked at contractually agreed upon rates, therefore revenue associated with these time and materials contracts are recognized based on hours worked at contracted rates. 

Fixed fee

From time to time and predominantly in our Engineering segment, the Company will enter into contracts requiring the completion of specific deliverables.  The Company has master services agreements with many of its customers that broadly define terms and conditions. Actual services performed under fixed fee arrangements are typically delivered under purchase orders that more specifically define terms and conditions related to that fixed fee project. While these master services agreements can often span several years, the Company's fixed fee purchase orders are typically performed over

six

to

nine

month periods.  In instances where project services are provided on a fixed-price basis, revenue is recorded in accordance with the terms of each contract.  In certain instances, revenue is invoiced at the time certain milestones are reached, as defined in the contract.  Revenue under these arrangements are recognized as the costs on these contracts are incurred.  On an infrequent basis, amounts paid in excess of revenue earned and recognized are recorded as deferred revenue, included in accounts payable and accrued expenses on the accompanying condensed balance sheets.  In other instances, revenue is billed and recorded based upon contractual rates per hour.  Additionally, some contracts contain “Performance Fees” (bonuses) for completing a contract under budget.  Performance Fees, if any, are recorded when earned.  Some contracts also limit revenue and billings to specified maximum amounts.  Provisions for contract losses, if any, are made in the period such losses are determined.  For contracts where there is a specific deliverable and the work is

not

complete and the revenue is

not

recognized, the costs incurred are deferred as a prepaid asset.  The associated costs are expensed when the related revenue is recognized.

Permanent Placement Services

The Company earns permanent placement fees from providing permanent placement services. Fees for placements are recognized at the time the candidate commences employment. The Company guarantees its permanent placements on a prorated basis for

90

days. In the event a candidate is

not

retained for the

90

-day period, the Company will provide a suitable replacement candidate. In the event a replacement candidate cannot be located, the Company will provide a prorated refund to the client. An allowance for refunds, based upon the Company's historical experience, is recorded in the financial statements. Permanent placement revenue was

$1.5

million for the fiscal year ended

January 2, 2021

and

$1.8

million for the fiscal year ended

December 28, 2019.

The deferred revenue balance as of both

January 2, 2021

and

December 28, 2019

was

$0.4

million. These amounts are included in accounts payable and accrued expense in the accompanying consolidated balance sheets at that date.  Revenue is recognized when the service has been performed.  Deferred revenue

may

be recognized over a period exceeding

one

year from the time it was recorded on the balance sheet, although this is an infrequent occurrence.  For the

fifty-three

week period ended

January 2, 2021

and the

fifty-two

week period ended

December 28, 2019,

the Company recognized revenue of

$0.4

million and

$0.2

million, respectively, that was included in deferred revenue at the beginning of the reporting period.

Transit Receivables and Transit Payables

From time to time, the Company's Engineering segment enters into agreements to provide, among other things, construction management and engineering services.  Pursuant to these agreements, the Company a)

may

engage subcontractors to provide construction or other services; b) typically earns a fixed percentage of the total project value; and c) assumes

no

ownership or risks of inventory.  Under the terms of the agreements, the Company is typically

not

required to pay the subcontractor until after the corresponding payment from the Company's end-client is received. Upon invoicing the end-client on behalf of the subcontractor or staffing agency the Company records this amount simultaneously as both a “transit account receivable” and “transit account payable” as the amount when paid to the Company is due to and generally paid to the subcontractor within a few days. The Company typically does

not

pay a given transit account payable until the related transit account receivable is collected. The Company is typically obligated to pay the subcontractor or staffing agency whether or

not

the client pays the Company. The Company's transit accounts payable generally exceeds the Company's transit accounts receivable but absolute amounts and spreads fluctuate significantly from quarter to quarter in the normal course of business. The transit accounts receivable was

$2.5

million and related transit accounts payable was

$4.9

million, for a net payable of

$2.4

million, as of

January 2, 2021.

The transit accounts receivable was

$4.9

million and related transit accounts payable was

$4.6

million, for a net receivable of

$0.3

million, as of

December 28, 2019.

Concentration

During the fiscal year ended

January 2, 2021,

New York City Board of Education represented

10.6%

of the Company's revenues.

No

other client accounted for

10%

or more of total revenues during the year. As of

January 2, 2021,

the following clients represented more than

10.0%

of the Company's accounts receivable, net: New York City Board of Education was

11.8%

and Hawaii Department of Education was

10.6%.

No

other customer accounted for

10%

or more of the Company's accounts receivable, net. The Company's

five

,

ten

and

twenty

largest customers accounted for approximately

33.4%,

46.6%

and

60.7%,

respectively, of the Company's revenues for the fiscal year ended

January 2, 2021.

During the fiscal year ended

December 28, 2019,

New York City Board of Education and Hawaii Department of Education represented

17.6%

and

11.1%

of the Company's revenues, respectively.

No

other client accounted for

10%

or more of total revenues during the year. As of

December 28, 2019,

the following clients represented more than

10.0%

of the Company's accounts receivable, net: New York Power Authority was

24.6%,

New York City Board of Education was

17.6%

and Hawaii Department of Education was

12.7%.

As of

December 28, 2019,

New York Power Authority total accounts receivable balance (including transit accounts receivable) was

27.3%

of the total of accounts receivable, net and transit accounts receivable. 

No

other customer accounted for

10%

or more of the Company's accounts receivable, net or total accounts receivable balance (including transit accounts receivable). The Company's

five

,

ten

and

twenty

largest customers accounted for approximately

43.5%,

57.0%

and

69.2%,

respectively, of the Company's revenues for the fiscal year ended

December 28, 2019.

Foreign Currency Translation

The functional currency of the Company's Canadian and Serbian subsidiaries is the local currency. Assets and liabilities are translated at period-end exchange rates. Income and expense items are translated at weighted average rates of exchange prevailing during the year. Any translation adjustments are included in the accumulated other comprehensive income account in stockholders' equity. Transactions executed in different currencies resulting in exchange adjustments are translated at spot rates and resulting foreign exchange transaction gains and losses are included in the results of operations.

Comprehensive Income

Comprehensive income consists of net income and foreign currency translation adjustments.

Per Share Data

Basic net income per share is calculated using the weighted-average number of common shares outstanding during the period. Diluted net income per share is calculated using the weighted-average number of common shares plus dilutive potential common shares outstanding during the period. Potential dilutive common shares consist of stock options and other stock-based awards under the Company's stock compensation plans, when their impact is dilutive. Because of the Company's capital structure, all reported earnings pertain to common shareholders and

no

other adjustments are necessary.

Share - Based Compensation

The Company recognizes share-based compensation over the vesting period of an award based on fair value at the grant date determined using the Black-Scholes option pricing model. Certain assumptions are used to determine the fair value of stock-based payment awards on the date of grant and require subjective judgment. Because employee stock options have characteristics significantly different from those of traded options, and because changes in the input assumptions can materially affect the fair value estimate, the existing models

may

not

provide a reliable single measure of the fair value of the employee stock options. Management assesses the assumptions and methodologies used to calculate estimated fair value of stock-based compensation when share-based awards are granted. Circumstances

may

change and additional data

may

become available over time, which could result in changes to these assumptions and methodologies and thereby materially impact our fair value determination. See Note

11

for additional share-based compensation information.

Restricted share awards are recognized at their fair value. The amount of compensation cost is measured on the grant date fair value of the equity instrument issued. The compensation cost of the restricted share awards is recognized over the vesting period of the restricted share awards on a straight-line basis. Restricted share awards typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period assuming the grantee's restricted stock unit fully vests. Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying consolidated balance sheet. Dividends for restricted share awards that ultimately do

not

vest are forfeited.

Advertising Costs

Advertising costs are expensed as incurred. Total advertising expense was

$800

and

$855

for the fiscal years ended

January 2, 2021

and

December 28, 2019,

respectively.

Fair Value Measurements

The Company values its financial assets and liabilities based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  In order to increase consistency and comparability in fair value measurements, a fair value hierarchy was established that prioritizes observable and unobservable inputs used to measure fair value into

three

broad levels, which are described below:

Level

1:

    Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.  The fair value hierarchy gives the highest priority to Level

1

inputs.

Level

2:

    Observable inputs other than Level

1

prices such as quoted prices for similar assets or liabilities; quoted prices in inactive markets; or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data.

Level

3:

    Unobservable inputs are used when little or

no

market data is available.  The fair value hierarchy gives the lowest priority to Level

3

inputs.

In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.

Reclassification

Certain prior year amounts have been reclassified to conform with the current year presentation.  These classifications had

no

effect on the previously reported results of operations.

XML

Note 2 - Fiscal Year

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Business Description and Basis of Presentation [Text Block]

2. FISCAL YEAR

The Company follows a

52/53

week fiscal reporting calendar ending on the Saturday closest to

December 31.

The fiscal year ended

January 2, 2021 (

fiscal

2020

) was a

53

-week reporting year. The fiscal year ended

December 28, 2019 (

fiscal

2019

) was a

52

-week reporting year.

XML

Note 3 - Use of Estimates and Uncertainties

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Basis of Presentation and Significant Accounting Policies [Text Block]

3. USE OF ESTIMATES AND UNCERTAINTIES

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expenses and disclosure of contingent assets and liabilities. Actual results could differ from those estimates.

The Company uses estimates to calculate an allowance for doubtful accounts on its accounts receivables, adequacy of reserves, goodwill impairment, if any, equity compensation, the tax rate applied and the valuation of certain assets and liability accounts. These estimates can be significant to the operating results and financial position of the Company. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-

19.

Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.

The Company has risk participation arrangements with respect to workers compensation and health care insurance. The amounts included in the Company's costs related to this risk participation are estimated and can vary based on changes in assumptions, the Company's claims experience or the providers included in the associated insurance programs.

The Company can be affected by a variety of factors including uncertainty relating to the performance of the general economy, competition, demand for the Company's services, adverse litigation and claims and the hiring, training and retention of key employees.

Fair Value of Financial Instruments

The Company's carrying value of financial instruments, consisting primarily of accounts receivable, transit accounts receivable, accounts payable and accrued expenses, and transit accounts payable and borrowings under line of credit approximates fair value due to their liquidity or their short-term nature and the line of credit's variable interest rate. The Company does

not

have derivative products in place to manage risks related to foreign currency fluctuations for its foreign operations or for interest rate changes.

The Company re-measures the fair value of the contingent consideration at each reporting period and any change in the fair value from either the passage of time or events occurring after the acquisition date, is recorded in earnings in the accompanying consolidated statement of operations.

XML

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

4. ACCOUNTS RECEIVABLE, TRANSIT ACCOUNTS RECEIVABLE AND TRANSIT ACCOUNTS PAYABLE

The Company's accounts receivable are comprised as follows:

	January 2, 2021			December 28, 2019
Billed	$	25,926		$	29,214
Accrued and unbilled		8,219			13,824
Work-in-progress		3,612			4,352
Accounts receivable subject to arbitration		-			14,095
Allowance for sales discounts and doubtful accounts		(1,750	)		(1,725	)
Accounts receivable, net	$	36,007		$	59,760

Unbilled receivables primarily represent revenue earned whereby those services are ready to be billed as of the balance sheet ending date. Work-in-progress primarily represents revenue earned under contracts which the Company contractually invoices at future dates.

From time to time, the Company's Engineering segment enters into agreements to provide, among other things, construction management and engineering services.  Pursuant to these agreements, the Company a)

may

engage subcontractors to provide construction or other services; b) typically earns a fixed percentage of the total project value; and c) assumes

no

ownership or risks of inventory.  Under the terms of the agreements, the Company is typically

not

required to pay the subcontractor until after the corresponding payment from the Company's end-client is received. Upon invoicing the end-client on behalf of the subcontractor or staffing agency the Company records this amount simultaneously as both a “transit account receivable” and “transit account payable” as the amount when paid to the Company is due to and generally paid to the subcontractor within a few days. The Company typically does

not

pay a given transit account payable until the related transit account receivable is collected. The Company is typically obligated to pay the subcontractor or staffing agency whether or

not

the client pays the Company. The Company's transit accounts payable generally exceeds the Company's transit accounts receivable but absolute amounts and spreads fluctuate significantly from quarter to quarter in the normal course of business. The transit accounts receivable was

$2.5

million and related transit accounts payable was

$4.9

million, for a net payable of

$2.4

million, as of

January 2, 2021.

The transit accounts receivable was

$4.9

million and related transit accounts payable was

$4.6

million, for a net receivable of

$0.3

million, as of

December 28, 2019.

The Company had a dispute with a customer that is a major utility in the United States. Both parties agreed in fiscal

2017

to resolve this dispute through binding arbitration.  Arbitration hearings with this customer started in fiscal

2018.

  Essentially, the customer did

not

pay the balance of accounts receivable the Company believes were owed for certain disputed projects.  As of

December 28, 2019,

the total amount of recorded receivables from this customer on these disputed projects was

$14.1

million.  Additionally, as part of the arbitration process, the customer asserted counter-claims of

$10.3

million. The arbitrator rendered a decision in this dispute in

April 2020,

awarding the Company

$7.4

million, and the arbitration award was paid during the

fifty-three

week period ended

January 2, 2021.

The counter-claims asserted against the Company of

$10.3

million were denied in their entirety. For the

fifty-three

week period ended

January 2, 2021,

the Company recorded a charge of

$8.4

million, including

$6.7

million constituting the portion of the accounts receivable relating to the disputed projects that was

not

awarded by the arbitrator,

$0.7

million from other projects with this customer that were

not

part of the arbitration,

$0.8

million in professional fees related to the dispute and arbitration, and

$0.2

million of transit accounts receivable associated with disputed projects that were part of the arbitration. The Company decided to write off the

$0.7

million of accounts receivable from other projects

not

part of the arbitration for business reasons.

XML

Note 5 - Property and Equipment

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Property, Plant and Equipment Disclosure [Text Block]

5. PROPERTY AND EQUIPMENT

Property and equipment are stated at cost and are depreciated on the straight-line method at rates calculated to provide for retirement of assets at the end of their estimated useful lives. The annual rates are

20%

for computer hardware and software as well as furniture and office equipment. Leasehold improvements are amortized over the shorter of the estimated life of the asset or the lease term.

Property and equipment are comprised of the following:

	January 2, 2021		December 28, 2019
Equipment and furniture	$	264	$	319
Computers and systems		4,686		5,628
Leasehold improvements		236		308
		5,185		6,255
Less: accumulated depreciation and amortization		3,107		3,538
Property and equipment, net	$	2,078	$	2,717

The Company periodically writes off fully depreciated and amortized assets.  The Company wrote off fully depreciated and amortized assets of

$1,529

and

$2,781

during the fiscal years ended

January 2, 2021

and

December 28, 2019,

respectively. For the fiscal years ended

January 2, 2021

and

December 28, 2019,

depreciation and amortization expense for property and equipment was

$1,065

and

$1,261,

respectively.

XML

Note 6 - Acquisitions

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Business Combination Disclosure [Text Block]

6. ACQUISITIONS

The purchase method of accounting in accordance with FASB ASC

805,

“Business Combination,” was applied for all acquisitions. This requires the cost of an acquisition to be allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their respective fair values at the date of acquisition with the excess cost accounted for as goodwill. Goodwill arising from the acquisitions is attributable to expected sales synergies from combining the operations of the acquired business with those of the Company.

Future Contingent Payments

As of

January 2, 2021,

the Company had

two

active acquisition agreements whereby additional contingent consideration

may

be earned by the former shareholders:

1

) effective

October 1, 2017,

the Company acquired all of the stock of PSR Engineering Solutions d.o.o. Beograd (Voždovac) (“PSR”) and

2

) effective

September 30, 2018,

the Company acquired certain assets of Thermal Kinetics Engineering, PLLC and Thermal Kinetics Systems, LLC (together, “TKE”). The Company estimates future contingent payments at

January 2, 2021

as follows:

Fiscal Year Ending	Total
January 1, 2022		500
December 31, 2022		2,358
Estimated future contingent consideration payments	$	2,858

Estimates of future contingent payments are subject to significant judgment and actual payments

may

materially differ from estimates. Potential future contingent payments to be made to all active acquisitions after

January 2, 2021

are capped at a cumulative maximum of

$3.1

million. The Company estimates future contingent consideration payments based on forecasted performance and recorded the fair value of those expected payments as of

January 2, 2021. 

During the

fifty-three

week period ended

January 2, 2021,

the Company measured contingent consideration at fair value on a non-recurring basis. Contingent consideration related to acquisitions are recorded at fair value level

3

due to the lack of observable market inputs. Changes in fair value are recorded in other (expense) income, net.

For acquisitions that involve contingent consideration, the Company records a liability equal to the fair value of the estimated contingent consideration obligation as of the acquisition date. The Company determines the acquisition date fair value of the contingent consideration based on the likelihood of paying the additional consideration. The fair value is estimated using projected future operating results and the corresponding future earn-out payments that can be earned upon the achievement of specified operating objectives and financial results by acquired companies using Level

3

inputs and the amounts are then discounted to present value. These liabilities are measured quarterly at fair value, and any change in the fair value of the contingent consideration liability is recognized in the consolidated statements of comprehensive (loss) income. During the measurement period, which

may

be up to

one

year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed with the corresponding adjustment to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recognized in the consolidated statements of comprehensive (loss) income.

The Company paid contingent consideration of

$0.3

million and

$0.6

million during the

fifty-three

week period ended

January 2, 2021

and the

fifty-two

week period ended

December 28, 2019,

respectively.

The changes in the liability for contingent consideration from acquisitions for the

fifty-three

week period ended

January 2, 2021

and the

fifty-two

week period ended

December 28, 2019

are as follows:

Balance as of December 29, 2018	$	4,773
Contingent payments made		(598	)
Increase to contingent payment estimates		(1,178	)
Changes in fair value of contingent payments		61
Balance as of December 28, 2019	$	3,058
Contingent payments made		(345	)
Changes in fair value of contingent consideration		145
Balance as of January 2, 2021	$	2,858

XML

Note 7 - Goodwill

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Goodwill Disclosure [Text Block]

7. GOODWILL

Goodwill represents the premium paid over the fair value of the net tangible and intangible assets acquired in business combinations.  The Company tests goodwill for impairment on an annual basis as of the last day of the Company's fiscal year or more frequently if events occur or circumstances change indicating that the fair value of goodwill

may

be below the carrying amount.  During the

fifty-three

week period ended

January 2, 2021,

the Company reviewed the carrying value of goodwill due to the events and circumstances surrounding the COVID-

19

pandemic. While COVID-

19

has negatively impacted the Company, and the Company expects this negative impact to continue at least through the

first

half of fiscal

2021

and likely beyond, the Company did

not

conclude in such review that this negative impact is permanent. The Company has determined that

no

other indicators of impairment of goodwill existed during the

fifty-three

week period ended

January 2, 2021

and

fifty-two

week period ended

December 28, 2019.

As such,

no

impairment loss on the Company's goodwill during the

fifty-three

week period ended

January 2, 2021

or the

fifty-two

week period ended

December 28, 2019

was recorded as a result of such review.

The changes in the carrying amount of goodwill for the

fifty-three

week period ended

January 2, 2021

and the

fifty-two

week period ended

December 28, 2019

are as follows:

	Engineering			Specialty Health Care		Information Technology		Total
Balance as of December 29, 2018	$	13,096		$	2,398	$	2,038	$	17,532
Adjustment to final TKE purchase price		(1,178	)		-		-		(1,178	)
Balance as of December 28, 2019	$	11,918		$	2,398	$	2,038	$	16,354
No change in fiscal 2020		-			-		-		-
Balance as of January 2, 2021	$	11,918		$	2,398	$	2,038	$	16,354

XML

Note 8 - Intangible Assets

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Intangible Assets Disclosure [Text Block]

8. INTANGIBLE ASSETS

The Company evaluates long-lived assets and intangible assets with definite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset

may

not

be recoverable. When the Company determines that it is probable that undiscounted future cash flows will

not

be sufficient to recover an asset's carrying amount, the asset is written down to its fair value. Assets to be disposed of by sale, if any, are reported at the lower of the carrying amount or fair value less cost to sell. The Company's intangible assets consist of customer relationships and non-compete agreements. During the

fifty-three

week period ended

January 2, 2021

and the

fifty-two

week period ended

December 28, 2019,

the Company reviewed the carrying value of its intangible assets due to the events and circumstances surrounding the COVID-

19

pandemic. While COVID-

19

has negatively impacted the Company, and the Company expects this negative impact to continue at least through the

first

half of fiscal

2021

and likely beyond, the Company does

not

believe at this time that this negative impact is permanent. As such,

no

impairment loss on the Company's intangible assets during the

fifty-three

week period ended

January 2, 2021

and the

fifty-two

week period ended

December 28, 2019

was recorded as a result of such review.

All of the Company's intangible assets are associated with the Engineering segment.  Intangible assets other than goodwill are amortized over their useful lives.  Intangible assets are carried at cost, less accumulated amortization.

Details of intangible assets by class at

January 2, 2021

and

December 28, 2019:

	January 2, 2021		December 28, 2019
Restricted covenants	$	12	$	28
Customer relationships		83		388
Total intangible assets	$	95	$	416

Amortization of acquired intangible assets for the

fifty-three

week period ended

January 2, 2021

and the

fifty-two

week period ended

December 28, 2019

was

$321

and

$327,

respectively. The remaining intangible asset balance will be amortized during fiscal

2021.

XML

Note 9 - Line of Credit

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Debt Disclosure [Text Block]

9. LINE OF CREDIT

The Company and its subsidiaries amended and restated its Revolving Credit Facility with Citizens Bank of Pennsylvania on

October 18, 2019. 

As amended and restated, the Revolving Credit Facility provides for a

$45.0

million revolving credit facility, has

no

sub-limit for letters of credit, and expires on

August 8, 2023.

On

September 29, 2020,

the Company entered into an amendment to its Revolving Credit Facility. The amendment (i) modifies certain aspects of the financial covenants under the Loan Agreement, including the manner in which the measurement periods for certain components of the financial covenants are determined, (ii) modifies the required compliance levels for certain ratios under the Loan Agreement, and (iii) permitted the repayment of

$2.2

million of indebtedness to a

third

party incurred in connection with the previously disclosed

June 2020

repurchase of stock.

Borrowings under the Revolving Credit Facility bear interest at

one

of

two

alternative rates, as selected by the Company at each incremental borrowing.  These alternatives are: (i) LIBOR (London Interbank Offered Rate), plus applicable margin, typically borrowed in fixed

30

-day increments or (ii) the agent bank's prime rate generally borrowed over shorter durations.  The Company also pays unused line fees based on the amount of the Revolving Credit Facility that is

not

drawn.  Unused line fees are recorded as interest expense.  The effective weighted average interest rate, including unused line fees, for the

fifty-three

week period ended

January 2, 2021

and

fifty-two

week period ended

December 28, 2019

were

2.7%

and

4.4%,

respectively.

All borrowings under the Revolving Credit Facility are collateralized by all of the assets of the Company and its subsidiaries and a pledge of the stock of its subsidiaries. The Revolving Credit Facility also contains various financial and non-financial covenants, such as a covenant that restricts on the Company's ability to borrow in order to pay dividends. As of

January 2, 2021,

the Company was in compliance with all covenants contained in the Revolving Credit Facility (as amended).The Company believes that it will maintain compliance with its financial covenants for the foreseeable future.

Borrowings under the line of credit as of

January 2, 2021

and

December 28, 2019

were

$11.9

million and

$34.8

million, respectively. At

January 2, 2021

and

December 28, 2019

there were letters of credit outstanding for

$1.9

million and

$1.6

million, respectively. At

January 2, 2021,

the Company had availability for additional borrowings under the Revolving Credit Facility of

$31.2

million.

Impact to Line of Credit from COVID-

19

The Company is negatively impacted by COVID-

19

as more fully described in Footnote

19

as well as the Segment Discussion, and Liquidity and Capital Resources sections in Management's Discussion and Analysis of Financial Condition and Results of Operations. The Company believes that its current line of credit is adequate to provide the necessary liquidity while COVID-

19

impacts its operations. While the Company does expect to be in compliance with its financial covenants in the line of credit for the foreseeable future, the Company can give

no

assurance that the line of credit will be available to the Company.

XML

Note 10 - Per Share Data

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Earnings Per Share [Text Block]

10. PER SHARE DATA

The Company uses the treasury stock method to calculate the weighted-average shares used for diluted earnings per share. The number of common shares used to calculate basic and diluted earnings (loss) per share for the fiscal years ended

January 2, 2021

and

December 28, 2019

was determined as follows:

	Fiscal Years Ended
	January 2, 2021		December 28, 2019
Basic weighted average shares outstanding		12,152,042		12,913,912
Dilutive effect of outstanding restricted share awards		-		58,241
Weighted average dilutive shares outstanding		12,152,042		12,972,153

Because the year ended

January 2, 2021

recorded a net loss, the otherwise dilutive effect of

46,873

outstanding restricted share awards has

not

been included in the weighted average diluted shares outstanding. For the years ended

January 2, 2021

and

December 28, 2019,

there were

no

anti-dilutive shares

not

included in the calculation of common stock equivalents.

Unissued shares of common stock were reserved for the following purposes:

	January 2, 2021		December 28, 2019
Time-based restricted stock awards outstanding		459,805		151,725
Unvested subscription restricted share awards		250,000		-
Performance-based restricted stock awards outstanding		-		240,000
Future grants of options or shares		520,929		268,326
Shares reserved for employee stock purchase plan		149,894		267,877
Total		1,380,628		927,928

XML

Note 11 - Share Based Compensation

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Share-based Payment Arrangement [Text Block]

11. SHARE BASED COMPENSATION

At

January 2, 2021,

the Company had

two

share-based employee compensation plans. The Company measures the fair value of share-based awards, if and when granted, based on the Black-Scholes method and using the closing market price of the Company's common stock on the date of grant. Awards typically vest over periods ranging from

one

to

three

years and expire within

10

years of issuance. The Company

may

also issue immediately vested equity awards. Share-based compensation expense related to time-based awards is amortized in accordance with applicable vesting periods using the straight-line method. The Company expenses performance-based awards only when the performance metrics are likely to be achieved and the associated awards are therefore likely to vest. Performance-based share awards that are likely to vest are also expensed on a straight-line basis over the vesting period but

may

vest on a retroactive basis or be reversed, depending on when it is determined that they are likely to vest, or in the case of a reversal when they are later determined to be unlikely to vest.

Share-based compensation expense of

$1,109

and

$806

was recognized for the fiscal years ended

January 2, 2021

and

December 28, 2019,

respectively. Fiscal year ended

January 2, 2021

did

not

include any expense associated with performance-based awards. Share based compensation for the fiscal year ended

December 28, 2019

included estimated expense of

$228

for performance-based awards. As of

January 2, 2021,

there were

no

performance-based restricted stock awards outstanding.

As of

January 2, 2021,

the Company had

$1.1

million of total unrecognized compensation cost related to all time-based non-vested share-based awards outstanding. The Company expects to recognize this expense over approximately

two

years.  These amounts do

not

include a) the cost of any additional share-based awards granted in future periods or b) the impact of any potential changes in the Company's forfeiture rate. 

2014

Omnibus Equity Compensation Plan (the

2014

Plan)

The

2014

Plan, approved by the Company's shareholders in

December 2014,

initially provided for the issuance of up to

625,000

shares of the Company's common stock to officers, non-employee directors, employees of the Company and its subsidiaries, or consultants and advisors utilized by the Company.  In fiscal

2016

and fiscal

2020,

the Company amended and restated the

2014

Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance under the Plan by an additional

500,000

and

850,000

shares, respectively, so that the total number of shares of stock reserved for issuance under the Plan is

1,975,000

shares.  The expiration date of the Plan is

December 17, 2030,

unless the

2014

Plan is terminated earlier by the Board or is extended by the Board with the approval of the stockholders.  The Compensation Committee of the Board of Directors determines the vesting period at the time of grant. 

As of

January 2, 2021,

under the

2014

Plan,

709,805

time-based shares were outstanding, there were

no

performance-based restricted share awards outstanding and

520,929

shares were available for awards thereunder.

The market value of equity grants for the

fifty-three

week period ended

January 2, 2021

and the

fifty-two

week period ended

December 28, 2019

was

$1.5

million and

$1.1

million respectively.

Employee Stock Purchase Plan

The Company implemented the

2001

Employee Stock Purchase Plan (the “Purchase Plan”) with shareholder approval, effective

January 1, 2001.

Under the Purchase Plan, employees meeting certain specific employment qualifications are eligible to participate and can purchase shares of common stock semi-annually through payroll deductions at the lower of

85%

of the fair market value of the stock at the commencement or end of the offering period. The purchase plan permits eligible employees to purchase shares of common stock through payroll deductions for up to

10%

of qualified compensation, subject to maximum purchases in any

one

fiscal year of

3,000

shares.

In fiscal

2015,

the Company amended the Purchase Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance or transfer under the Plan by an additional

300,000

shares so that the total number of shares of stock reserved for issuance or transfer under the Plan shall be

1,100,000

shares and to extend the expiration date of the Plan to

December 31, 2025.

In fiscal

2018,

the Company amended the Purchase Plan with shareholder approval to increase the aggregate number of shares of stock reserved for issuance or transfer under the Plan by an additional

300,000

shares so that the total number of shares of stock reserved for issuance or transfer under the Plan shall be

1,400,000

shares.

The Company has

two

offering periods in the Purchase Plan coinciding with the Company's

first

two

fiscal quarters and the last

two

fiscal quarters. Actual shares are issued on the

first

business day of the subsequent offering period for the prior offering period payroll deductions. During the fiscal years ended

January 2, 2021

and

December 28, 2019,

there were

117,983

and

118,526

shares issued under the Purchase Plan for net proceeds of

$208

and

$321,

respectively. As of

January 2, 2021,

there were

149,894

shares available for issuance under the Purchase Plan. Compensation expense, representing the discount to the quoted market price, for the Purchase Plan for the fiscal years ended

January 2, 2021

and

December 28, 2019

was

$44

and

$91,

respectively.

Time-Based Restricted Stock Awards / Stock Subscription Receivable

From time-to-time the Company issues time-based restricted stock awards. These time-based restricted stock awards typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period assuming the grantee's restricted stock award fully vests. Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying condensed consolidated balance sheet. As of

January 2, 2021,

there were

no

accrued dividends. Dividends for time-based restricted stock awards that ultimately do

not

vest are forfeited.

The following summarizes the activity in the time-based restricted stock awards under the

2014

Plan during the

fifty-three

week period ended

January 2, 2021:

	Number of Time-Based Restricted Stock Awards			Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at December 28, 2019		151,725		$	3.64
Granted		719,805		$	1.88
Vested		(139,225	)	$	3.61
Forfeited or expired		(22,500	)	$	1.55
Outstanding non-vested at January 2, 2021		709,805		$	1.92

Based on the closing price of the Company's common stock of

$2.07

per share on

December 31, 2020 (

the last trading day prior to

January 2, 2021),

the intrinsic value of the time-based non-vested restricted stock awards at

January 2, 2021

was approximately

$1.5

million. As of

January 2, 2021,

there was approximately

$1.1

million of total unrecognized compensation cost related to time-based restricted stock awards, which is expected to be recognized over the vesting period of the restricted stock awards.

Time-Based Restricted Stock Awards / Stock Subscription Receivable (Continued)

In

December 2020,

the Company granted senior management a

one

-time restricted stock award of

250,000

shares in exchange for a stock subscription receivable. The shares will be acquired by senior management through repayment of the stock subscription receivable over

twelve

months beginning in

January 2021

and ending in

December 2021.

During fiscal

2020,

the Company awarded

100,092

immediately vested share awards at an average price of

$1.33.

Performance-Based Restricted Stock Awards

From time-to-time the Company issues performance-based restricted stock awards to its executives.  Performance-based restricted stock awards are typically vested based on certain multi-year performance metrics as determined by the Board of Directors Compensation Committee. These performance-based restricted stock awards typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period on any stock awards that actually vest, if any.  Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying condensed consolidated balance sheet.  As of

January 2, 2021,

there were

no

accrued dividends. Dividends for performance-based restricted stock awards that ultimately do

not

vest are forfeited.  

To date, the Company has issued performance-based restricted stock awards only under the

2014

Plan.  The following summarizes the activity in the performance-based restricted stock awards during the

fifty-three

week period ended

January 2, 2021:

	Number of Performance-Based Restricted Stock Awards			Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at December 28, 2019		240,000		$	4.81
Granted		-			-
Vested		(40,000	)	$	4.38
Forfeited or expired		(200,000	)	$	4.89
Outstanding non-vested at January 2, 2021		-			-

As of

January 2, 2021,

there were

no

outstanding performance-based restricted stock awards. The Company will reassess at each reporting date whether achievement of any performance condition is probable and would begin recognizing additional compensation cost if and when achievement of the performance condition becomes probable.  The Company will then recognize the appropriate expense cumulatively in the year performance becomes probable and recognize the remaining compensation cost over the remaining requisite service period. If at a later measurement date the Company determines that performance-based restricted stock awards deemed as likely to vest are deemed as unlikely to vest, the expense recognized will be reversed.

	Number of Restricted Stock Awards			Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at December 29, 2018		347,372		$	4.74
Granted – time-based vesting		99,225		$	3.02
Granted – performance-based vesting		167,148		$	4.35
Vested		(130,020	)	$	3.91
Forfeited or expired		(92,000	)	$	4.98
Outstanding non-vested at December 28, 2019		391,725		$	4.36
Granted – time-based vesting		719,805		$	1.88
Granted – performance-based vesting		-			-
Vested		(179,225	)	$	3.78
Forfeited or expired		(222,500	)	$	4.55
Outstanding non-vested at January 2, 2021		709,805		$	1.92

Based on the closing price of the Company's common stock of

$2.07

per share on

December 31, 2020,

the intrinsic value of all restricted share awards at

January 2, 2021

was

$1.5

million. This amount does

not

include any intrinsic value that

may

be associated with the performance-based restricted share awards that are deemed unlikely to vest.

XML

Note 12 - Treasury Stock Transactions

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Treasury Stock [Text Block]

12. TREASURY STOCK TRANSACTIONS

On

June 2, 2020,

the Company entered into a stock purchase agreement with certain stockholders of the Company, whereby the Company purchased an aggregate of

1,858,139

shares of the Company's common stock for a negotiated purchase price of

$1.20

per share or

$2.2

million in total. The negotiated price of

$1.20

per share was less than the lowest trading price of the stock on the day of the repurchase. The consideration paid by the Company consisted entirely of an unsecured subordinated promissory note for

$2.2

million. The note accrues interest at an annual rate of

9.0%,

compounded annually, payable quarterly in arrears commencing on

September 1, 2020

and continuing on each

December 1,

March 1,

June 1

and

September 1

thereafter, and initially had a maturity date of

August 10, 2023

.

On

September 25, 2020,

the Company repaid the subordinated promissory note in the amount of

$2.2

million.

The shares repurchased on

June 2, 2020

were

not

purchased under a stock repurchase plan. The Company did

not

repurchase any shares in the comparable prior year period.

On

January 13, 2021,

the Company's Board of Directors authorized a program to repurchase shares of the Company's common stock constituting, in the aggregate, up to an amount

not

to exceed

$7.5

million, consistent with the maximum limitation set forth by the Company's revolving line of credit. The program is designed to provide the Company with enhanced flexibility over the long term to optimize its capital structure. Shares of the common stock

may

be repurchased in the open market or through negotiated transactions. The program

may

be terminated or suspended at any time at the discretion of the Company.

XML

Note 13 - New Accounting Standards

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Accounting Standards Update and Change in Accounting Principle [Text Block]

13. NEW ACCOUNTING STANDARDS

In

June 2016,

the FASB issued ASU

2016

-

13,

Financial Instruments - Credit Losses (Topic

326

).

The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. In

February 2020,

the FASB issued ASU

2020

-

02,

Financial Instruments-Credit Losses (Topic

326

) and Leases (Topic

842

) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin

No.

119

and Update to SEC Section on Effective Date Related to Accounting Standards Update

No.

2016

-

02,

Leases (Topic

842

),

 which amends the effective date of the original pronouncement for smaller reporting companies.  ASU

2016

-

13

and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after

December 15, 2022.  

The Company believes the adoption will modify the way the Company analyzes financial instruments, but it does

not

anticipate a material impact on results of operations. The Company is in the process of determining the effects the adoption will have on its condensed consolidated financial statements.

In

March 2020,

the FASB issued ASU

No.

2020

-

04,

Reference Rate Reform (Topic

848

): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.

This standard only applies to contracts and other transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. This guidance provides temporary optional expedients and exceptions to accounting guidance on contract modifications and hedge accounting to ease entities' financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. The Company

may

elect to apply the amendments prospectively through

December 31, 2022.

The Company is currently evaluating the impact this guidance will have on its condensed consolidated financial statements and related disclosures.

XML

Note 14 - Segment Information

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

14. SEGMENT INFORMATION

The Company follows “Disclosures about Segments of an Enterprise and Related Information,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each segment are the same as those described in the summary of significant accounting policies (see Note

1

to these Consolidated Financial Statements.)

Segment operating income includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments. The following tables reflect the results of the segments consistent with the Company's management system:

Fiscal Year Ended January 2, 2021	Engineering			Specialty Health Care			Information Technology			Corporate			Total
Revenue	$	57,715		$	60,481		$	32,213		$	-		$	150,409
Cost of services		41,227			47,116			23,211			-			111,554
Gross profit		16,488			13,365			9,002			-			38,855
Selling, general and administrative		12,931			15,504			9,116			-			37,551
Depreciation and amortization of property and equipment		638			319			108			-			1,065
Amortization of acquired intangible assets		321			-			-			-			321
Write-off of receivables and professional fees incurred related to arbitration		8,397			-			-			-			8,397
Impairment of right of use assets and related costs		-			-			-			2,231			2,231
Tax credit professional fees		-			-			-			240			240
Operating income (loss)	$	(5,799	)	$	(2,458	)	$	(222	)	$	(2,471	)	$	(10,950	)
Total assets as of January 2, 2021	$	33,782		$	19,141		$	7,498		$	7,918		$	68,339
Capital expenditures	$	26		$	36		$	48		$	350		$	460

Fiscal Year Ended December 28, 2019	Engineering		Specialty Health Care		Information Technology		Corporate			Total
Revenue	$	67,873	$	89,348	$	33,879	$	-		$	191,100
Cost of services		49,395		68,464		24,649		-			142,508
Gross profit		18,478		20,884		9,230		-			48,592
Selling, general and administrative		13,648		17,643		9,099		-			40,390
Depreciation and amortization of property and equipment		841		336		84		-			1,261
Amortization of acquired intangible assets		327		-		-		-			327
Tax credit professional fees		-		-		-		47			47
Operating income (loss)	$	3,662	$	2,905	$	47	$	(47	)	$	6,567
Total assets as of December 28, 2019	$	52,342	$	29,781	$	8,178	$	5,872		$	96,173
Capital expenditures	$	82	$	121	$	69	$	95		$	367

The Company derives a majority of its revenue from offices in the United States. Revenues reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada, Puerto Rico and Serbia. Revenues by geographic area for the fiscal years ended

January 2, 2021

and

December 28, 2019

are as follows:

	Fiscal Year Ended
	January 2,		December 28,
	2021		2019
Revenues
United States	$	126,238	$	166,750
Canada		15,310		16,822
Puerto Rico		5,702		4,942
Serbia		3,159		2,586
	$	150,409	$	191,100

Total assets by geographic area as of the reported periods are as follows:

	Fiscal Year Ended
	January 2,		December 28,
	2021		2019
Total Assets
United States	$	56,308	$	82,110
Canada		7,067		9,638
Puerto Rico		1,483		1,103
Serbia		3,481		3,322
	$	68,339	$	96,173

XML

Note 15 - Income Taxes

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Income Tax Disclosure [Text Block]

15. INCOME TAXES

Generally, the Company's relative income or loss generated in each of its jurisdictions can materially impact the consolidated effective income tax rate of the Company, particularly the ratio of Canadian and Serbian pretax income, versus United States pretax income. The consolidated effective income tax rate for fiscal

2020

was

26.4%

as compared to

15.8%

for the comparable prior year period.  The Company's United States Federal statutory tax rate for the

fifty-three

week period ended

January 2, 2021

and the comparable prior year period, before any adjustments, was

21.0%.

  The income tax provisions reconciled to the tax computed at the United States Federal statutory rate for both fiscal

2020

and

2019

are as follows:

	January 2, 2021			December 28, 2019
Federal statutory rate		21.0	%		21.0	%
Tax expense on taxable (loss) income at federal statutory rate	$	(2,532	)	$	1,013
State and Puerto Rico income taxes, net of Federal income tax benefit		(535	)		305
Prior year United States R&D tax credits in current year		-			(668	)
Permanent differences		154			77
Foreign income tax rates		(21	)		(101	)
Adjustments to NOL and repatriation taxes		(53	)		154
Other		(201	)		(16	)
Total income tax expense	$	(3,188	)	$	764

The Company did

not

experience any significant adjustments that impacted its

2020

income tax benefit of

$3.2

million. The Company experienced the following significant adjustments for the

2019

fiscal year that impacted its net income tax expense of

$0.8

million: prior year United States R&D tax credits of

$0.7

million recognized in fiscal

2019,

and expense from changes to its United States net operating loss carryforward and repatriation taxes of

$0.2

million.

The components of income tax expense are as follows:

	Fiscal Years Ended
	January 2, 2021			December 28, 2019
Current
Federal	$	(32	)	$	(688	)
State and local		174			181
Foreign		382			166
		524			(341	)
Deferred
Federal		(2,844	)		892
State		(851	)		229
Foreign		(17	)		(16	)
		(3,755	)		1,105
Total	$	(3,188	)	$	764

The components of earnings before income taxes by United States and foreign jurisdictions were as follows:

	Fiscal Years Ended
	January 2, 2021			December 28, 2019
United States	$	(13,898	)	$	3,626
Foreign jurisdictions		1,841			1,196
	$	12,057	)	$	4,822

The Company accounts for penalties or interest related to uncertain tax positions as part of its provision for income taxes and records such amounts to interest expense.  The Company recorded

no

expense for penalties or interest in the fiscal years ended

January 2, 2021

and

December 28, 2019.

At

January 2, 2021

and

December 28, 2019,

deferred tax assets and liabilities consist of the following:

	January 2, 2021			December 28, 2019
Deferred tax assets:
Allowance for doubtful accounts	$	455		$	432
Federal and state net operating loss carryforward		2,634			330
Reserves and accruals		1,491			255
Other		318			185
Total deferred tax assets		4,898			1,202
Deferred tax liabilities:
Acquisition amortization, net		(716	)		(569	)
Prepaid expense deferral		(602	)		(701	)
Bonus depreciation to be reversed		(280	)		(327	)
Canada deferred tax liability, net		(365	)		(382	)
Total deferred tax liabilities		(1,963	)		(1,979	)
Total deferred tax assets (liabilities), net	$	2,935		$	(777	)

The Company has gross net operating losses of

$8.4

million and

$13.6

million to be applied to the net income of future federal and state tax returns, respectively. The principal amount of the federal net operating loss has an unlimited life. The Company conducts business in many states. Net operating losses in these states expire at differing periods but the majority of these expire from

2038

through

2040.

The Company accounts for penalties or interest related to uncertain tax positions as part of its provision for income taxes and records such amounts to interest expense. The Company recorded

no

expense for penalties or interest in the fiscal years ended

January 2, 2021

and

December 28, 2019.

The Company conducts its operations in multiple tax jurisdictions in the United States, Canada, Puerto Rico and Serbia. The Company and its subsidiaries file a consolidated United States Federal income tax return and file in various states. The Company's federal income tax returns have been examined through

2017.

The Company has

no

open federal audits as of

January 2, 2021.

The State of New Jersey is currently examining fiscal tax years

2009

through

2012.

Except for New Jersey and other limited exceptions, the Company is

no

longer subject to audits by state and local tax authorities for tax years prior to

2017.

The Company is

no

longer subject to audit in Canada for the tax years prior to tax year

2016.

The Company is

no

longer subject to audit in Puerto Rico for the tax years prior to tax year

2010.

Differences between the effective tax rate and the applicable U.S. federal statutory rate

may

arise, primarily from the effect of state and local income taxes, share-based compensation, and potential tax credits available to the Company.

XML

Note 16 - Contingencies

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Contingencies Disclosure [Text Block]

16. CONTINGENCIES

From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the ordinary business course.  These matters

may

relate to professional liability, tax, compensation, contract, competitor disputes, and employee-related matters and include individual and class action lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company's employment and compensation practices. Additionally, some of the Company's clients

may

also become subject to claims, governmental inquiries and investigations, and legal actions relating to the Company's professional services. Depending upon the particular facts and circumstances, the Company

may

also be subject to indemnification obligations under its contracts with such clients relating to these matters.

As such, the Company is required to assess the likelihood of any adverse outcomes to these matters as well as potential ranges of losses and possible recoveries.  The Company

may

not

be covered by insurance as it pertains to some or all of these matters.  A determination of the amount of the provision required for these commitments and contingencies, if any, which would be charged to earnings, is made after careful analysis of each matter.  The Company records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. Once established, a provision

may

change in the future due to new developments or changes in circumstances and could increase or decrease the Company's earnings in the period that the changes are made. 

The Company has reserved

$1.7

million for the settlement of a class action suit in California that alleges the Company did

not

properly pay its travel nurses overtime wages. While the Company believes it did

not

violate any overtime wage laws, it nevertheless decided to settle this class action lawsuit in

December 2020.

The Company expects to pay the

$1.7

million settlement sometime during its

third

quarter of fiscal

2021.

The Company is exposed to other asserted claims as of

January 2, 2021,

but the Company does

not

believe any of these other claims have a probability of loss. As of

January 2, 2021,

the Company did

not

have an accrual for any such other claims.  Furthermore, even if any of these other claims do result in an unfavorable outcome or settlement, the Company believes that such matters will

not,

either individually or in the aggregate, have a material adverse effect on its business, consolidated financial position, results of operations, or cash flows.

The Company had a dispute with a customer that is a major utility in the United States. Both parties agreed in fiscal

2017

to resolve this dispute through binding arbitration.  Arbitration hearings with this customer started in fiscal

2018.

  Essentially, the customer did

not

pay the balance of accounts receivable the Company believes were owed for certain disputed projects.  As of

December 28, 2019,

the total amount of recorded receivables from this customer on these disputed projects was

$14.1

million.  Additionally, as part of the arbitration process, the customer asserted counter-claims of

$10.3

million. The arbitrator rendered a decision in this dispute in

April 2020,

awarding the Company

$7.4

million, and the arbitration award was paid during the

fifty-three

week period ended

January 2, 2021.

The counter-claims asserted against the Company of

$10.3

million were denied in their entirety. For the

fifty-three

week period ended

January 2, 2021,

the Company recorded a charge of

$8.4

million, including

$6.7

million constituting the portion of the accounts receivable relating to the disputed projects that was

not

awarded by the arbitrator,

$0.7

million from other projects with this customer that were

not

part of the arbitration,

$0.8

million in professional fees related to the dispute and arbitration, and

$0.2

million of transit accounts receivable associated with disputed projects that were part of the arbitration. The Company decided to write off the

$0.7

million of accounts receivable from other projects

not

part of the arbitration for business reasons.

XML

Note 17 - Retirement Plans

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Retirement Benefits [Text Block]

17. RETIREMENT PLANS

Profit Sharing Plans

The Company maintains a

401

(k) profit sharing plan for the benefit of eligible employees in the United States and other similar plans in Canada, Puerto Rico and Serbia (the “Retirement Plans”). The

401

(k) plan includes a cash or deferred arrangement pursuant to Section

401

(k) of the Internal Revenue Code sponsored by the Company to provide eligible employees an opportunity to defer compensation and have such deferred amounts contributed to the

401

(k) plan on a pre-tax basis, subject to certain limitations. The Company, at the discretion of the Board of Directors,

may

make contributions of cash to match deferrals of compensation by participants in the Retirement Plans. Contributions to the Retirement Plans charged to operations by the Company for the fiscal years ended

January 2, 2021

and

December 28, 2019

were

$217

and

$296,

respectively.

XML

Note 18 - Commitments

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Commitments and Contingencies Disclosure [Text Block]

18. COMMITMENTS

Executive Severance Agreements

The Company is a party to Executive Severance Agreement (the “Executive Severance Agreement”) each of Bradley S. Vizi, the Company's Executive Chairman and President (dated as of

June 1, 2018),

and Kevin Miller, the Company's Chief Financial Officer (dated as of

February 28, 2014,

as amended), which set forth the terms and conditions of certain payments to be made by the Company to the executive in the event, while employed by the Company, such executive experiences (a) a termination of employment unrelated to a “Change in Control” (as defined therein) or (b) there occurs a Change in Control and either (i) the executive's employment is terminated for a reason related to the Change in Control or (ii) in the case of Mr. Miller, the executive remains continuously employed with the Company for a period of

three

months following the Change in Control. Each Executive Severance Agreement also provide for certain payments, if either (a) the executive is involuntarily terminated by the Company for any reason other than “Cause” (as defined therein), “Disability” (as defined therein) or death, or (b) the executive resigns for “Good Reason” (as defined therein), and, in each case, the termination is

not

a “Termination Related to a Change in Control” (as defined therein).

Leases

In

February 2016,

the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)

No.

2016

-

02,

Leases (Topic

842

)

, which requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability for all leases with terms greater than

12

months and requires disclosures by lessees and lessors about the amount, timing and uncertainty of cash flows arising from leases. The accounting applied by a lessor is largely unchanged from that applied under the prior standard. After the issuance of Topic

842,

the FASB clarified the guidance through several ASUS; hereinafter the collection of lease guidance is referred to as “ASC

842”.

In connection with the continuing developments from COVID-

19,

the Company has reduced its leased office space as a result of its employees moving to a remote work environment. The Company does

not

believe there is an opportunity to sublet any of the vacant office space due to the current commercial rental marketplace. This decision and reduction in the use of the office spaces resulted in a right-of-use asset impairment of

$1.9

million. This loss was determined by identifying the fair value of the impacted right-of-use assets as compared to the carrying value of the assets as of the measurement date, in accordance with

Property, Plant and Equipment

Topic of the FASB ASC. The fair value of the right-of-use assets was based on the remaining term of each lease. In addition, the Company wrote off a total of

$0.3

million in other office lease costs and obsolete equipment.

On

December 30, 2018,

the Company adopted ASC

842

using the modified retrospective method for all lease arrangements at the beginning of the period of adoption. Results for reporting periods beginning

December 30, 2018

are presented under ASC

842,

while prior period amounts were

not

adjusted and continue to be reported in accordance with the Company's historic accounting under ASC

840,

Leases

. The standard had a material impact on the Company's Consolidated Condensed Balance Sheet but did

not

have a significant impact on the Company's consolidated net earnings and cash flows. The most significant impact was the recognition of right of use assets and lease liabilities for operating leases, while the accounting for finance leases remained substantially unchanged. For leases that commenced before the effective date of ASC

842,

the Company elected the permitted practical expedients to

not

reassess the following: (i) whether any expired or existing contracts contain leases; (ii) the lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases.  Consequently, financial information will

not

be updated, and the disclosures required under the new standard will

not

be provided for dates before

December 30, 2018.

As a result of the cumulative impact of adopting ASC

842,

the Company recorded operating lease right of use assets of

$3.9

million and operating lease liabilities of

$4.1

million as of

December 30, 2018,

primarily related to real estate and office equipment leases, based on the present value of the future lease payments on the date of adoption.

The Company determines if an arrangement is a lease at inception. For leases where the Company is the lessee, right of use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent an obligation to make lease payments arising from the lease. Right of use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As most of the Company's leases do

not

provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments

.

The right of use asset also consists of any lease incentives received. The lease terms used to calculate the right of use asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense using the accelerated interest method of recognition. The Company has lease agreements which require payments for lease and non-lease components.  The Company has elected to account for these as a single lease component with the exception of its real estate leases.

The components of lease expense were as follows:

	Fifty-Three Week Period Ended January 2, 2021		Fifty-Two Week Period Ended December 28, 2019
Operating lease cost	$	2,524	$	2,314
Amortization of right of use assets	$	366	$	305
Interest on lease liabilities		10		8
Total finance lease cost	$	376	$	313

Supplemental Cash Flow information related to leases was as follows:

	Fifty-Three Week Period Ended January 2, 2021		Fifty-Two Week Period Ended December 28, 2019
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	2,589	$	2,290
Operating cash flows from finance leases	$	7	$	8
Financing cash flows from finance leases	$	402	$	310
Right of use assets obtained in exchange for lease obligations
Operating leases	$	1,257	$	7,894
Finance leases	$	258	$	126

Supplemental Balance Sheet information as of

January 2, 2021

related to leases was as follows:

	Fifty-Three Week Period Ended January 2, 2021			Fifty-Two Week Period Ended December 28, 2019
Operating leases
Operating lease right of use assets	$	2,409		$	5,820
Operating right of use liability - current	$	(1,886	)	$	(2,134	)
Operating right of use liability - non-current		(2,641	)		(3,921	)
Total operating lease liabilities	$	(4,527	)	$	(6,055	)
Finance leases
Property and equipment - (right of use assets)	$	1,140		$	985
Accumulated depreciation		(746	)		(475	)
Property and equipment, net	$	394		$	510
Other current liabilities	$	(247	)	$	(315	)
Other long term liabilities		(106	)		(189	)
Total finance lease liabilities	$	(353	)	$	(504	)
Weighted average remaining lease term
Operating leases	2.03 Years			2.54 Years
Finance leases	1.45 Years			1.62 Years
Weighted average discount rate
Operating leases		4.06	%		4.11	%
Finance leases		2.63	%		1.78	%

Maturities of lease liabilities are as follows:

Fiscal Year Ending	Operating Leases			Finance Leases
2021		2,019			255
2022		1,505			109
2023		955			-
2024		232			-
2025		48			-
Thereafter		-			-
Total lease payments		4,759			364
Less: imputed interest		(232	)		(11	)
Total	$	4,527		$	353

XML

Note 19 - Related Party Transactions

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Related Party Transactions Disclosure [Text Block]

19. RELATED PARTY TRANSACTIONS

There have been

no

related party transactions during the time periods presented.

XML

Note 20 - Stockholder Rights Plan

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

20. STOCKHOLDER RIGHTS PLAN

On

May 22, 2020,

the Board of Directors of the Company approved a stockholder rights plan (the “Rights Plan”) and declared a dividend distribution to stockholders of record as of the close of business on

June 2, 2020

of

one

preferred stock purchase right (a “Right”) for each outstanding share of Common Stock of the Company. Each Right entitles the holder to purchase from the Company a unit consisting of

one one

-hundredth of a share (a “Unit”) of a newly-authorized series of junior participating preferred stock of the Company, upon the occurrence of certain events, as more fully described below, at a purchase price of

$5.60

per Unit.

In connection with the adoption of the stockholder rights plan, the Company designated

250,000

shares of the Company's authorized shares of Preferred Stock, par value

$1.00,

as Series A-

3

Junior Participating Preferred Shares,

none

of which are issued and outstanding. As provided in the Certificate of Designation filed by the Company with the Department of State of the State of Nevada, each Series A-

3

Preferred Share shall entitle the holder

100

votes on all matters submitted to a vote of the stockholders of the Company, subject to adjustment for future dividends and combinations of common stock. The holders of Series A-

3

Preferred Shares and the holders of shares of Common Stock shall vote together as

one

class on all matters submitted to a vote of stockholders of the Company. The Series A-

3

Preferred Shares shall, after issuance, be entitled to receive quarterly dividends in an amount equal to the greater of

$50.00

per share or an amount per share, subject to adjustment, equal to

100

times the aggregate per share amount of all non-cash dividends or other distributions other than a dividend payable in shares of common stock or a subdivision of the outstanding shares of common stock declared on the common stock since the immediately preceding quarterly dividend payment date of the Series A-

3

Preferred Shares, or, with respect to the

first

such quarterly dividend payment date, since the

first

issuance of any share or fraction of a share of the Series A-

3

Preferred Shares. The Series A-

3

Preferred Shares shall rank junior to all other series of the Company's Preferred Stock as to the payment of dividends and the distribution of assets, unless the terms of any such series shall provide otherwise. The Series A-

3

Preferred Shares shall

not

be redeemable. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Series A-

3

Preferred Shares shall be entitled to receive the greater of

$100.00

per share, plus accrued dividends, or an amount per share, subject to adjustment, equal to

100

times the aggregate amount to be distributed per share to holders of Common Stock. In the event the Company shall enter into any consolidation, merger, combination or other transaction in which the shares of Common Stock are exchanged for or changed into other stock or securities, cash and/or any other property, then in any such event the Series A-

3

Preferred Shares shall at the same time be similarly exchanged or changed in an amount per share, subject to adjustment, equal to

100

times the aggregate amount of stock, securities, cash and/or any other property (payable in kind), as the case

may

be, into which or for which each share of Common Stock is changed or exchanged. These preferences are protected by customary anti-dilution provisions.

Initially, the Rights are

not

exercisable and are attached to each existing outstanding share of the Company's Common Stock. The Rights will separate and become exercisable if a person or group acquires

10%

or more of the Company's Common Stock in a transaction, including the open market purchase of shares,

not

approved by our Board. If a person or group acquires

10%,

each Right will entitle its holder (other than such person or members of such group) to purchase, at the Right's exercise price (subject to adjustment as provided in the Rights Plan), a number of shares of the Company's Common Stock having a then-current market value of twice the exercise price. The Rights Plan will cause substantial dilution to a person or group that attempts to acquire control of the Company on terms or in a manner

not

approved by our Board.

The initial issuance of the Rights as a dividend had

no

financial accounting or reporting impact. The fair value of the Rights was nominal because the Rights were

not

exercisable when issued and

no

value is attributable to them. Additionally, the Rights do

not

meet the definition of a liability under generally accepted accounting principles in the United States and are therefore

not

accounted for as a long-term obligation. Accordingly, unless the Rights become exercisable as discussed above, the Rights Plan has

no

impact on the Company's Condensed Consolidated Financial Statements.

The Company's Board of Directors

may

redeem the Rights for

$0.001

per Right at any time before an event that causes the Rights to become exercisable. The Rights will expire on

May 22, 2021,

unless the Rights have previously been redeemed by the Board of Directors.

The Rights Plan is

not

intended to interfere with any merger, tender or exchange offer or other business combination approved by our Board. Nor does the Rights Plan prevent

our

Board from considering any offer that it considers to be in the best interest of its stockholders.

XML

Note 21 - COVID-19

12 Months Ended

Jan. 02, 2021

Notes to Financial Statements

Effect of COVID-19 Pandemic [Text Block]

21. COVID- 19

In

March 2020,

the World Health Organization declared the outbreak of a novel coronavirus (COVID-

19

) as a pandemic, which continues to present various health, business and other challenges throughout the United States. As a result, we have temporarily closed most of our office locations, with most of our workforce working from home, and have seen a reduction in customer demand, all resulting in a negative impact on Company revenue, gross profit, and operating income. The duration and ultimate magnitude of the disruption remains uncertain. Therefore, while we experienced a negative impact during

2020,

we expect this matter to continue to impact negatively our business, results of operations, and financial position at least through the

first

half of fiscal

2021

and likely beyond, and the related financial impact cannot be reasonably estimated at this time. Please see more detailed disclosure by segment in our Segment Discussion and the impact to our condensed consolidated financial position under Financial Activities under Liquidity and Capital Resources, all in Management's Discussion and Analysis of Financial Condition and Results of Operations.

XML

Significant Accounting Policies (Policies)

12 Months Ended

Jan. 02, 2021

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Description of Business and Basis of Presentation

RCM Technologies, Inc. (the “Company” or “RCM”) is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced engineering and information technology services. Additionally, the Company provides specialty health care staffing services through its Specialty Health Care Services group. RCM's offices are primarily located in major metropolitan centers throughout North America.

The consolidated financial statements are comprised of the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Cash Equivalents

The Company considers its holdings of highly liquid money-market instruments and certificates of deposits to be cash equivalents if the securities mature within

90

days from the date of acquisition.  These investments are carried at cost, which approximates fair value.  The Company's cash balances are maintained in accounts held by major banks and financial institutions.  The majority of these balances

may

exceed federally insured amounts.  The Company held

$42

and

$56

of cash and cash equivalents in Canadian banks as of

January 2, 2021

and

December 28, 2019,

respectively, which was held principally in Canadian dollars.  The Company held

$246

and

$129

of cash and cash equivalents in Serbian banks as of

January 2, 2021

and

December 28, 2019,

respectively, which was held in various currencies. 

Fair Value of Financial Instruments, Policy [Policy Text Block]

Fair Value of Financial Instruments

The Company's carrying value of financial instruments, consisting primarily of accounts receivable, transit accounts receivable, accounts payable and accrued expenses, and transit accounts payable and borrowings under line of credit approximates fair value due to their liquidity or their short-term nature and the line of credit's variable interest rate. The Company does

not

have derivative products in place to manage risks related to foreign currency fluctuations for its foreign operations or for interest rate changes.

Receivable [Policy Text Block]

Accounts Receivable and Allowance for Doubtful Accounts

The Company's accounts receivable are primarily due from trade customers. Credit is extended based on evaluation of customers' financial condition and, generally, collateral is

not

required. Accounts receivable payment terms vary and are stated in the financial statements at amounts due from customers net of an allowance for doubtful accounts. Accounts outstanding longer than the payment terms are considered past due. The Company determines its allowance by considering a number of factors, including the length of time trade accounts receivable are past due, the Company's previous loss history, the customer's current ability to pay its obligation to the Company, and the condition of the general economy and the industry as a whole. The Company writes off accounts receivable when they become uncollectible, and payments subsequently received on such receivables previously written off are credited to bad debt expense.

Accrued and Unbilled Accounts Receivable and Work in Process [Policy Text Block]

Accrued and Unbilled Accounts Receivable and Work-in-Process

Unbilled receivables primarily represent revenues earned whereby those services are ready to be billed as of the balance sheet ending date. Work-in-process primarily represents revenues earned under contracts which the Company is contractually precluded from invoicing until future dates as project milestones are realized. See Note

4

for further details.

Transit Receivable and Transit Payable [Policy Text Block]

Transit Receivables and Transit Payables

From time to time, the Company's Engineering segment enters into agreements to provide, among other things, construction management and engineering services.  Pursuant to these agreements, the Company a)

may

engage subcontractors to provide construction or other services; b) typically earns a fixed percentage of the total project value; and c) assumes

no

ownership or risks of inventory.  In such situations, the Company acts as an agent under the provisions of FASB ASC

606

“Revenue from Contracts with Customers” and therefore recognizing revenue on a “net-basis.”  The Company records revenue on a “net” basis on relevant engineering and construction management projects, which require subcontractor/procurement costs or transit costs. In those situations, the Company charges the client a negotiated fee, which is reported as net revenue when earned. 

Under the terms of the agreements, the Company is typically

not

required to pay the subcontractor until after the corresponding payment from the Company's end-client is received. Upon invoicing the end-client on behalf of the subcontractor or staffing agency the Company records this amount simultaneously as both a “transit account receivable” and “transit account payable” as the amount when paid to the Company is due to and generally paid to the subcontractor within a few days. The Company typically does

not

pay a given transit account payable until the related transit account receivable is collected. The Company is typically obligated to pay the subcontractor or staffing agency whether or

not

the client pays the Company. The Company's transit accounts payable generally exceeds the Company's transit accounts receivable but absolute amounts and spreads fluctuate significantly from quarter to quarter in the normal course of business.

Property, Plant and Equipment, Policy [Policy Text Block]

Property and Equipment

Property and equipment are stated at cost and are depreciated on the straight-line method at rates calculated to provide for retirement of assets at the end of their estimated useful lives. The annual rates are

20%

for computer hardware and software as well as furniture and office equipment. Leasehold improvements are amortized over the shorter of the estimated life of the asset or the lease term.

Goodwill and Intangible Assets, Policy [Policy Text Block]

Intangible Assets

The Company's intangible assets have been generated through acquisitions. The Company maintains responsibility for valuing and determining the useful life of intangible assets. As a general rule, the Company amortizes restricted covenants over

four

years and customer relationships over

six

years. However, circumstances

may

dictate other amortization terms as determined by the Company and assisted by their

third

party advisors.

Canadian Sales Tax [Policy Text Block]

Canadian Sales Tax

The Company is required to charge and collect sales tax for all Canadian clients and remits invoiced sales tax monthly to the Canadian taxing authorities whether collected or

not.

The Company does

not

collect the sales tax from its clients until they have paid their respective invoices. The Company includes uncollected Canadian sales tax invoiced to clients in its prepaid and other current assets.

Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]

Goodwill

Goodwill is

not

amortized but is subject to periodic testing for impairment in accordance with FASB ASC

350

“

Intangibles - Goodwill and Other.

” The Company tests goodwill for impairment on an annual basis as of the last day of the Company's fiscal

December

each year or more frequently if events occur or circumstances change indicating that the fair value of the goodwill

may

be below its carrying amount. The Company has

three

reporting units. The Company uses a market-based approach to determine the fair value of the reporting units. This approach uses earnings/revenue multiples of similar companies recently completing acquisitions and the ability of our reporting units to generate cash flows as measures of fair value of our reporting units. The Company adopted Accounting Standards Update (“ASU”)

2017

-

04,

“Intangibles - Goodwill and Other (Topic

350

): Simplifying the Test for Goodwill Impairment” effective

December 28, 2019

which has eliminated Step

2

from the goodwill impairment test. Under this update, an entity should perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount.

The Company did

not

record a goodwill impairment charge in fiscal years ended

January 2, 2021

and

December 28, 2019.

There can be

no

assurance that future indicators of impairment and tests of goodwill impairment will

not

result in an impairment charge.

Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]

Long-Lived and Intangible Assets

The Company evaluates long-lived assets and intangible assets with definite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset

may

not

be recoverable. When the Company determines that it is probable that undiscounted future cash flows will

not

be sufficient to recover an asset's carrying amount, the asset is written down to its fair value. Assets to be disposed of by sale, if any, are reported at the lower of the carrying amount or fair value less cost to sell. The Company's intangible assets consist of customer relationships and non-compete agreements.

Research, Development, and Computer Software, Policy [Policy Text Block]

Software

In accordance with FASB ASC

350

-

40

“Accounting for Internal Use Software,” certain costs related to the development or purchase of internal-use software are capitalized and amortized over the estimated useful life of the software. During the fiscal years ended

January 2, 2021

and

December 28, 2019,

the Company capitalized

$305

and

$139,

respectively, for software costs. The net balance after accumulated depreciation for all software costs capitalized as of

January 2, 2021

and

December 28, 2019

was

$1,389

and

$1,726,

respectively.

Income Tax, Policy [Policy Text Block]

Income Taxes

The Company makes judgments and interpretations based on enacted tax laws, published tax guidance, as well as estimates of future earnings. These judgments and interpretations affect the provision for income taxes, deferred tax assets and liabilities and the valuation allowance. The Company evaluated the deferred tax assets and determined on the basis of objective factors that the net assets will be realized through future years' taxable income. In the event that actual results differ from these estimates and assessments, additional valuation allowances

may

be required. The Company did

not

have any valuation allowance as of

January 2, 2021

or

December 28, 2019.

The Company accounts for income taxes in accordance with FASB ACS

740

“Income Taxes” (FASB ASC

740

) which requires an asset and liability approach of accounting for income taxes.  FASB ASC

740

requires assessment of the likelihood of realizing benefits associated with deferred tax assets for purposes of determining whether a valuation allowance is needed for such deferred tax assets.  Deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that such tax rate changes are enacted. The Company measures its deferred tax assets and liabilities using the tax rates that the Company believes will apply in the years in which the temporary differences are expected to be recovered or paid. The Company and its wholly owned United States subsidiaries file a consolidated federal income tax return.  The Company also files tax returns in Canada, Puerto Rico and Serbia.

The Company also follows the provisions of FASB ASC

740

which prescribes a model for the recognition and measurement of a tax position taken or expected to be taken in a tax return, and provides guidance on derecognition, classification, interest and penalties, disclosure and transition.  The Company's policy is to record interest and penalty, if any, as interest expense.

Revenue from Contract with Customer [Policy Text Block]

Revenue Recognition

The Company records revenue under Accounting Standards Codification ("ASC") Topic

606,

 

Revenue from Contracts with Customers

. Revenue is recognized when we satisfy a performance obligation by transferring services promised in a contract to a customer, in an amount that reflects the consideration that we expect to receive in exchange for those services. Performance obligations in our contracts represent distinct or separate service streams that we provide to our customers.

We evaluate our revenue contracts with customers based on the

five

-step model under ASC

606:

(

1

) Identify the contract with the customer; (

2

) Identify the performance obligations in the contract; (

3

) Determine the transaction price; (

4

) Allocate the transaction price to separate performance obligations; and (

5

) Recognize revenue when (or as) each performance obligation is satisfied.

The Company derives its revenue from several sources. The Company's Engineering Services and Information Technology Services segments perform consulting and project solution services. The Healthcare segment specializes in long-term and short-term staffing and placement services to hospitals, schools and long-term care facilities amongst others. All of the Company's segments perform staff augmentation services and derive revenue from permanent placement fees. The majority of the Company's revenue is invoiced on a time and materials basis.

The following table presents our revenues disaggregated by revenue source for the

fifty-three

week period ended

January 2, 2021

and the

fifty-two

week period

December 28, 2019:

	January 2, 2021		December 28, 2019
Engineering:
Time and Material	$	43,359	$	55,195
Fixed Fee		14,145		12,678
Permanent Placement Services		211		-
Total Engineering	$	57,715	$	67,873
Specialty Health Care:
Time and Material	$	59,692	$	88,057
Permanent Placement Services		789		1,291
Total Specialty Health Care	$	60,481	$	89,348
Information Technology:
Time and Material	$	31,723	$	33,384
Permanent Placement Services		490		495
Total Information Technology	$	32,213	$	33,879
	$	150,409	$	191,100

Time and Material

The Company's IT and Healthcare segments predominantly recognize revenue through time and material work while its Engineering segment recognizes revenue through both time and material and fixed fee work. The Company's time and material contracts are typically based on the number of hours worked at contractually agreed upon rates, therefore revenue associated with these time and materials contracts are recognized based on hours worked at contracted rates. 

Fixed fee

From time to time and predominantly in our Engineering segment, the Company will enter into contracts requiring the completion of specific deliverables.  The Company has master services agreements with many of its customers that broadly define terms and conditions. Actual services performed under fixed fee arrangements are typically delivered under purchase orders that more specifically define terms and conditions related to that fixed fee project. While these master services agreements can often span several years, the Company's fixed fee purchase orders are typically performed over

six

to

nine

month periods.  In instances where project services are provided on a fixed-price basis, revenue is recorded in accordance with the terms of each contract.  In certain instances, revenue is invoiced at the time certain milestones are reached, as defined in the contract.  Revenue under these arrangements are recognized as the costs on these contracts are incurred.  On an infrequent basis, amounts paid in excess of revenue earned and recognized are recorded as deferred revenue, included in accounts payable and accrued expenses on the accompanying condensed balance sheets.  In other instances, revenue is billed and recorded based upon contractual rates per hour.  Additionally, some contracts contain “Performance Fees” (bonuses) for completing a contract under budget.  Performance Fees, if any, are recorded when earned.  Some contracts also limit revenue and billings to specified maximum amounts.  Provisions for contract losses, if any, are made in the period such losses are determined.  For contracts where there is a specific deliverable and the work is

not

complete and the revenue is

not

recognized, the costs incurred are deferred as a prepaid asset.  The associated costs are expensed when the related revenue is recognized.

Permanent Placement Services

The Company earns permanent placement fees from providing permanent placement services. Fees for placements are recognized at the time the candidate commences employment. The Company guarantees its permanent placements on a prorated basis for

90

days. In the event a candidate is

not

retained for the

90

-day period, the Company will provide a suitable replacement candidate. In the event a replacement candidate cannot be located, the Company will provide a prorated refund to the client. An allowance for refunds, based upon the Company's historical experience, is recorded in the financial statements. Permanent placement revenue was

$1.5

million for the fiscal year ended

January 2, 2021

and

$1.8

million for the fiscal year ended

December 28, 2019.

The deferred revenue balance as of both

January 2, 2021

and

December 28, 2019

was

$0.4

million. These amounts are included in accounts payable and accrued expense in the accompanying consolidated balance sheets at that date.  Revenue is recognized when the service has been performed.  Deferred revenue

may

be recognized over a period exceeding

one

year from the time it was recorded on the balance sheet, although this is an infrequent occurrence.  For the

fifty-three

week period ended

January 2, 2021

and the

fifty-two

week period ended

December 28, 2019,

the Company recognized revenue of

$0.4

million and

$0.2

million, respectively, that was included in deferred revenue at the beginning of the reporting period.

Transit Receivables and Transit Payables

From time to time, the Company's Engineering segment enters into agreements to provide, among other things, construction management and engineering services.  Pursuant to these agreements, the Company a)

may

engage subcontractors to provide construction or other services; b) typically earns a fixed percentage of the total project value; and c) assumes

no

ownership or risks of inventory.  Under the terms of the agreements, the Company is typically

not

required to pay the subcontractor until after the corresponding payment from the Company's end-client is received. Upon invoicing the end-client on behalf of the subcontractor or staffing agency the Company records this amount simultaneously as both a “transit account receivable” and “transit account payable” as the amount when paid to the Company is due to and generally paid to the subcontractor within a few days. The Company typically does

not

pay a given transit account payable until the related transit account receivable is collected. The Company is typically obligated to pay the subcontractor or staffing agency whether or

not

the client pays the Company. The Company's transit accounts payable generally exceeds the Company's transit accounts receivable but absolute amounts and spreads fluctuate significantly from quarter to quarter in the normal course of business. The transit accounts receivable was

$2.5

million and related transit accounts payable was

$4.9

million, for a net payable of

$2.4

million, as of

January 2, 2021.

The transit accounts receivable was

$4.9

million and related transit accounts payable was

$4.6

million, for a net receivable of

$0.3

million, as of

December 28, 2019.

Concentration Risk, Credit Risk, Policy [Policy Text Block]

Concentration

During the fiscal year ended

January 2, 2021,

New York City Board of Education represented

10.6%

of the Company's revenues.

No

other client accounted for

10%

or more of total revenues during the year. As of

January 2, 2021,

the following clients represented more than

10.0%

of the Company's accounts receivable, net: New York City Board of Education was

11.8%

and Hawaii Department of Education was

10.6%.

No

other customer accounted for

10%

or more of the Company's accounts receivable, net. The Company's

five

,

ten

and

twenty

largest customers accounted for approximately

33.4%,

46.6%

and

60.7%,

respectively, of the Company's revenues for the fiscal year ended

January 2, 2021.

During the fiscal year ended

December 28, 2019,

New York City Board of Education and Hawaii Department of Education represented

17.6%

and

11.1%

of the Company's revenues, respectively.

No

other client accounted for

10%

or more of total revenues during the year. As of

December 28, 2019,

the following clients represented more than

10.0%

of the Company's accounts receivable, net: New York Power Authority was

24.6%,

New York City Board of Education was

17.6%

and Hawaii Department of Education was

12.7%.

As of

December 28, 2019,

New York Power Authority total accounts receivable balance (including transit accounts receivable) was

27.3%

of the total of accounts receivable, net and transit accounts receivable. 

No

other customer accounted for

10%

or more of the Company's accounts receivable, net or total accounts receivable balance (including transit accounts receivable). The Company's

five

,

ten

and

twenty

largest customers accounted for approximately

43.5%,

57.0%

and

69.2%,

respectively, of the Company's revenues for the fiscal year ended

December 28, 2019.

Foreign Currency Transactions and Translations Policy [Policy Text Block]

Foreign Currency Translation

The functional currency of the Company's Canadian and Serbian subsidiaries is the local currency. Assets and liabilities are translated at period-end exchange rates. Income and expense items are translated at weighted average rates of exchange prevailing during the year. Any translation adjustments are included in the accumulated other comprehensive income account in stockholders' equity. Transactions executed in different currencies resulting in exchange adjustments are translated at spot rates and resulting foreign exchange transaction gains and losses are included in the results of operations.

Comprehensive Income, Policy [Policy Text Block]

Comprehensive Income

Comprehensive income consists of net income and foreign currency translation adjustments.

Earnings Per Share, Policy [Policy Text Block]

Per Share Data

Basic net income per share is calculated using the weighted-average number of common shares outstanding during the period. Diluted net income per share is calculated using the weighted-average number of common shares plus dilutive potential common shares outstanding during the period. Potential dilutive common shares consist of stock options and other stock-based awards under the Company's stock compensation plans, when their impact is dilutive. Because of the Company's capital structure, all reported earnings pertain to common shareholders and

no

other adjustments are necessary.

Share-based Payment Arrangement [Policy Text Block]

Share - Based Compensation

The Company recognizes share-based compensation over the vesting period of an award based on fair value at the grant date determined using the Black-Scholes option pricing model. Certain assumptions are used to determine the fair value of stock-based payment awards on the date of grant and require subjective judgment. Because employee stock options have characteristics significantly different from those of traded options, and because changes in the input assumptions can materially affect the fair value estimate, the existing models

may

not

provide a reliable single measure of the fair value of the employee stock options. Management assesses the assumptions and methodologies used to calculate estimated fair value of stock-based compensation when share-based awards are granted. Circumstances

may

change and additional data

may

become available over time, which could result in changes to these assumptions and methodologies and thereby materially impact our fair value determination. See Note

11

for additional share-based compensation information.

Restricted share awards are recognized at their fair value. The amount of compensation cost is measured on the grant date fair value of the equity instrument issued. The compensation cost of the restricted share awards is recognized over the vesting period of the restricted share awards on a straight-line basis. Restricted share awards typically include dividend accrual equivalents, which means that any dividends paid by the Company during the vesting period become due and payable after the vesting period assuming the grantee's restricted stock unit fully vests. Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying consolidated balance sheet. Dividends for restricted share awards that ultimately do

not

vest are forfeited.

Advertising Cost [Policy Text Block]

Advertising Costs

Advertising costs are expensed as incurred. Total advertising expense was

$800

and

$855

for the fiscal years ended

January 2, 2021

and

December 28, 2019,

respectively.

Fair Value Measurement, Policy [Policy Text Block]

Fair Value Measurements

The Company values its financial assets and liabilities based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  In order to increase consistency and comparability in fair value measurements, a fair value hierarchy was established that prioritizes observable and unobservable inputs used to measure fair value into

three

broad levels, which are described below:

Level

1:

    Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities.  The fair value hierarchy gives the highest priority to Level

1

inputs.

Level

2:

    Observable inputs other than Level

1

prices such as quoted prices for similar assets or liabilities; quoted prices in inactive markets; or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data.

Level

3:

    Unobservable inputs are used when little or

no

market data is available.  The fair value hierarchy gives the lowest priority to Level

3

inputs.

In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value.

Reclassification, Comparability Adjustment [Policy Text Block]

Reclassification

Certain prior year amounts have been reclassified to conform with the current year presentation.  These classifications had

no

effect on the previously reported results of operations.

XML

Note 1 - Summary of Significant Accounting Policies (Tables)

12 Months Ended

Jan. 02, 2021

Notes Tables

Disaggregation of Revenue [Table Text Block]

	January 2, 2021		December 28, 2019
Engineering:
Time and Material	$	43,359	$	55,195
Fixed Fee		14,145		12,678
Permanent Placement Services		211		-
Total Engineering	$	57,715	$	67,873
Specialty Health Care:
Time and Material	$	59,692	$	88,057
Permanent Placement Services		789		1,291
Total Specialty Health Care	$	60,481	$	89,348
Information Technology:
Time and Material	$	31,723	$	33,384
Permanent Placement Services		490		495
Total Information Technology	$	32,213	$	33,879
	$	150,409	$	191,100

XML

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable (Tables)

12 Months Ended

Jan. 02, 2021

Notes Tables

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]

	January 2, 2021			December 28, 2019
Billed	$	25,926		$	29,214
Accrued and unbilled		8,219			13,824
Work-in-progress		3,612			4,352
Accounts receivable subject to arbitration		-			14,095
Allowance for sales discounts and doubtful accounts		(1,750	)		(1,725	)
Accounts receivable, net	$	36,007		$	59,760

XML

Note 5 - Property and Equipment (Tables)

12 Months Ended

Jan. 02, 2021

Notes Tables

Property, Plant and Equipment [Table Text Block]

	January 2, 2021		December 28, 2019
Equipment and furniture	$	264	$	319
Computers and systems		4,686		5,628
Leasehold improvements		236		308
		5,185		6,255
Less: accumulated depreciation and amortization		3,107		3,538
Property and equipment, net	$	2,078	$	2,717

XML

Note 6 - Acquisitions (Tables)

12 Months Ended

Jan. 02, 2021

Notes Tables

Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]

Fiscal Year Ending	Total
January 1, 2022		500
December 31, 2022		2,358
Estimated future contingent consideration payments	$	2,858

Balance as of December 29, 2018	$	4,773
Contingent payments made		(598	)
Increase to contingent payment estimates		(1,178	)
Changes in fair value of contingent payments		61
Balance as of December 28, 2019	$	3,058
Contingent payments made		(345	)
Changes in fair value of contingent consideration		145
Balance as of January 2, 2021	$	2,858

XML

Note 7 - Goodwill (Tables)

12 Months Ended

Jan. 02, 2021

Notes Tables

Schedule of Goodwill [Table Text Block]

	Engineering			Specialty Health Care		Information Technology		Total
Balance as of December 29, 2018	$	13,096		$	2,398	$	2,038	$	17,532
Adjustment to final TKE purchase price		(1,178	)		-		-		(1,178	)
Balance as of December 28, 2019	$	11,918		$	2,398	$	2,038	$	16,354
No change in fiscal 2020		-			-		-		-
Balance as of January 2, 2021	$	11,918		$	2,398	$	2,038	$	16,354

XML

Note 8 - Intangible Assets (Tables)

12 Months Ended

Jan. 02, 2021

Notes Tables

Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]

	January 2, 2021		December 28, 2019
Restricted covenants	$	12	$	28
Customer relationships		83		388
Total intangible assets	$	95	$	416

XML

Note 10 - Per Share Data (Tables)

12 Months Ended

Jan. 02, 2021

Notes Tables

Schedule of Weighted Average Number of Shares [Table Text Block]

	Fiscal Years Ended
	January 2, 2021		December 28, 2019
Basic weighted average shares outstanding		12,152,042		12,913,912
Dilutive effect of outstanding restricted share awards		-		58,241
Weighted average dilutive shares outstanding		12,152,042		12,972,153

Unissued Shares of Common Stock [Table Text Block]

	January 2, 2021		December 28, 2019
Time-based restricted stock awards outstanding		459,805		151,725
Unvested subscription restricted share awards		250,000		-
Performance-based restricted stock awards outstanding		-		240,000
Future grants of options or shares		520,929		268,326
Shares reserved for employee stock purchase plan		149,894		267,877
Total		1,380,628		927,928

XML

Note 11 - Share Based Compensation (Tables)

12 Months Ended

Jan. 02, 2021

Notes Tables

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

	Number of Time-Based Restricted Stock Awards			Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at December 28, 2019		151,725		$	3.64
Granted		719,805		$	1.88
Vested		(139,225	)	$	3.61
Forfeited or expired		(22,500	)	$	1.55
Outstanding non-vested at January 2, 2021		709,805		$	1.92

	Number of Performance-Based Restricted Stock Awards			Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at December 28, 2019		240,000		$	4.81
Granted		-			-
Vested		(40,000	)	$	4.38
Forfeited or expired		(200,000	)	$	4.89
Outstanding non-vested at January 2, 2021		-			-

	Number of Restricted Stock Awards			Weighted Average Grant Date Fair Value per Share
Outstanding non-vested at December 29, 2018		347,372		$	4.74
Granted – time-based vesting		99,225		$	3.02
Granted – performance-based vesting		167,148		$	4.35
Vested		(130,020	)	$	3.91
Forfeited or expired		(92,000	)	$	4.98
Outstanding non-vested at December 28, 2019		391,725		$	4.36
Granted – time-based vesting		719,805		$	1.88
Granted – performance-based vesting		-			-
Vested		(179,225	)	$	3.78
Forfeited or expired		(222,500	)	$	4.55
Outstanding non-vested at January 2, 2021		709,805		$	1.92

XML

Note 14 - Segment Information (Tables)

12 Months Ended

Jan. 02, 2021

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Fiscal Year Ended January 2, 2021	Engineering			Specialty Health Care			Information Technology			Corporate			Total
Revenue	$	57,715		$	60,481		$	32,213		$	-		$	150,409
Cost of services		41,227			47,116			23,211			-			111,554
Gross profit		16,488			13,365			9,002			-			38,855
Selling, general and administrative		12,931			15,504			9,116			-			37,551
Depreciation and amortization of property and equipment		638			319			108			-			1,065
Amortization of acquired intangible assets		321			-			-			-			321
Write-off of receivables and professional fees incurred related to arbitration		8,397			-			-			-			8,397
Impairment of right of use assets and related costs		-			-			-			2,231			2,231
Tax credit professional fees		-			-			-			240			240
Operating income (loss)	$	(5,799	)	$	(2,458	)	$	(222	)	$	(2,471	)	$	(10,950	)
Total assets as of January 2, 2021	$	33,782		$	19,141		$	7,498		$	7,918		$	68,339
Capital expenditures	$	26		$	36		$	48		$	350		$	460

Fiscal Year Ended December 28, 2019	Engineering		Specialty Health Care		Information Technology		Corporate			Total
Revenue	$	67,873	$	89,348	$	33,879	$	-		$	191,100
Cost of services		49,395		68,464		24,649		-			142,508
Gross profit		18,478		20,884		9,230		-			48,592
Selling, general and administrative		13,648		17,643		9,099		-			40,390
Depreciation and amortization of property and equipment		841		336		84		-			1,261
Amortization of acquired intangible assets		327		-		-		-			327
Tax credit professional fees		-		-		-		47			47
Operating income (loss)	$	3,662	$	2,905	$	47	$	(47	)	$	6,567
Total assets as of December 28, 2019	$	52,342	$	29,781	$	8,178	$	5,872		$	96,173
Capital expenditures	$	82	$	121	$	69	$	95		$	367

Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]

	Fiscal Year Ended
	January 2,		December 28,
	2021		2019
Revenues
United States	$	126,238	$	166,750
Canada		15,310		16,822
Puerto Rico		5,702		4,942
Serbia		3,159		2,586
	$	150,409	$	191,100

Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]

	Fiscal Year Ended
	January 2,		December 28,
	2021		2019
Total Assets
United States	$	56,308	$	82,110
Canada		7,067		9,638
Puerto Rico		1,483		1,103
Serbia		3,481		3,322
	$	68,339	$	96,173

XML

Note 15 - Income Taxes (Tables)

12 Months Ended

Jan. 02, 2021

Notes Tables

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

	January 2, 2021			December 28, 2019
Federal statutory rate		21.0	%		21.0	%
Tax expense on taxable (loss) income at federal statutory rate	$	(2,532	)	$	1,013
State and Puerto Rico income taxes, net of Federal income tax benefit		(535	)		305
Prior year United States R&D tax credits in current year		-			(668	)
Permanent differences		154			77
Foreign income tax rates		(21	)		(101	)
Adjustments to NOL and repatriation taxes		(53	)		154
Other		(201	)		(16	)
Total income tax expense	$	(3,188	)	$	764

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

	Fiscal Years Ended
	January 2, 2021			December 28, 2019
Current
Federal	$	(32	)	$	(688	)
State and local		174			181
Foreign		382			166
		524			(341	)
Deferred
Federal		(2,844	)		892
State		(851	)		229
Foreign		(17	)		(16	)
		(3,755	)		1,105
Total	$	(3,188	)	$	764

	Fiscal Years Ended
	January 2, 2021			December 28, 2019
United States	$	(13,898	)	$	3,626
Foreign jurisdictions		1,841			1,196
	$	12,057	)	$	4,822

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

	January 2, 2021			December 28, 2019
Deferred tax assets:
Allowance for doubtful accounts	$	455		$	432
Federal and state net operating loss carryforward		2,634			330
Reserves and accruals		1,491			255
Other		318			185
Total deferred tax assets		4,898			1,202
Deferred tax liabilities:
Acquisition amortization, net		(716	)		(569	)
Prepaid expense deferral		(602	)		(701	)
Bonus depreciation to be reversed		(280	)		(327	)
Canada deferred tax liability, net		(365	)		(382	)
Total deferred tax liabilities		(1,963	)		(1,979	)
Total deferred tax assets (liabilities), net	$	2,935		$	(777	)

XML

Note 18 - Commitments (Tables)

12 Months Ended

Jan. 02, 2021

Notes Tables

Lease, Cost [Table Text Block]

	Fifty-Three Week Period Ended January 2, 2021		Fifty-Two Week Period Ended December 28, 2019
Operating lease cost	$	2,524	$	2,314
Amortization of right of use assets	$	366	$	305
Interest on lease liabilities		10		8
Total finance lease cost	$	376	$	313

Lease, Cash Flow Information [Table Text Block]

	Fifty-Three Week Period Ended January 2, 2021		Fifty-Two Week Period Ended December 28, 2019
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases	$	2,589	$	2,290
Operating cash flows from finance leases	$	7	$	8
Financing cash flows from finance leases	$	402	$	310
Right of use assets obtained in exchange for lease obligations
Operating leases	$	1,257	$	7,894
Finance leases	$	258	$	126

Lease, Balance Sheet Information [Table Text Block]

	Fifty-Three Week Period Ended January 2, 2021			Fifty-Two Week Period Ended December 28, 2019
Operating leases
Operating lease right of use assets	$	2,409		$	5,820
Operating right of use liability - current	$	(1,886	)	$	(2,134	)
Operating right of use liability - non-current		(2,641	)		(3,921	)
Total operating lease liabilities	$	(4,527	)	$	(6,055	)
Finance leases
Property and equipment - (right of use assets)	$	1,140		$	985
Accumulated depreciation		(746	)		(475	)
Property and equipment, net	$	394		$	510
Other current liabilities	$	(247	)	$	(315	)
Other long term liabilities		(106	)		(189	)
Total finance lease liabilities	$	(353	)	$	(504	)
Weighted average remaining lease term
Operating leases	2.03 Years			2.54 Years
Finance leases	1.45 Years			1.62 Years
Weighted average discount rate
Operating leases		4.06	%		4.11	%
Finance leases		2.63	%		1.78	%

Lease, Liability, Maturity [Table Text Block]

Fiscal Year Ending	Operating Leases			Finance Leases
2021		2,019			255
2022		1,505			109
2023		955			-
2024		232			-
2025		48			-
Thereafter		-			-
Total lease payments		4,759			364
Less: imputed interest		(232	)		(11	)
Total	$	4,527		$	353

XML

Note 1 - Summary of Significant Accounting Policies (Details Textual) $ in Thousands	12 Months Ended
	Jan. 02, 2021 USD ($)	Dec. 28, 2019 USD ($)	Jun. 27, 2020
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 734	$ 1,847
Annual Depreciation Rate	20.00%		20.00%
Number of Reporting Units	3
Goodwill, Impairment Loss	$ 0	0
Capitalized Computer Software, Additions	305	139
Capitalized Computer Software, Net, Ending Balance	1,389	1,726
Deferred Tax Assets, Valuation Allowance, Total	0	0
Revenue from Contract with Customer, Including Assessed Tax	150,409	191,100
Contract with Customer, Liability, Total	400	400
Contract with Customer, Liability, Revenue Recognized	400	200
Accounts Receivable, after Allowance for Credit Loss, Current, Total	36,007	59,760
Advertising Expense	$ 800	$ 855
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | New York City Board of Education [Member]
Concentration Risk, Percentage	10.60%	17.60%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Hawaii Department of Education [Member]
Concentration Risk, Percentage		11.10%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Five Largest Customers [Member]
Concentration Risk, Percentage	33.40%	43.50%
Number of Customers	5	5
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Ten Largest Customers [Member]
Concentration Risk, Percentage	46.60%	57.00%
Number of Customers	10	10
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Twenty Largest Customers [Member]
Concentration Risk, Percentage	60.70%	69.20%
Number of Customers	20	20
Accounts Receivable [Member] | Customer Concentration Risk [Member] | New York City Board of Education [Member]
Concentration Risk, Percentage	11.80%	17.60%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Hawaii Department of Education [Member]
Concentration Risk, Percentage	10.60%	12.70%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | New York Power Authority [Member]
Concentration Risk, Percentage		24.60%
Total Accounts Receivable and Transit Accounts Receivable [Member] | Customer Concentration Risk [Member] | New York Power Authority [Member]
Concentration Risk, Percentage		27.30%
Transit Accounts Payable [Member]
Accounts Payable, Current, Total	$ 4,900	$ 4,600
Accounts Payable, Net	2,400
Transit Accounts Receivable [Member]
Accounts Receivable, before Allowance for Credit Loss, Current	2,500	4,900
Accounts Receivable, after Allowance for Credit Loss, Current, Total		300
Service, Other [Member]
Revenue from Contract with Customer, Including Assessed Tax	$ 1,500	1,800
Restricted Covenants [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	4 years
Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	6 years
CANADA
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 42	56
Revenue from Contract with Customer, Including Assessed Tax	15,310	16,822
SERBIA
Cash and Cash Equivalents, at Carrying Value, Ending Balance	246	129
Revenue from Contract with Customer, Including Assessed Tax	$ 3,159	$ 2,586

XML

Note 1 - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Revenues	$ 150,409	$ 191,100
Engineering Services [Member]
Revenues	57,715	67,873
Engineering Services [Member] | Time-and-materials Contract [Member]
Revenues	43,359	55,195
Engineering Services [Member] | Fixed-price Contract [Member]
Revenues	14,145	12,678
Engineering Services [Member] | Permanent Placement Services [Member]
Revenues	211
Health Care [Member]
Revenues	60,481	89,348
Health Care [Member] | Time-and-materials Contract [Member]
Revenues	59,692	88,057
Health Care [Member] | Permanent Placement Services [Member]
Revenues	789	1,291
Technology Service [Member]
Revenues	32,213	33,879
Technology Service [Member] | Time-and-materials Contract [Member]
Revenues	31,723	33,384
Technology Service [Member] | Permanent Placement Services [Member]
Revenues	$ 490	$ 495

XML

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable (Details Textual) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Apr. 30, 2020	Jan. 02, 2021	Dec. 28, 2019
Accounts Receivable, after Allowance for Credit Loss, Current, Total		$ 36,007	$ 59,760
Loss Contingency, Receivable, Ending Balance		14,100	14,100
Loss Contingency, Estimate of Possible Loss		10,300
Arbitration to Settle Dispute with Major Utility [Member]
Litigation Settlement, Amount Awarded from Other Party	$ 7,400
Litigation Settlement, Expense		8,400
Legal Fees		800
Accounts Receivable, Allowance for Credit Loss, Writeoff		700
Arbitration to Settle Dispute with Major Utility [Member] | Expense Related to Disputed Projects not Awards by Arbitrator [Member]
Litigation Settlement, Expense		6,700
Arbitration to Settle Dispute with Major Utility [Member] | Expense Related to Other Projects not Part of Arbitration [Member]
Litigation Settlement, Expense		700
Arbitration to Settle Dispute with Major Utility [Member] | Expense Related to Disputed Projects Part of Arbitration [Member]
Litigation Settlement, Expense		200
Collectibility of Receivables [Member]
Loss Contingency, Estimate of Possible Loss			10,300
Transit Accounts Payable [Member]
Accounts Payable, Current, Total		4,900	4,600
Accounts Payable, Net		2,400
Transit Accounts Receivable [Member]
Accounts Receivable, before Allowance for Credit Loss, Current		2,500	4,900
Accounts Receivable, after Allowance for Credit Loss, Current, Total			$ 300
Accounts Receivable not Part of Arbitration [Member]
Accounts Receivable, Allowance for Credit Loss, Writeoff		$ 700

XML

Note 4 - Accounts Receivable, Transit Accounts Receivable and Transit Accounts Payable - Accounts Receivable (Details) - USD ($) $ in Thousands	Jan. 02, 2021	Dec. 28, 2019
Allowance for sales discounts and doubtful accounts	$ (1,750)	$ (1,725)
Accounts receivable, net	36,007	59,760
Billed Revenues [Member]
Accounts receivable, current	25,926	29,214
Unbilled Revenues [Member]
Accounts receivable, current	8,219	13,824
Work In Progress [Member]
Accounts receivable, current	3,612	4,352
Accounts Receivable Subject to Arbitration [Member]
Accounts receivable, current		$ 14,095

XML

Note 5 - Property and Equipment (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019	Jun. 27, 2020
Annual Depreciation Rate	20.00%		20.00%
Write Off of Fully Depreciated Property and Equipment	$ 1,529	$ 2,781
Depreciation, Total	$ 1,065	$ 1,261

XML

Note 5 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Jan. 02, 2021	Dec. 28, 2019
Property and equipment	$ 5,185	$ 6,255
Less: accumulated depreciation and amortization	3,107	3,538
Property and equipment, net	2,078	2,717
Equipment and Furniture [Member]
Property and equipment	264	319
Computers and Systems [Member]
Property and equipment	4,686	5,628
Leasehold Improvements [Member]
Property and equipment	$ 236	$ 308

XML

Note 6 - Acquisitions (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	$ 3,100
Payment for Contingent Consideration Liability, Financing Activities	$ 345	$ 598

XML

Note 6 - Acquisitions - Maximum Deferred Consideration Payments (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
January 1, 2022	$ 500
December 31, 2022	2,358
Estimated future contingent consideration payments	2,858
Contingent consideration paid	(345)	$ (598)
Increase to contingent payment estimates		(1,178)
Changes in fair value of contingent payments	145	61
Balance	$ 2,858	$ 3,058

XML

Note 7 - Goodwill (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Goodwill, Impairment Loss	$ 0	$ 0

XML

Note 7 - Goodwill - Changes in Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Balance	$ 16,354	$ 17,532
Adjustment to final TKE purchase price
Balance	16,354	16,354
TKE [Member]
Adjustment to final TKE purchase price		(1,178)
Engineering [Member]
Balance	11,918	13,096
Adjustment to final TKE purchase price
Balance	11,918	11,918
Engineering [Member] | TKE [Member]
Adjustment to final TKE purchase price		(1,178)
Specialty Health Care [Member]
Balance	2,398	2,398
Adjustment to final TKE purchase price
Balance	2,398	2,398
Specialty Health Care [Member] | TKE [Member]
Adjustment to final TKE purchase price
Information Technology [Member]
Balance	2,038	2,038
Adjustment to final TKE purchase price
Balance	$ 2,038	2,038
Information Technology [Member] | TKE [Member]
Adjustment to final TKE purchase price

XML

Note 8 - Intangible Assets (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Impairment of Intangible Assets (Excluding Goodwill), Total	$ 0	$ 0
Amortization of Intangible Assets, Total	$ 321	$ 327

XML

Note 8 - Intangible Assets - Intangible Assets by Class (Details) - USD ($) $ in Thousands	Jan. 02, 2021	Dec. 28, 2019
Intangible assets, net	$ 95	$ 416
Restricted Covenants [Member]
Intangible assets, net	12	28
Customer Relationships [Member]
Intangible assets, net	$ 83	$ 388

XML

Note 9 - Line of Credit (Details Textual) - USD ($) $ in Thousands		12 Months Ended
	Sep. 25, 2020	Jan. 02, 2021	Dec. 28, 2019	Oct. 18, 2019
Repayments of Subordinated Debt, Total		$ 2,230
Long-term Line of Credit, Noncurrent		$ 11,890	$ 34,761
Note Issued to Acquire Treasury Stock [Member]
Repayments of Subordinated Debt, Total	$ 2,200
Citizens Bank of Pennsylvania [Member] | Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity				$ 45,000
Debt Instrument, Interest Rate, Effective Percentage		2.70%	4.40%
Long-term Line of Credit, Noncurrent		$ 11,900	$ 34,800
Letters of Credit Outstanding, Amount		1,900	$ 1,600
Line of Credit Facility, Remaining Borrowing Capacity		$ 31,200

XML

Note 10 - Per Share Data (Details Textual) - shares		12 Months Ended
	Jan. 02, 2021	Jan. 02, 2021	Dec. 28, 2019
Dilutive Securities Not Included In The Calculation Of Weighted Average Diluted Shares (in shares)	46,873
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)		0	0

XML

Note 10 - Per Share Data - Weighted Average Number of Common Shares (Details) - shares	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Basic weighted average shares outstanding (in shares)	12,152,042	12,913,912
Dilutive effect of outstanding restricted share awards (in shares)		58,241
Weighted average dilutive shares outstanding (in shares)	12,152,042	12,972,153

XML

Note 10 - Per Share Data - Unissued Shares of Common Stock Were Reserved for the Following Purposes (Details) - shares	Jan. 02, 2021	Dec. 28, 2019
Future grants of options or shares (in shares)	520,929	268,326
Shares reserved for employee stock purchase plan (in shares)	149,894	267,877
Total (in shares)	1,380,628	927,928
Time-based Restricted Stock Units [Member]
Restricted stock units outstanding (in shares)	459,805	151,725
Unvested Subscription Restricted Share Awards [Member]
Restricted stock units outstanding (in shares)	250,000
Performance-based Restricted Stock Units [Member]
Restricted stock units outstanding (in shares)		240,000

XML

Note 11 - Share Based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	12 Months Ended
	Dec. 31, 2020	Jan. 03, 2021	Jan. 02, 2021	Dec. 31, 2020	Dec. 28, 2019	Dec. 29, 2018	Dec. 31, 2016	Dec. 27, 2015	Sep. 26, 2020	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)			10 years
Share-based Payment Arrangement, Expense			$ 1,109		$ 806
Common Stock, Capital Shares Reserved for Future Issuance (in shares)			1,380,628		927,928
Share Price (in dollars per share)	$ 2.07			$ 2.07
Performance-based Restricted Stock Units [Member]
Share-based Payment Arrangement, Expense					$ 228
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)					167,148
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)					$ 4.35
Time-based Restricted Stock Units [Member]
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total			$ 1,100
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)			2 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)			719,805		99,225
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)			$ 1.88		$ 3.02
Time-based Restricted Stock Units [Member] | Immediately Vested [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)				100,092
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)				$ 1.33
Time-based Restricted Stock Units [Member] | Senior Management [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	250,000
The 2014 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)							1,975,000			625,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized (in shares)		850,000					500,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)			520,929
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value			$ 1,500		$ 1,100
The 2014 Plan [Member] | Performance-based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)			0		240,000				0
Dividends Payable			$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)
The 2014 Plan [Member] | Time-based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)			709,805		151,725
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total			$ 1,100
Dividends Payable			0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested			$ 1,500
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)			719,805
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)			$ 1.88
Employee Stock Purchase Plan [Member]
Share-based Payment Arrangement, Expense			$ 44		$ 91
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)			149,894
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date			85.00%
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate			10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee (in shares)			3,000
Additional Shares of Common Stock Reserved for Future Issuance (in shares)						300,000		300,000
Common Stock, Capital Shares Reserved for Future Issuance (in shares)						1,400,000		1,100,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans (in shares)			117,983		118,526
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised, Total			$ 208		$ 321
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)			1 year
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)			3 years

XML

Note 11 - Share Based Compensation - Restricted Stock Units Activity (Details) - $ / shares	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Time-based Restricted Stock Units [Member]
Granted (in shares)	719,805	99,225
Granted, weighted average grant date fair value (in dollars per share)	$ 1.88	$ 3.02
Time-based Restricted Stock Units [Member] | The 2014 Plan [Member]
Outstanding non-vested (in shares)	151,725
Outstanding non-vested, weighted average grant date fair value (in dollars per share)	$ 3.64
Granted (in shares)	719,805
Granted, weighted average grant date fair value (in dollars per share)	$ 1.88
Vested (in shares)	(139,225)
Vested, weighted average grant date fair value (in dollars per share)	$ 3.61
Forfeited or expired (in shares)	(22,500)
Forfeited or expired, weighted average grant date fair value (in dollars per share)	$ 1.55
Outstanding non-vested (in shares)	709,805	151,725
Outstanding non-vested, weighted average grant date fair value (in dollars per share)	$ 1.92	$ 3.64
Performance-based Restricted Stock Units [Member]
Granted (in shares)		167,148
Granted, weighted average grant date fair value (in dollars per share)		$ 4.35
Performance-based Restricted Stock Units [Member] | The 2014 Plan [Member]
Outstanding non-vested (in shares)	240,000
Outstanding non-vested, weighted average grant date fair value (in dollars per share)	$ 4.81
Granted (in shares)
Granted, weighted average grant date fair value (in dollars per share)
Vested (in shares)	(40,000)
Vested, weighted average grant date fair value (in dollars per share)	$ 4.38
Forfeited or expired (in shares)	(200,000)
Forfeited or expired, weighted average grant date fair value (in dollars per share)	$ 4.89
Outstanding non-vested (in shares)	0	240,000
Outstanding non-vested, weighted average grant date fair value (in dollars per share)		$ 4.81
Restricted Stock Units (RSUs) [Member]
Outstanding non-vested (in shares)	391,725	347,372
Outstanding non-vested, weighted average grant date fair value (in dollars per share)	$ 4.36	$ 4.74
Vested (in shares)	(179,225)	(130,020)
Vested, weighted average grant date fair value (in dollars per share)	$ 3.78	$ 3.91
Forfeited or expired (in shares)	(222,500)	(92,000)
Forfeited or expired, weighted average grant date fair value (in dollars per share)	$ 4.55	$ 4.98
Outstanding non-vested (in shares)	709,805	391,725
Outstanding non-vested, weighted average grant date fair value (in dollars per share)	$ 1.92	$ 4.36

XML

Note 12 - Treasury Stock Transactions (Details Textual) - USD ($) $ / shares in Units, $ in Thousands			12 Months Ended
	Sep. 25, 2020	Jun. 02, 2020	Jan. 02, 2021	Dec. 28, 2019	Jan. 13, 2021
Treasury Stock, Shares, Acquired (in shares)		1,858,139
Treasury Stock Acquired, Average Cost Per Share (in dollars per share)		$ 1.20
Treasury Stock, Value, Acquired, Cost Method		$ 2,200	$ 2,230
Repayments of Subordinated Debt, Total			$ 2,230
Subsequent Event [Member] | Maximum [Member]
Stock Repurchase Program, Authorized Amount					$ 7,500
Note Issued to Acquire Treasury Stock [Member]
Notes Issued		$ 2,200
Debt Instrument, Interest Rate, Stated Percentage		9.00%
Repayments of Subordinated Debt, Total	$ 2,200
Debt Instrument, Maturity Date		Aug. 10, 2023

XML

Note 14 - Segment Information - Results of the Segments (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Revenues	$ 150,409	$ 191,100
Cost of services	111,554	142,508
Gross profit	38,855	48,592
Selling, general and administrative	37,551	40,390
Depreciation and amortization of property and equipment	1,065	1,261
Amortization of acquired intangible assets	321	327
Write-off of receivables and professional fees incurred related to arbitration	8,397
Impairment of right of use assets and related costs	2,231
Tax credit professional fees	240	47
Operating income (loss)	(10,950)	6,567
Total assets	68,339	96,173
Capital expenditures	460	367
Engineering [Member]
Revenues	57,715	67,873
Cost of services	41,227	49,395
Gross profit	16,488	18,478
Selling, general and administrative	12,931	13,648
Depreciation and amortization of property and equipment	638	841
Amortization of acquired intangible assets	321	327
Write-off of receivables and professional fees incurred related to arbitration	8,397
Impairment of right of use assets and related costs
Tax credit professional fees
Operating income (loss)	(5,799)	3,662
Total assets	33,782	52,342
Capital expenditures	26	82
Specialty Health Care [Member]
Revenues	60,481	89,348
Cost of services	47,116	68,464
Gross profit	13,365	20,884
Selling, general and administrative	15,504	17,643
Depreciation and amortization of property and equipment	319	336
Amortization of acquired intangible assets
Write-off of receivables and professional fees incurred related to arbitration
Impairment of right of use assets and related costs
Tax credit professional fees
Operating income (loss)	(2,458)	2,905
Total assets	19,141	29,781
Capital expenditures	36	121
Information Technology [Member]
Revenues	32,213	33,879
Cost of services	23,211	24,649
Gross profit	9,002	9,230
Selling, general and administrative	9,116	9,099
Depreciation and amortization of property and equipment	108	84
Amortization of acquired intangible assets
Write-off of receivables and professional fees incurred related to arbitration
Impairment of right of use assets and related costs
Tax credit professional fees
Operating income (loss)	(222)	47
Total assets	7,498	8,178
Capital expenditures	48	69
Corporate Segment [Member]
Revenues
Cost of services
Gross profit
Selling, general and administrative
Depreciation and amortization of property and equipment
Amortization of acquired intangible assets
Write-off of receivables and professional fees incurred related to arbitration
Impairment of right of use assets and related costs	2,231
Tax credit professional fees	240	47
Operating income (loss)	(2,471)	(47)
Total assets	7,918	5,872
Capital expenditures	$ 350	$ 95

XML

Note 14 - Segment Information - Revenues by Geographic Area (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Revenues	$ 150,409	$ 191,100
UNITED STATES
Revenues	126,238	166,750
CANADA
Revenues	15,310	16,822
PUERTO RICO
Revenues	5,702	4,942
SERBIA
Revenues	$ 3,159	$ 2,586

XML

Note 14 - Segment Information - Total Assets by Geographic Area (Details) - USD ($) $ in Thousands	Jan. 02, 2021	Dec. 28, 2019
Total assets	$ 68,339	$ 96,173
UNITED STATES
Total assets	56,308	82,110
CANADA
Total assets	7,067	9,638
PUERTO RICO
Total assets	1,483	1,103
SERBIA
Total assets	$ 3,481	$ 3,322

XML

Note 15 - Income Taxes (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Effective Income Tax Rate Reconciliation, Percent, Total	26.40%	15.80%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%	21.00%
Income Tax Expense (Benefit), Total	$ (3,188)	$ 764
Effective Income Tax Rate Reconciliation, Tax Credit, Amount, Total		668
Effective Income Tax Rate Reconciliation, NOL Adjustments and Repatriation Taxes, Amount	(53)	$ 154
Domestic Tax Authority [Member]
Operating Loss Carryforwards, Total	8,400
State and Local Jurisdiction [Member]
Operating Loss Carryforwards, Total	$ 13,600
State and Local Jurisdiction [Member] | New Jersey Division of Taxation [Member]
Income Tax Examination, Year under Examination	2009 2010 2011 2012

XML

Note 15 - Income Taxes - Income Tax Provision Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Federal statutory rate	21.00%	21.00%
Tax expense on taxable (loss) income at federal statutory rate	$ (2,532)	$ 1,013
State and Puerto Rico income taxes, net of Federal income tax benefit	(535)	305
Prior year United States R&D tax credits in current year		(668)
Permanent differences	154	77
Foreign income tax rates	(21)	(101)
Adjustments to NOL and repatriation taxes	(53)	154
Other	(201)	(16)
Total income tax expense	$ (3,188)	$ 764

XML

Note 15 - Income Taxes - Components of Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Current
Federal	$ (32)	$ (688)
State and local	174	181
Foreign	382	166
Current Income Tax Expense (Benefit), Total	524	(341)
Deferred
Federal	(2,844)	892
State	(851)	229
Foreign	(17)	(16)
Deferred Income Tax Expense (Benefit), Total	(3,755)	1,105
Total income tax expense	(3,188)	764
United States	(13,898)	3,626
Foreign jurisdictions	1,841	1,196
(Loss) income before income taxes	$ (12,057)	$ 4,822

XML

Note 15 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Jan. 02, 2021	Dec. 29, 2019
Deferred tax assets:
Allowance for doubtful accounts	$ 455	$ 432
Federal and state net operating loss carryforward	2,634	330
Reserves and accruals	1,491	255
Other	318	185
Total deferred tax assets	4,898	1,202
Deferred tax liabilities:
Acquisition amortization, net	(716)	(569)
Prepaid expense deferral	(602)	(701)
Bonus depreciation to be reversed	(280)	(327)
Canada deferred tax liability, net	(365)	(382)
Total deferred tax liabilities	(1,963)	(1,979)
Total deferred tax assets, net	$ 2,935
Total deferred tax liability, net		$ (777)

XML

Note 16 - Contingencies (Details Textual) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Apr. 30, 2020	Jan. 02, 2021	Dec. 28, 2019
Loss Contingency, Receivable, Ending Balance		$ 14.1	$ 14.1
Loss Contingency, Estimate of Possible Loss		10.3
Class Action Suit for Unpaid Overtime Wages to Travel Nurses [Member]
Estimated Litigation Liability		1.7
Arbitration to Settle Dispute with Major Utility [Member]
Litigation Settlement, Amount Awarded from Other Party	$ 7.4
Litigation Settlement, Expense		8.4
Legal Fees		0.8
Accounts Receivable, Allowance for Credit Loss, Writeoff		0.7
Arbitration to Settle Dispute with Major Utility [Member] | Expense Related to Disputed Projects not Awards by Arbitrator [Member]
Litigation Settlement, Expense		6.7
Arbitration to Settle Dispute with Major Utility [Member] | Expense Related to Other Projects not Part of Arbitration [Member]
Litigation Settlement, Expense		0.7
Arbitration to Settle Dispute with Major Utility [Member] | Expense Related to Disputed Projects Part of Arbitration [Member]
Litigation Settlement, Expense		$ 0.2

XML

Note 17 - Retirement Plans (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Deferred Compensation Arrangement with Individual, Contributions by Employer	$ 217	$ 296

XML

Note 18 - Commitments (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019	Dec. 30, 2018
Operating Lease, Impairment Loss	$ 2,231
Operating Lease, Right-of-Use Asset	2,409	5,820
Operating Lease, Liability, Total	4,527	$ 6,055
Accounting Standards Update 2016-02 [Member]
Operating Lease, Right-of-Use Asset			$ 3,900
Operating Lease, Liability, Total			$ 4,100
COVID-19 [Member]
Operating Lease, Impairment Loss	1,900
Write off Lease Cost and Obsolete Equipment	$ 300

XML

Note 18 - Commitments - Lease Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Operating lease cost	$ 2,524	$ 2,314
Amortization of right of use assets	366	305
Finance lease cost, Interest on lease liabilities	10	8
Total finance lease cost	$ 376	$ 313

XML

Note 18 - Commitments - Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019
Operating cash flows from operating leases	$ 2,589	$ 2,290
Operating cash flows from finance leases	7	8
Financing cash flows from finance leases	402	310
Operating leases	1,257	7,894
Finance leases	$ 258	$ 126

XML

Note 18 - Commitments - Balance Sheet Information (Details) - USD ($) $ in Thousands	Jan. 02, 2021	Dec. 28, 2019
Operating lease right of use assets	$ 2,409	$ 5,820
Operating right of use liability - current	(1,886)	(2,134)
Operating right of use liability - non-current	(2,641)	(3,921)
Total operating lease liabilities, 2021	(4,527)	(6,055)
Property and equipment - (right of use assets)	1,140	985
Accumulated depreciation	(746)	(475)
Property and equipment, net	394	510
Other current liabilities	(247)	(315)
Other long term liabilities	(106)	(189)
Total finance lease liabilities	$ (353)	$ (504)
Operating leases (Year)	2 years 10 days	2 years 197 days
Finance leases (Year)	1 year 164 days	1 year 226 days
Operating leases	4.06%	4.11%
Finance leases	2.63%	1.78%

XML

Note 18 - Commitments - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Jan. 02, 2021	Dec. 28, 2019
2021, operating leases	$ 2,019
2021, finance leases	255
2022, operating leases	1,505
2022, finance leases	109
2023, operating leases	955
2023, finance leases
2024, operating leases	232
2024, finance leases
2025, operating leases	48
2025, finance leases
Thereafter, operating leases
Thereafter, finance leases
Total lease payments, operating leases	4,759
Total lease payments, finance leases	364
Less: imputed interest, operating leases	(232)
Less: imputed interest, finance leases	(11)
Total, operating leases	4,527	$ 6,055
Total, finance leases	$ 353	$ 504

XML

Note 20 - Stockholder Rights Plan (Details Textual) - $ / shares	Jan. 02, 2021	May 22, 2020	Dec. 28, 2019
Number of Units Called by Each Right (in shares)		0.01
Preferred Stock, Shares Authorized (in shares)	5,000,000		5,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 1		$ 1
Preferred Stock, Shares Issued, Total (in shares)	0		0
Minimum Percent of Common Stock to be Purchased for Rights to Become Exercisable		10.00%
Preferred Stock, Shares Outstanding, Ending Balance (in shares)	0		0
Series A-3 Junior Participating Preferred Shares [Member]
Preferred Stock, Shares Authorized (in shares)		250,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)		$ 1
Preferred Stock, Shares Issued, Total (in shares)		0
Preferred Stock, Redemption Price Per Share (in dollars per share)		$ 50
Preferred Stock, Redemption Price Multiplier		100
Preferred Stock, Shares Outstanding, Ending Balance (in shares)		0
Series A-3 Junior Participating Preferred Shares [Member] | Voluntary or Involuntary Liquidation, Dissolution or Winding up of the Company [Member]
Preferred Stock, Redemption Price Per Share (in dollars per share)		$ 100
Preferred Stock, Redemption Price Multiplier		100
Series A-3 Junior Participating Preferred Shares [Member] | Consolidation, Merger, Combination or Other Transaction in which Shares of Common Stock are Exchanged [Member]
Preferred Stock, Redemption Price Multiplier		100
Right [Member]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)		1
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 5.60
Class of Warrant or Right, Price Per Right (in dollars per share)		$ 0.001